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INTRODUCTION

This progress report from the Biomedical Computer Laboratory (BCL)
summarizes activities during the period from July 1, 1983 through June 30,
1984. The Biomedical Computer Laboratory collaborates with research
investigators throughout the Washington University School of Medicine and
its affiliated hospitals in the application of advanced computer techniques
to problems in biology and medicine. This often requires work in areas
stretching from basic physiology through mathematical models to equipment
design. Our orientation is interdisciplinary with the recognition that
effective communication for workers with differing backgrounds comes only
through extended collaboration and mutual respect.
The vigorous development and evolution of specialized computer
systems for use in the solution of research and clinical problems has
continued to be the central focus of BCL activities. Several systems now
in clinical use have seen a progression from exploratory pilot studies, to
major developmental project, to local clinical trial, to clinical trials in
multiple locations, to public availability through commercial manufacture.
Perseverance in this sometimes tedious chain of development has found
reward in the effective fielding of specialized computer systems to the
medical community.
One class of computer applications requires strong coupling of the
computer to its environment for digital signal processing. These
applications typically involve the use of commercially available
minicomputers and microprocessors in conjunct+on with specialized hardware
designed and built locally. We have pursued many such applications by
bringing signals from hospital wards and research laboratories to BCL by
means of either analog or digital tape recordings or telephone lines and,
more frequently, by taking the computers to the investigator's laboratory
or the patient's bedside. In this context, of particular importance to
current and future BCL projects is the development, in a closely related
sister lab (Computer Systems Laboratory, or CSL), of a capability for the
design and fabrication of custom very-Iarge-scale integrated (VLSI)
circuits. The realization of such circuits through collaboration with CSL
is already opening up new opportunities for solving problems intractable
with conventional computing devices.
For those classes of applications dominated by information
processing requirements, provisions have matured from telephone lines
linking our minicomputers to the IBM System/370 at the Washington
University Computing Facilities, through development and support of a
minicomputer based MUMPS system, to the establishment of independent groups
such as the Medical Computing Facility and the Medical Computing Service
Group which serve the local medical complex. Diverse needs continue to be
met by these various options while collaborative work continues on more
advanced information-processing developments.

t

Still another class of applications requires extensive use of large
scale computational services. Many investigators are assisted in their
research through the use of generalized numerical, non-numerical, and
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statistical routines. This work is carried out in part by staff members of
BCL, but primarily by members of the Division of Biostatistics and under
direction of Dr. Dabeeru C. Rao, and the University Computing Facilities
whose director is Robert J. Benson.
The BCL enjoys collaboration with most departmental divisions within
the medical school but also finds support and enrichment through close ties
with other facilities throughout the University. These arrangements are of
benefit both to the BCL and to graduate students who find projects and
employment among the activities in the laboratory. The Department of
Computer Science is under the direction of Dr. Jerome R. Cox, Jr., past
Director of the BCL.
Close collaboration with the department has
emphasized the area of information systems. Strong ties with the
Department of Electrical Engineering are sustained through the Engineering
School's Biomedical Engineering Program and common interest in digital
signal processing techniques. The Department of Electrical Engineering is
chaired by Dr. Donald L. Snyder, past Associate Director of BCL.
A major development completed during the past year has been the
establishment at Washington University of an interschool Institute for
Biomedical Computing. The new Institute encompasses the Biomedical
Computer Laboratory and the Computer Systems Laboratory in an
organizational setting designed to recognize and foster the joint interests
in biomedical computing of the School of Medicine and the School of
Engineering and Applied Science. The purpose of the reorganization is to
recognize that the development and application of advanced computing and
engineering technology to problems in biomedical science are essential
components of the research and teaching activities of Washington
University. Accordingly, attention has been given to the development of a
stable organizational structure that will 1) provide a means by which the
primary academic affiliations of its faculty can be in an organizational
setting with an adequately broad commitment to research and teaching in
biomedical computing; 2) establish a formal administrative connection to
the School of Engineering and Applied Science that will facilitate the
involvement of its students and faculty in research and instructional
activities in biomedical computing; 3) establish mechanisms for
adminstration, funding, and review of appointments, promotion, and tenure
for the academic staff of this activity; 4) foster organizational and
procedural coherence between the Biomedical Computer Laboratory and the
Computer Systems Laboratory by placing them within a common administrative
structure; 5) create a focal point for interdisciplinary teaching and
student research, both in the School of Medicine and the School of
Engineering and Applied Science, in areas that do not fit comfortably into
existing departments; and 6) encourage a scholarly environment for the
activities of the two computer laboratories that will promote and encourage
teaching, research, and publication as vehicles for personal development
and academic contribution.
In addition to current BCL and CSL space on the Medical School
campus, space for part of the activities of the Institute has been provided
on the Engineering School campus by completion of a fifth-floor addition to
Lopata Hall in December of 1983. This new space (about 6000 square feet),
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called the Edward L. Bowles Laboratory, is immediately adjacent to the
Departments of Computer Science and Electrical Engineering.
The Institute for Biomedical Computing (IBC) now replaces the former
Washington University Computer Laboratories (WUCL) which was a less formal
federation of BCL and CSL plus working groups within the Departments of
Computer Science and Electrical Engineering. Dr. Charles E. Molnar,
Director of the Computer Systems Laboratory, and Dr. Lewis J. Thomas, Jr.,
Director of the Biomedical Computer Laboratory, have been appointed as
respective Director and Associate Director of the Institute. Both BCL and
CSL continue to retain their identities and internal organizations.
Accordingly, this Progress Report addresses activities centered primarily
within BCL.
Planning and policy development of the Institute are overseen by a
Governing Board, the membership of which is drawn from both Schools. The
present composition of the Governing Board is:
J.
R.
M.
D.
E.
J.
C.
P.
D.
L.

R. Cox, Jr., Chairman, Department of Computer Science
G. Evens, Head, Department of Radiology
K. King, Dean, School of Medicine
M. Kipnis, Chairman, Department of Internal Medicine
L. MacCordy, Associate Vice-Chancellor for Research
M. McKelvey, Dean, School of Engineering and Applied Science
E. Molnar, Director, Computer Systems Laboratory
Needleman, Head, Department of Pharmacology
L. Snyder, Chairman, Department of Electrical Engineering
J. Thomas, Jr., Pirector, Biomedical Computer Laboratory

To aid in long-range planning of the health-related activities of
the Institute, a National Advisory Panel is convened periodically.
Particular attention is given to the confluence of important needs in
biology and medicine with the technical advances capable of meeting these
needs. Successful development may suggest implementation on a larger,
perhaps national scale. The present composition of the National Advisory
Panel is:
P. H. Abbrecht, Professor of Physiology and Internal Medicine,
Uniform Services University of the Health Sciences, Bethesda,
Maryland
H. L. Bleich, Associate Professor of Medicine, Harvard University
W. A. Clark, Consultant and former Director of CSL, New York,
New York
J. N. Gray, Tandem Computer Company, Cupertino, California
F. E. Heart, Bolt, Beranek & Newman, Cambridge, Massachusetts
D. M. Kipnis, Professor and Chairman, Department of Internal
Medicine, Washington University
B. W. Matthews, Professor of Physics and Director of the Institute
of Molecular Biology, University of Oregon

J. M. Smith, Computer Corporation of America, Cambridge,
Massachusetts
E. A. Stead, Jr., Professor of Medicine, Duke University
C. Vallbona, Professor and Chairman, Department of Community
Medicine, Baylor College of Medicine

I
I
I

I
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II.

SOURCES OF SUPPORT

During the period covered by this report the primary source of
support for the Biomedical Computer Laboratory was from two grants from the
National Institutes of Health, Division of Research Resources.
RR 01380
RR 01362

A Resource for Biomedical Computing.
Tissue Characterization via Ultrasonic Imaging.

NHLBI contract N01 HV 72941 continues to fund a Holter Monitoring
Core Laboratory to support a Multicenter Investigation of Limitation of
Infarct Size.
NCHSR grant HS 03792, to develop a medical information systems
design methodology, continues to support the research in the Computer
Science Department and this Laboratory.
Collaboration with other investigators often involved work already
supported by other grants.
Public Health Services Grant.
AM 07296

Cell Biological Approaches to Diabetes Research,

AM 20579

Diabetes Research and Training Center,

EY 03703

Chromatic Static Perimetry in the Diagnosis of
Glaucoma,

GM 07564

Analytical and Computational Methods in Physiology,

GM 27889

Yeast TRNA Genes,

GM 28232

Physical Mapping of Yeast Chromosomal DNA,

HL 12839

Erythrocyte Deformability and Vascular Pathophysiology,

HL 13851

Cyclotron Produced Isotopes in Biology and Medicine,

HL 17646

Study of Ischemic Heart Disease,

HL 25430

Characterization of Left Ventricular Diastolic
Function,

HL 25944

Time-of-Flight Positron Tomography for Cardiac Imaging,

HL 28995

Adrenergic Factors and Arrhythmogenic Metabolites,

HL 28998

Tissue Characterization with Ultrasound,

HL 29229

Familial Hypercholesterolemia in Cultured Cells,
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NS 06833

An Interdisciplinary Stroke Program,

NS 14834

Mechanisms of Seizures and Anticonvulsant Drugs,

NS 15070

Regeneration and Functional Recovery in Cerebral
Cortex,

RR 01379

Research in VLSI Systems for Biomedical Applications,

RR 01828

A New Approach to Fast Gamma-Radiation Detection.
National Science Foundation Grant.

ECS-82-15181 Study of Time-of-Flight Tomography.
Research support was also received from the following industrial
collaborators.
Biosensor Corporation, Brooklyn Center, Minnesota,
Computer Services Corporation (CSK), Tokyo, Japan,
Mead Johnson, Evansville, Indiana.
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III.

PERSONNEL

EMPLOYEES
Personnel employed by the Biomedical Computer Laboratory during the
period covered by this report were:
Director
Lewis J. Thomas, Jr., M.D., and Associate Director of Institute for
Biomedical Computing, and Associate Professor of Anesthesiology,
Physiology and Biophysics, Biomedical Engineering, and Electrical
Engineering
Associate Director
G. James Blaine III, D.Sc., and Affiliate Associate Professor
of Electrical Engineering and Computer Science, and Senior
Research Associate, Computer Systems Laboratory
Senior Research Associates
Jerome R. Cox, Jr., Sc.D., and Chairman and Professor of Computer
Science, and Professor of Electrical Engineering, and Senior
Research Associate, Computer Systems Laboratory
Harold W. Shipton, C.Eng., and Chairman and Professor of Biomedical
Engineering
Donald L. Snyder, Ph.D., and Chairman and Professor of Electrical
Engineering, and Senior Research Associate, Computer Systems
Laboratory
Business Manager
Virginia M. Bixon, B.S.
Research Associates
Robert J. Arnzen, Ph.D., and Computer Systems Laboratory
R. Martin Arthur, Ph.D., and Associate Professor of Electrical
Engineering
Kenneth W. Clark, M.S.
James G. Dunham, Ph.D., and Associate Professor of Electrical
Engineering
Robert O. Gregory, D.Sc., and Professor of Electrical Engineering
Kenneth B. Larson, Ph.D.
James G. Miller, Ph.D., and Professor of Physics, and Associate
Director for Biomedical Physics, Laboratory for Ultrasonics,
and Research Associate Professor of Medicine
Michael I. Miller, Ph.D., Assistant Professor of Electrical
Engineering
Frederick U. Rosenberger, D.Sc., and Associate Director, Computer
Systems Laboratory, and Assistant Professor of Electrical
Engineering
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Research Assistants
David E. Beecher, M.S., Lecturer in Computer Science
Steven R. Broadstone, B.A., B.S.
John C. Chabut, B.S., B.A.
John D. Gorman, B.S.
Russell E. Hermes, M.S.
Timothy J. Holmes, M.S.
Patrick H. Johnston, M.A.
Joanne Markham, M.S., Research Instructor in Medicine
Charles N. Mead, M.D.
J. Philip Miller, A.B., and Associate Professor of Biostatistics
in Preventive Medicine
Stephen M. Moore, M.S.
Jack G. Mottley, M.A.
John M. Ollinger, M.S.
David G. Politte, M.S.
Kenneth B. Schechtman, Ph.D., Instructor in Biostatistics in
Preventive Medicine, and Research Instructor in Medicine
Chung-Dak Shum, M.S.
Engineering Assistant
Stanley R. Phillips, A.A.S.
Technical Assistants
Kristin K. Foss, B.S.
Kathleen A. Madden, B.A.
Melissa Marlo McLear, A.B.
Alexander w. Stangl
Donald w. Stein, Jr.
Electronic Technicians
Michael J. Rainey
Deborah A. Schwab
Librarian
Monica

w.

I

I
I

I
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Shieh, M.L.S.

Secretaries
Rebecca J. Bozesky
Shirley A. Gonzalez-Rubio
Polly E. Raith
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The following members from other departments and divisions have
joint appointments with the Biomedical Computer Laboratory to facilitate
collaboration and enhance interdisciplinary research:
H. Dieter Ambos, Research Assistant Professor of Medicine
(Cardiology)
A. Maynard Engebretson, D.Sc., Assistant Director of Research in
Engineering, Central Institute for the Deaf, and Affiliate
Associate Professor of Computer Science
William M. Hart, Jr., M.D., Ph.D., Associate Professor of
Ophthalmology
Rexford L. Hill, III, M.S., Associate Professor of Computer
Applications in Radiology
J. Stevadson Massey, M.S., Research Assistant in Neurological
Surgery
John W. Wong, Ph.D., Assistant Professor of Radiation Physics
in Radiology
In addition, the following people worked at the laboratory for
brief periods:
George L. Engel, B.A., B.S.
Abdelkader Gacem
Sudjiwo Husodo
Rosalie J. Paisley, M.S.
David F. Sandel, B.S.
RESEARCH COLLABORATORS
During the period covered by this report the following investigators
from other laboratories, departments, or institutions, collaborated with
BCL staff members on problems of joint interest.
D.
J.
G.
H.
T.
W.
B.
R.
S.
D.
W~

S.
T.
M.
T.
K.
P.
J.
P.
M.

R. Abendschein, Ph.D., Medicine
Achtenberg, A.B., Medical Computing Service
G. Ahumada, M.D., Medicine
D. Ambos, Medicine
R. Baird, Medicine
E. Ball, D.Sc., Computer Science
Becker, M.D., Ophthalmology
J. Benson, J.D., Computing Facilities
R. Bergmann, Ph.D., Medicine
R. Biello, M.D. Radiology
R. Bosch, M.S., Computer Systems Laboratory
R. Broadstone, B.A., B.S., Electrical Engineering
L. Buettner, Medicine
E. Cain, M.D., Medicine
J. Chaney, M.S., Computer Systems Laboratory
C. Chang, Ph.D., Pathology
A. Cole, B.S., Pathology
D. Collins, B.S., Computer Systems Laboratory
B. Corr, Ph.D., Medicine and Pharmacology
R. Courtois, M.A., Medicine
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R.
J.
J.
P.
S.
B.
R.
D.
L.
K.
P.
M.
M.
E~

R.
E.

w.
R.
S.
M.
A~

E.
R.
W.
K.
H.
P.
G.
J.
B.
S.
A.
G.
E.
R.
M.
E~

R.
S~

J.
A.
P.
J.
F~

B.
P~

P.
E~
J~

J.
J.
T~
M~

D. Edelman, B.S., Computer Systems Laboratory
O. Eichling, Ph.D., Radiology
D. Eisenberg, M.D., Medicine
R. Eisenberg, M.D., Medicine
E. Elnahas, M.S., Electrical Engineering
Emami, M.D., Radiology
G. Evens, M.D., Radiology
C. Ficke, B.S., Radiology
Fields, M.D. Medicine
A. A. Fox, M.B., Ch.,B., Medicine
T. Fox, M.D., Neurology and Radiology
S. Frank, M.D., Genetics
H~ Gado, M.D. Radiology
D. Galie, R.N., Medicine
A. Gardner, Ph.D., Mechanical Engineering
M. Geltman, M.D., Medicine
D~ Gillette, Ph.D., Computer Sciences
M~ Glueck, M.D., Medicine
Goldring, M.D., Neurological Surgery
E. Gordon, Ph.D., Ophthalmology
M. Grace, Medicine
M. Gregorie, M.D., Neurological Surgery
L. Grubb, Jr., M.D., Neurological Surgery
M. Hart, Jr., M.D., Ph.D., Ophthalmology
H. Haserodt, M.S., Computer Science
Hashimoto, M.D., Medicine
Herscovitch, M.D., Neurology and Radiology
R. Hoffman, B.A., Radiology
T. Hood, B.S., Radiology
Hughes, Ph.D., Medicine
Igielnik, Ph.D., Medical Computing Facilities
S. Jaffe, M.D., Medicine
C. Johns, B.S., Computer Systems Laboratory
G. Jones, M.D., Ph.D., Anatomy
G. Jost, M.D., Radiology
A. Kass, M.D., Ophthalmology
W~ Kiebler, M.S., Computer Systems Laboratory
M. Knabbe, Ph.D., Medicine
J. Kovacks, Jr., M.D., Ph.D., Medicine
B. Kramer, M.D., Medicine and Surgery
Kumar, B. Tech., Radiology
B. Kurnik, M.D., Medicine
L. Lauter, Ph.D., Central Institute for the Deaf
Lifshits, Medicine
D. Lindsay, M.D., Medicine
Lombardo, B.A., Neurological Surgery
A. LUdbrook, M.D., Medicine
T. Macke, M.S., Computer Systems Laboratory
S. Marvel, B.S., Pathology
W. Matthews, D.Sc., Computer Systems Laboratory
M~ McAninch, Medicine
R. Miller, Radiology
A. Mintun, M.D., Neurology
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C.
R.
S.
H.
M~
R~
D~

C.
J~
D~

W.
J.
J.
M.
D.
C.
A.
J~

M.
B.
B.
J.
A.
S.
A.
M~

W~
A~

R.
A.
D.
M~

M.
R~

J.
F~

K.
J.
A.
J.

E. Molnar, SC.D., Computer Systems Laboratory
A. Moses, M.D., Ophthalmology
R. Mumm, Medicine
Nomura, M.D., Medicine
V. Olson, Ph.D., Genetics
E. Ostlund, Jr., M.D., Medicine
S. Payne, Medicine
A~ Perez, M.D., Radiology
E~ Perez, M.D., Medicine
G. Politte, M.S., Radiology
J. Powers, M.D., Neurology and Radiology
L. Price, Ph.D., Anatomy
A. Purdy, Ph.D., Radiology
E. Raichle, M.D., Neurology and Radiology
C. Rao, Ph.D., Biostatistics
S. Ritter, Medicine
P~ Rueter, B.S., Radiology
E. Saffitz, M.D., Pathology
L. Sieger, B.S., Electrical Engineering
A~ Siegel, M.D., Radiology
E. Sobel, M.D., Medicine
J. Spadero, Jr., M.D., Medicine
W. Strauss, M.D., Biochemistry
P. Sutera, Ph.D., Mechanical Engineering
G. Swift, B.A., Radiology
M. Ter-Pogossian, Ph.D., Radiology
J. Thomas, M.S., Electrical Engineering
J. Tiefenbrunn, M.D., Medicine
G. Tilton, Ph.D., Pathology
W~ Toga, Ph.D., Neurology
F. Wann, D.Sc., Electrical Engineering
R~ Weber, Electrical Engineering
J. Welch, Ph.D., Radiology
A~ Wet tach, Medicine
R~ Williamson, M.D., Pathology
X. Witkowski, M.D., Medicine
F. Wong, M.S., Computer Science
W. Wong, Ph.D., Radiology
L. Ysaguirre, Medicine
D. Zions, Pathology

Columbia University, New York, New York
J. T. Bigger, Jr., M.D.
Creighton University, Omaha, Nebraska
F. M. Nolle, D.Sc.
Z. Zencka, M.D.
Hahnemann Medical College, Philadelphia, Pennsylvania
R. A. Levy, M.D.
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Indiana University School of Medicine, Indianapolis, Indiana
C. Fisch, M.D.
S. B. Knoebel, M.D.
Jewish Hospital, St. Louis, Missouri
B. R. Hieb, M.D.
R. E. Kleiger, M.D.
R~ J. Krone, M.D.
R. Ruffy, M.D.
Massachusetts General Hospital, Boston, Massachusetts
H. K. Gold, M.D.
W~ Strauss, M.D.

H~

Pennsylvania State University, University Park, Pennsylvania
D. B. Geselowitz, Ph.D.
Peter Bent Brigham Hospital, Boston, Massachusetts
E. Braunwald, M.D.
Research Triangle Institute, Research Triangle Park, North Carolina
W. K. Poole, Ph.D.
Roosevelt Hospital, New York, New York
H. M. Greenberg, M.D.
St. Louis University, St. Louis, Missouri
E. D. Slessinger, B.S.
University of Illinois at Chicago Circle, Chicago, Illinois
R. Langendorf, M.D.
University of Iowa, Iowa City, Iowa
R. C. Arzbaecher, Ph.D.
University of Kentucky College of Medicine, Lexington, Kentucky
B. Surawicz, M.D.
University of Louisville School of Medicine, Louisville, Kentucky
N. C. Flowers, M.D.
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University of Texas Health Science Center, Dallas, Texas
J. T. Willerson, M.D.
University of Vermont College of Medicine, Burlington, Vermont
D. S. Raabe, M.D.
As in the past, collaborative efforts with various commercial firms
continue (see Section VI). This year projects of joint interest have
involved:
Biosensor Corporation, Brooklyn Center, Minnesota,
Computer Services Corporation (CSK), Tokyo, Japan,
International Business Machines (IBM) Biomedical Systems,
Hopewell Junction, New York,
Mead Johnson, Pharmaceutical Division, Evansville, Indiana,
Medicomp, Inc., Melbourne, Florida,
Mennen-Medical, Inc., Clarence, New York.
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IV.

PHYSICAL RESOURCES

The Biomedical Computer Laboratory (BCL) was formed on April 15, 1964
and the original staff moved into 3,800 square feet (net) of laboratory
space at 700 South Euclid Avenue in St. Louis. While remaining at this
location, adjacent to the Washington University School of Medicine's main
bUilding complex, the floor space has been increased to the present 12,000
square feet (net). As a result of the establishment of an interschool
Institute for Biomedical Computing at Washington University, space for part
of the activities of the Institute (which encompasses both the BCL and the
Computer Systems Laboratory (CSL) has been created on the Engineering
School campus by completion of a fifth-floor addition to Lopata Hall. This
new space (about 6000 square feet), called the Edward L. Bowles Laboratory,
is immediately adjacent to the Departments of Computer Science and
Electrical Engineering. It became available in December, 1983. In
addition to the 700 South Euclid and Bowles Laboratory space, BCL staff
members and systems frequently occupy other areas within the Washington
University Medical Center at the sites of collaborative project activities.
During the past twenty years BCL has addressed diverse biomedical
problems for which digital computing techniques seemed promising and
appropriate. A single Laboratory Instrument Computer (LINC) provided the
original staff with an opportunity to apply digital computing to a few
interesting problems in medicine and biology. Currently BCL has interest
and involvement in several specialized instrumentation and computing
systems which provide access to diverse image-data sources (modalities) and
offer opportunities for collaborative research in biological modeling and
algorithm development. BCL has primary responsibility for a complement of
computing hardware and software from a variety of system manufacturers.
These resources include: PDP-l1 's and LSI-ll 's from Digital Equipment
Corporation, TI-980's from Texas Instruments Incorporated, l35's from
California Data Processors and Versamodule M68000's from Motorola, Inc. An
MMS-X stroke graphics display system developed by the Computer Systems
Laboratory, a Lexidata raster-graphic display system and a MASSCOMP raster
graphic workstation are available for biomedical imaging studies.
A local computer network, TERRANET, provides remote terminal-to
computer and inter-computer data communications at rates up to 9600 bps
among thirty stations including terminals and processor ports located
throughout the laboratories. Personal-class microcomputer systems have
been incorporated into the design of biomedical research systems and
numerous special-purpose devices have been developed using microprocessor
chip-sets and microcomputer board-level assemblies.
A machine shop and reference room are located on the 700 S. Euclid
premises and shared with CSL. Other physical resources include a well
stocked electronics shop, a large inventory of electronic and computer test
eqUipment, a variety of digital system modules and both analog and digital
recording instruments. Systems for use in developing eight-bit, sixteen
bit and bit-slice microprocessor applications are available.
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V.

RESEARCH PROJECTS

Introduction
The research program of the Biomedical Computer Laboratory (BCL) is
organized into several major project areas with the staff grouped into
teams whose interests are focused correspondingly. For this Progress
Report, the following paragraphs offer a brief orientation to the headings
under which research activities are discussed. For each category, a
summary is provided on the first page of the corresponding section.
Ischemic heart disease and ECG analysis (Section A) continues to be
a major category of research activity, but the development of new
algorithms for ECG processing has become less prominent than in the past as
a result of a shift in emphasis to exportation of the latest version of our
"Argus" algor i thm. More prominent than before are modeli ng, signal
processing, and data analysis work in collaboration with the division of
Cardiovascular Medicine as part of their broad program addressed to
ischemic heart disease.
Information extraction from quantitative biomedical images continues
to increase in prominence within the BCL program. Accordingly, last year's
organization of such activities into three categories (by imaging modality)
is continued this year. The work in ultrasonic tissue characterization
(Section B) now emphasizes the interpretation of backscatter to achieve
quantitative estimates of tissue properties, including anisotropy and the
state of contraction of cardiac and skeletal muscle, while parallel efforts
are directed toward design of a system to employ adaptive beamforming for
backscatter measurements.
Work in radiation treatment planning (Section C) has moved ahead
with enhancements and evaluations of our "delta volume" algorithm for
three-dimensional absorbed-dose calculations, display experiments employing
high-performance stroke graphics (MMS-X system), and the recent submission
for fabrication of two VLSI circuits for expeditious achievement of a
demanding kernel of the computations (3-D ray tracing).
For positron-emission tomography (Section D) work in support of
applications and system improvements have continued on several fronts, but
the main thrust of BCL activities has been in research on algorithms.
Emphasis has been on application of the maximum-likelihood method for
improving image quality and for achieving better estimates of physiological
parameters through studies of dynamic distributions of tracers.
':'

Systems for Specialized Biomedical Studies (Section E) embraces a
variety of projects that are less broad in scope either because they are in
an earlier stage of development or because the nature of the work is
necessarily more specialized. The biomedical-imaging theme is well
represented in this section as well.
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Projects reported under Resource Development Activities (Section F)
are directed toward improving the Laboratory's capabilities for addressing
the needs of more than one project area. Again. the biomedical-imaging
theme is manifest in work to upgrade BeL's resources for communicating and
processing image data from a variety sources and in a variety of contexts.
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Individual Projects
A.

Ischemic Heart Disease and ECG Analysis

The projects reported in this section continue longstanding work in
real-time and high-speed ECG analysis. Many of the clinical studies
reported here are natural outgrowths of the ECG-analysis work, as are the
strong interests in the evaluation of automated arrhythmia detectors.
Modeling and signal-processing endeavors in the field of cardiology have
supported collaborations which address other aspects of ischemic heart
disease, such as myocardial metabolism and blood flow, the
electro physiologic characterization of abnormal myocardial depolarization,
various antidysrhythmic drug studies, infarct-size modification, and the
study of ventricular diastolic mechanics.
A real-time computer-based arrhythmia monitoring system, called
Argus, in operation in the Barnes Hospital Coronary Care Unit from 1969
1975, w~ replaced in 1975 by "Argus/Sentinel," a commercially available
version developed through collaboration with the Mennen-Greatbatch Company.
The experience garnered with Argus led directly to the development of a
system, called Argus/H, for the high-speed (60 times real time) processing
of long-term ECG recordings. Argus/H has since processed several thousand
recordings for a study of ventricular arrhythmias in survivors of
myocardial infarction and several hundred recordings for a host of other
studies. Extensive evaluations have verified the integrity of the analysis
algorithms, proven the value of the quantified results as compared to
conventional manual-scanning techniques, and confirmed the consistency of
results on reprocessing. The importance of such issues stimulated the more
recent development of a stochastic model for the performance evaluation of
event detectors.
By the mid-1970's, it was apparent that Argus/H could not support
rigorous algorithm development, could not efficiently process the now more
popular dual-channel recordings, and could not meet the demand for the
system from the growing volume of recordings resulting from interests in
therapeutic trials of antiarrhythmic agents and interventions designed to
protect the ischemic myocardium. A newer system, called Argus/2H, emerged
in 1977 and was duplicated in 1978. The two Argus/2H systems have
processed long-term ECGs for national multicenter clinical studies of
interventions to limit infarct size and of post-infarction risk
stratification. The systems also provide the power and flexibility
necessary for work on algorithm revision and on new signal-processing
strategies and they have further served the analysis and documentation
needs of other work to generate an annotated digital ECG database for the
evaluation of automated arrhythmia detectors. Newer signal-processing
strategies employing frequency-domain analysis of the ECG are now bearing
fruit and have led to a continuing industrial collaboration to implement
the algorithms in a CMOS processor for real-time dysrhythmia analysis in
the ambulatory setting.
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A-1.

Argus Algorithm Development

Personnel:

K.
K.
C.
D.
L.

W.
B.
N.
W.
J.

Clark, BCL
Larson, BCL
Mead, BCL
Stein, Jr., BCL
Thomas, Jr., BCL

Support:

RR 01380
Biosensor Corporation
Washington University

For more than 15 years, this laboratory has been developing
algorithms for efficient analysis of the surface ECG signal (PR 19, A-1).
These efforts have culminated in the implementation of a device designed
and marketed by Biosensor Corporation (see VI. Industrial Collaboration).
The device is a portable "real-time analyzer" which continuously monitors a
patient's ECG, records clinically significant data (heart-rate trends,
ectopic depolarizations, waveform examples), and transmits stored
information to a central station. The central station prints a summary for
the patient's physician. Much of the past year was expended assisting
Biosensor with their implementation and debugging.
Concurrently, additional efforts have focused on improvements in
several areas of the time-domain-based QRS detector/delineator algorithm.
First, logic was added for inclusion of small septal vectors at the leading
edge of QRS complexes. Second, the logic for detecting low-amplitude
events was completely redone; the prior version performed well for isolated
events but not so well for consecutive and interpolated low-amplitude
events. Third, the noise rejection logic was completely redone and is
still undergoing evaluation and tuning.
There have been several enhancements in the area of QRS
classification. First, the QRS centroid replaces the point of maximum
sample difference as a fiducial point for aligning QRS complexes to be
correlated in the frequency domain. The correlation is performed when the
algorithm updates the ideal "time-local" normal against which suspicious
beats are compared. For purposes of speed, the centroid computation uses
Aztec data rather than raw data. Second, the frequency-domain logic,
invoked when time-domain analysis has flagged a QRS as non-normal (PR 19,
A-2), is being translated from FORTRAN in a time-shared environment (where
it was developed) to assembly language in a (faster than) real-time
environment. Third, plans have been laid for a Sequence processor to
follow QRS classification. Sequence may re-Iabel one or more QRS complexes
after examining those complexes in their larger neighborhood of several or
many QRSs. Ideally, Sequence mimics the cardiologist who looks at beats in
context and their relationships to one another rather than judging isolated
complexes.
In the next several months, when these enhancements have been put in
place, we plan to evaluate the full system against the American Heart
Association database of ventricular arrhythmias (PR 19, A-4).
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A-2.

Processing of Long-term ECG Recordings

Personnel:

K.
K.
M.
C.
A.

W.
A.
A.
N.
W.

Clark, BCL
Madden, BCL
Marlo, BCL
Mead, BCL
Stangl, BCL

Support:

RR 01380
Biosensor Corporation
Jewish Hospital
Mead-Johnson Pharmaceuticals

After many years of analyzing long-term ECG recordings for a variety
of local studies and multicenter trials, these activities have been greatly
reduced. A few recordings (10-20 per month) are still analyzed for Jewish
Hospital patients who are being studied with a variety of antiarrhythmic
agents. A few recordings are analyzed for Mead-Johnson Pharmaceuticals in
a multicenter, placebo-controlled study of an antidepressant agent,
trazadone (see VI, Industrial Collaboration).
Biosensor Corporation, which recently implemented and now markets a
portable device for analyzing ECG signals in real time (see VI, Industrial
Collaboration), has enlisted our help in providing them with a variety of
ECG arrhythmias in digital form against which they might test their
product(s). After Biosensor analyzes those digital signals and sends to us
their beat-by-beat results, we plot waveforms and labels in condensed
fashion for rapid review and analysis. The arrangement has allowed
Biosensor access toa wealth of diverse waveforms and precluded the
investment of duplicating proven or investing in new support software.

~~~,
~
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A-3.

Assessment of Vascular Integrity of the Myocardium Following
Ischemic Inj ury

Personnel:

R.
K.
P.
R.
K.
J.
B.
S.
J.
J.

G.
C.
A.
A.
B.
S.
E.
P.
R.
D.

Tilton, Ph.D., Pathology
Chang, Ph.D., Pathology
Cole, B.S., Pathology
Gardner, Ph.D., Mechanical Engineering
Larson, BCL
Marvel, B.S., Pathology
Sobel, M.D., Medicine
Sutera, Ph.D., Mechanical Engineering
Williamson, M.D., Pathology
Zions, Pathology

Support:

RR 01380
AM 07296
HL 12839
HL 17646
The Kilo Diabetes and Vascular Research Foundation

We have continued our previously reported studies (PR 15, A-10; PR
16, A-10, PR 17, A-7; PR 18, A-7; PR 19, A-7) of the pathophysiology of
ischemic injury to the heart. In these studies, we employed bolus
injection, external-detection radiotracer techniques to quantify albumin
transport across the coronary vasculature under physiological conditions,
and during reperfusion after selected intervals of global, no-flow ischemia
in isolated-perfused rabbit hearts. The resulting residue-detection data,
analyzed on the basis of a two-compartment model of tracer transport, were
used to estimate parameters indicative of microvascular integrity such as
permeability and ultrafiltration conductance of the endothelium. Our
continuing goal has been to understand the role of endothelium in the
pathogenesis of the vascular hemodynamic and permeability changes
associated with ischemia and reperfusion.
We have studied the effects of diltiazem on coronary vascular
hemodynamics and permeability changes during reperfusion after ischemia.
Four-~M diltiazem significantly increased total water content (8.5%) and
decreased perfusion pressure (11%), left ventricular developed pressure
(22%), and +dP/dt (24%) in nonischemic control experiments, but did not
affect estimates of vascular volume, interstitial fluid volume, mean
transit time, or albumin permeation. Four-~M diltiazem blocked ischemia
and reperfusion-induced increases in water content, interstitial fluid
volume, vascular resistance, vascular volume, and vascular permeability to
125I-BSA, without reducing left ventricular developed pressure or +dP/dt
relative to nonischemic diltiazem controls. These data suggest that
production of ischemic myocardium by diltiazem is mediated, at least in
part, by preservation of vascular functional integrity.
To study the effect of selective phospholipase A2 damage to
endothelium, we have developed techniques for covalently linking
proteolytic and lipolytic enzymes to uniformly sized O.2-~m spherical
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carboxylate-modified, polystyrene particles. In preliminary experiments,
we have assessed vascular permeability and myocardial contractility changes
in isolated, buffer-perfused rabbit hearts exposed to phospholipase A2
bound to 0.2 ~m microspheres during 30 minutes of no flow.
During
reperfusion following the no-flow period, increases in vascular resistance
were of equal magnitude in untreated and phospholipase-A2-treated hearts.
Our interpretation of this observation is that the resistance increases are
probably caused by ischemic injury to arterial smooth muscle which would be
expected to be similar in both groups. On the other hand, albumin leakage
in the phospholipase-A2-treated hearts was about twice that of untreated
ischemic hearts during reflow, and was about six times that of nonischemic
control hearts at comparable time intervals.
We have carried out additional experiments to optimize conditions of
bead concentration and duration of contact with the vasculature in which
the duration of no flow is decreased by 50%. Changes in vascular tone and
myocardial contractility are reversible after this brief interval of
ischemia and vascular permeability is unaffected during reperfusion of
control hearts. Experiments currently in progress are extending these
initial findings and are evaluating effects of trypsin and phospholipase C
on endothelium as well.
To determine whether hypercholesterolemia renders vascular
endothelium more susceptible to ischemia-reperfusion injury, we have
utilized our external detection technique to characterize permeation of the
coronary vasculature by 125I-BSA in hearts of rabbits fed a 2% cholesterol
diet for 2-3 weeks. In these experiments, isolated rabbit hearts were
perfused at constant flow for 1 hour prior to 30 minutes of global, no-flow
ischemia, then reperfused for 3.5 hours. In continuously perfused controls
and in ischemic hearts of animals on a normal cholesterol diet, indices of
vascular and myocardial function were identical to the values reported in
our previous studies with this model. Albumin permeation across the
coronary vasculature was twice that of control values prior to ischemia in
hearts from hypercholesterolemic rabbits and, during reflow, was two to
three times the values in ischemic hearts of animals on a normal diet.
During reperfusion of hypercholesterolemic hearts, vascular resistance
increased 85%, while vascular volume increased about eight times over
baseline (compared to 58% and 37% increases, respectively, in hearts from
normal cholesterolemic animals). We have attributed the dramatic increase
in vascular volume to a breakdown of the endothelial cell barrier to
albumin.
In these studies, we have shown for the first time that after
rabbits have been kept on a high cholesterol diet for only 3 weeks,
coronary vascular permeability is significantly increased even before
ischemia, and the damaging effects of ischemia on vascular integrity are
far greater than in control animals. These changes are independent of the
presence or absence of atherosclerotic occlusive disease of the coronary
vasculature and therefore suggest an important, independent mechanism
whereby hypercholesterolemia may render an individual at increased risk for
ischemic heart disease. In studies currently in progress we are assessing
the effect of still shorter durations of hypercholesterolemia (7-10 days),
and preliminary results are consistent with the findings reported above.
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In our previous isolated-heart experiments, flow rate was held
constant; if perfusion pressure has been held constant, presumably the flow
rate would have declined and left-ventricular contractile function would
not have recovered during reperfusion. In future experiments, we shall
test this hypothesis and examine the impact of these vascular changes on
myocardial contractile performance during reperfusion following ischemia.
Alternate hearts will be perfused under conditions of constant pressure or
constant flow. We anticipate that when hearts are perfused under
conditions of constant flow, myocardial contractile function will be
preserved but that increases in perfusion pressure during reflow after
ischemia may further damage vessels, contributing to increased vascular
leakage and myocardial edema as we have observed previously. On the other
hand, during reperfusion under conditions of constant pressure, we
anticipate that vascular leakage and interstitial myocardial edema may be
somewhat reduced, but that flow rate also will be reduced causing
deterioration of myocardial contractile function. If these predictions are
confirmed, the experiments would demonstrate the potential importance of
compromised vascular integrity, induced by ischemic injury, in the
pathogenesis of ischemic heart disease caused by transient vasospasm or
vascular narrowing.
In additional experiments planned for the future, we shall evaluate
vascular permeability changes in hearts from alloxan-diabetic rabbits to
assess the effects of diabetes on the susceptibility of the vasculature to
ischemic injury. We shall investigate these problems in rabbits with
experimental diabetes of two to three months duration using both constant
flow and constant-pressure perfusion protocols.
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A-4.

Modification of Infarct Size

Personnel:

A.
H.
J.
P.
E.
R.
S.
P.
B.
P.
J.
B.
J.
A.

S. Jaffe, M.D., Medicine
D. Ambos, BCL
D. Eisenberg, M.D., Medicine
R. Eisenberg, M.D., Medicine
M. Geltman, M.D., Medicine
M. Glueck, M.D., Medicine
J. Kovacs, Jr., M.D., Ph.D., Medicine
B. Kurnik, M.D., Medicine
D. Lindsay, M.D., Medicine
A. LUdbrook, M.D., Medicine
Markham, BCL
E. Sobel, M.D., Medicine
J. Spadaro, Jr., M.D., Medicine
J. Tiefenbrunn, M.D., Medicine

Support:

RR 01380
HL 17646

Studies were performed in the Cardiac Care Unit at Barnes Hospital
to assess the effects of pharmacological therapy on infarct size. Infarct
size was estimated from serial plasma creatine kinase changes and with the
use of serial positron emission transaxial tomographs. Results in control
were compared to those observed in the treated groups. During the past
year our efforts have focused on the evaluation of thrombolytic therapy,
treatment of extension of infarction, an important contributor to the
overall infarct size in patients with non-transmural infarction, and
defining the relationship of extension and the complications of infarction
to abnormalities in platelet function as assessed by platelet factor 4 and
beta thromboglobulin.
To evaluate the effects of thrombolytic therapy directly on the
heart, we studied 19 patients with first transmural myocardial infarction
immediately upon admission and again 48 to 72 hours after the intracoronary
administration of either tissue plasminogen activator or streptokinase. In
all patients who received streptokinase, there was marked depression in
fibrinogen, elevations of fibrin degradation products to a dilution of
> 1 :16, abnormal thrombin times, prothrombin times, and partial
thromboplastin times. Patients treated with tissue plasminogen activator
did not manifest reductions in fibrinogen nor coagulation parameters. In
nine patients, lysis was achieved with streptokinase and in two with tissue
plasminogen activator. In eight patients, lysis was not achieved. The
mean time to the onset of symptoms to the initiation of the infusion with
streptokinase was 5.4 ±1.3 (SE) hours in the group that achieved lysis and
9.9 ±2.8 hours in patients who did not achieve lysis. The two patients
treated with tissue plasminogen activator received therapy in 3.8 to 7.5
hours after the onset of symptoms. In all patients in whom lysis occurred,
there was a prompt rise in creatine kinase which reached peak levels
rapidly.
This was not observed in patients who did not achieve
thrombolysis. After thrombolytic therapy, patients were maintained on
heparin to keep the partial thromboplastin time at approximately two times
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the normal level. Patients in whom thrombolysis was achieved, manifested a
29% reduction in PET infarct size (areas manifesting < 50% of maximal
ventricular counts). Improvement was 27% in patients with anterior
infarction and 30% in those with inferior infarction.
This was
significantly different than the results in the patients in whom lysis
could not be achieved. Only two patients in the latter group improved, and
the mean change was an increase of 4 PETT gm-eq. An example of myocardial
salvage documented by positron tomography is shown in Figure 1. Although
myocardial salvage was documented by positron-emission tomography, overall
the left ventricular ejection fraction did not change significantly (50.9
±3.6% before to 51.4 ±4.1% after thrombolysis) although the trend was
favorable in these patients. 1
Encouraged by the beneficial effects indicated by positron-emission
tomography in patients utilizing streptokinase, and aware of data reported
in project 0-1 that tissue plasminogen activator (t-PA) had comparable
benefit, we proceeded with a pilot project to evaluate the efficacy of t
PA. Tissue plasminogen activator is a naturally occurring clot-selective
activator of fibrinolysis similar if not identical to the activator found
in uterus. Recent experiments by Dr. Desire Collen in Belgium indicated
that it does not bind avidly to circulating plasminogen (K m = 65 ~M) but
has a high affinity for fibrin (Kd = .16 ~M). Circulating plasminogen
binds avidly to the tissue plasminogen activator fibrin c/mplex through the
plasminogen lysine binding sites (Km = .14 ~M). Thus, plasminogen is not
converted to plasmin in the plasma but is converted at the fibrin surface
of the clot, making t-PA a very selective fibrin active agent with little
effect on fibrinogen. Any plasmin that does escape into the circulation is
rapidly inactivated by alpha-2 anti-plasmin. We utilized a t-PA product
extracted from a melanoma cell culture line which we previously utilized to
lyse clots in animals. We showed that prompt thrombolysis could be induced
without effects on circulating fibrinogen or plasminogen or consumption of
circulating alpha-2 anti-plasmin in seven patients studied with our Belgian
colleagues. Coronary thrombolysis was induced in 19 to 50 minutes with
either intravenous or intracoronary utilization of the agent. Circulating
fibrinogen and alpha-2 anti-plasmin were not depleted in these patients
except for the two patients who necessitated some degree of streptokinase
therapy because the large amount of the clot exceeded the doses allowed for
administration of tissue plasminogen activator (see Figure 2). In
association with these findings, there was a prompt reduction in chest
pain, resolution of 3T segment abnormalities and improved ventricular
performance. We have followed those studies with a pilot trial looking at
the efficacy of tissue plasminogen activator made in a different manner
which would allow more extensive utilization. Positron-emission tomographs
also have been obtained in such patients, however the experience to date is
not ripe for analysis. The lack of changes in coagulation parameters or
bleeding is encouraging and suggests that t-PA will be an important agent
in thrombolytic therapy in the future. 2
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Figure 1. Positron emission tomograms reflecting uptake of
Cpalmitate in four 1.5 crn thick transverse sections from the base,
high ventricle, midventricle, and apex of the heart before (left)
and after thrombolysis (right) induced with t-PA. Compromise of
myocardial metabolism in the anterior left venilicular wall is visualized
as a confluent, diminution of accumulation of
C-palmitate before
thrombolysis (arrow). The anterior left ventricular regions indicated
by arrows in the tomograms after thrombolysis show increased accumulation
of llC-palmitate in jeopardized zones (arrows) in several sections.
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An additional interest of ours for many years has been in the impact
of recurrent injury on overall infarct size and our ability to reduce its
incidence. We recently completed a 50-patient trial to assess the
contribution of coro~ary vasospasm to the pathogenesis of chest pain in
patients with non-transmural infarction. We hypothesized that the
mechanism of recurrent injury, which in many studies occurs in as many as
40% of the patients, is likely similar to that which induces recurrent
chest discomfort. Since many feel that ST-segment depression at the time
of presentation of acute infarction is indicative of subtotal coronary
occlusion and a propensity to a high incidence of recurrent infarction,
coronary vasospasm has been suggested as a possible mechanism. Such a
hypothesis has been bolstered by the suggestion that ST segment elevation
occurs in some of these patients. In our randomized study, 50 patients
with non-transmural infarction were randomized and received nifedipine or
placebo in a double-blinded randomized manner. Chest pain occurred in 52%
of the treated patients; 38 episodes on 33 days compared to 49% of control
patients; 42 episodes on 35 days. Concurrent therapy with beta blockers
was utilized in 11 patients in the control group and 11 in the treated
group, and with nitrates in 12 patients in the control group and 11 in the
treated group. There was no relationship between concurrent therapy and
the incidence of chest discomfort. Recurrent infarction occurred in 12%
and was comparable between the groups. The incidence of recurrent
infarction was identical to that of all patients with non-transmural
infarction followed prospectively (12%). In an attempt to improve the
sensitivity for the diagnosis of recurrent injury, we also evaluated MB
creatine kinase data to select patients in whom a 50% change in the level
of MB CK occurred regardless of whether or not the absolute value reached
the abnormal range. In patients stratified in this manner, 48% of the
treated group and 44% of the control group had evidence of recurrent
ischemia/infarction by this measure. Accordingly, it seems unlikely that
the lack of a higher incidence of recurrent injury was related to a lack of
sensitivity of the MB creatine kinase criteria. Ejection fraction, which
was also monitored sequentially throughout the study, was identical between
the groups. It increased in six control patients, decreased in nine, and
did not change in six. In treated patients, ejection fraction increased in
seven, did not change in seven, and decreased in six. Logistic regression
failed to identify predictors for the recurrent chest discomfort or
extension. Accordingly, we felt that remediable coronary vasospasm is not
a likely cause of post infarction ischemia in these patients and therefore
attempts to preclude increases in infarct size by precluding extension will
likely have to focus on other interventions such as thrombosis, impaired
myocardial function, or fixed obstructive disease.
In an attempt to further understand the pathophysiology of acute
infarction and its complications, we utilized serial determinations of
platelet factor 4 and beta thromboglobulin to assess the possible role of
platelet aggregation in the pathophysiology of these phenomena. Platelet
factor 4 and beta thromboglobulin are protein constituents of platelet
granules. Their elevation in plasma is a sensitive marker of platelet
degranulation. We utilized both platelet factor 4 and beta thromboglobulin
since the clearance of platelet factor 4 is qUite rapid, allowing for more
precise timing of events, whereas beta thromboglobulin has a longer half
life, allowing one to delineate whether elevations are spurious due to
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rough handling of the sample or due to in vivo degranulation. Previous
data had suggested that platelet factor 4 was elevated in patients with
acute infarction and therefore was a reflection of coronary thrombosis. We
evaluated 52 patients with acute myocardial infarction under rigorous
conditions verified to minimize platelet degranulation in vitro and
performed correlative studies to detect left ventricular mural thrombus as
well as other clinical complications of acute infarction. In a subset,
coronary thrombosis was evaluated with indium-labeled platelets. Platelet
factor four was normal at the time of admission in patients with infarction
averaging 6.3 ±3.3 nglml (SO), similar to values in 44 other patients with
chest pain without subsequent infarction (5.7 ±2.7) and in 25 normal
subjects (4.3 ±1.6). Platelet factor four generally did not increase
throughout the hospitalization in patients with infarction, recurrent chest
pain, development of left ventricular thrombus, or documented recurrent
infarction.
The mean level of platelet factor 4 over time did not
correlate with transmural versus non-transmural infarction, the presence of
diabetes, the location of infarction (i.e., inferior or anterior), the
incidence of prior infarction, the use of anti-platelet drugs, the presence
of prior bypass surgery, or clinical congestive heart failure. Platelet
factor 4 was, however, increased consistently after invasive procedures.
Elevations after invasive procedures accounted for 104 of the total of 110
elevations that were seen. Such elevations were confirmed to be real by
concomitant and sustained elevations (in the next sampling period) of beta
thromboglobulin. An additional 86 elevations were thought to be due to in
vitro granulation since beta thromboglobulin returned promptly to normal in
the next sampling period. In only six other samples, platelet factor 4 was
found to be elevated in vivo as confirmed by persistent elevation in beta
thromboglobulin. These six samples came from one young woman with acute
anterior myocardial infarction who was receiving oral contraceptive agents,
and subsequently appeared to have a recanalized left anterior descending
coronary artery. In this patient massive thrombosis was likely the
etiology of her infarction. In patients studied with indium-labeled
platelets, we were unable to delineate patients with positive or negative
indium images on the basis of platelet factor 4. Thus, we found that
platelet factor 4 values generally remained normal despite myocardial
infarction. The rare elevations that we found were due to sampling
artifacts in vitro which could be corrected with the use of beta
thromboglobulin due to invasive procedures. Thus, platelet factor 4 does
not provide a definitive basis for the assessment of abnormalities either
acutely or during the evolution of acute myocardial infarction.
1.
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The overall purpose of these studies is the correlation of
electrophysiological derangements with biochemical and adrenergic neural
factors underlying malignant arrhythmias associated with ischemia as well
as evolving myocardial infarction. The overall concept of the research is
that potential arrhythmogenic metabolites accumulate in ischemic tissue and
exert deleterious effects on membranes and that their effects may be
exacerbated by the concomitant influences of the adrenergic nervous system.
. Over the past several years studies have been completed demonstrating a
major electrophysiological role of a-adrenergic stimulation during
myocardial ischemia as well as reperfusion. In addition t it has been
demonstrated using radioligand binding procedures that there is a
reversible increase in a1-adrenergic binding sites in ischemic and
reperfused myocardium. More recentlYt we have demonstrated that a
adrenergic blockade specifically attenuates the increase in intracellular
calcium associated with reperfusion in reversibly injured tissue. 1 Studies
performed in our laboratory have also indicated that lysophosphatides t
including lysophophatidyl choline (LPC) and ethanolamine (LPE) accumulate
in ischemic myocardium in situ and have been implicated as potential
mediators of arrhythmogenesis in the ischemic heart. 2
During the past year t studies have been completed assessing the
influence of a-adrenergic blockade on the functional abnormalities
associated with reperfusion of ischemic tissue. These studies were
performed to assess whether a-adrenergic blockade could attenuate the
depression in mitochondrial function associated with 35 minutes of ischemia
followed by 10 minutes of reperfusion in vivo. After the ischemic and
reperfusion interval t hearts were excised t rinsed in saline (40) and
anterior ischemic and posterior normal zones were removed and placed in
sucrose (4°). Mitochondria were isolated by differential centrifugation
and their function was assayed polarographically. State III oxygen
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consumption (Q02) was significantly depressed in the untreated group, n = 8
(195 ±11 natoms 02/min/mg in the normal zone versus 138 ±5 natoms/min/mg in
the ischemic zone, p < 0.01). Treatment with phentolamine (1 mg/kg), 2 to
4 min prior to reperfusion (n = 7), prevented the depression of
mitochondrial function in the ischemic zone (185 ±18 natom/min/mg) as
compared to the nonischemic zone (194 ±12 natoms/min/mg). Thus, blockade
of a-adrenergic receptors during reperfusion in reversibly injured tissue
enhances mitochondrial functional recovery independent of changes occurring
during the antecedent ischemic interval. Currently, studies are underway
to assess whether long-term ischemia (2 to 3 hours) with subsequent
reperfusion can be influenced by a-adrenergic blockade just prior to the
reperfusion interval.
Since delayed after-depolarizations (DADs) and triggered activity
(TA) have been implicated in arrhythmogenesis in the ischemic heart, a
series of studies have been completed recently to determine whether
lysophosphatides, which accumulate within minutes in ischemic tissue, could
induce DADs and TA in normoxic canine Purkinje fibers superfused with Krebs
buffer studied with standard microelectrode procedures (n = 10). When
maximum diastolic potential (MDP) was modestly depressed by -11.5 ±4 mV and
amplitude by -18.8 ±5 mV, p < .01, 8 of 10 fibers exhibited DADs with a
mean amplitude of 7.8 ±1.2 mV. Triggered activity was seen in 4 of 10
fibers, even at an extracellular calcium concentration of 3.0 mM.
Treatment with epinephrine (10- 6 M) in the presence of LPC, increased the
DAD amplitude nearly 2-fold to 13 ±2.9 mV (p < .05). Five of 6 fibers
exhibited TA. Increases in extracellular calcium increased DAD amplitude
as well without increasing the incidence of TA. Thus, LPC-induced DADs and
TA may contribute to initiation of arrhythmias in the ischemic heart and
these effects appear to be enhanced by catecholamines. This lends further
support to the contention that lysophosphatides accumulate in the ischemic
heart and may contribute substantially to arrhythmogenesis and that
inhibition of their accumulation is likely to influence the generation of
malignant arrhythmias during myocardial ischemia.
Previously, transmural isochronic and isovoltaic mapping from
multiple simultaneous sites has been limited by the need for analysis of
stable repetitive rhythms. In a new system recently developed in our
laboratory, electrograms from epicardial and transmural electrodes can be
simultaneously recorded from up to 240 sites. 3 Likewise, this system is
now operational in the cardiothoracic operating room for detailed
transmural mapping for use in the surgical interruption of refractory
atrial and ventricular arrhythmias. With the aid of this unique three
dimensional mapping system, we have recently identified a specific
mechanism responsible for inducible ventricular tachycardia in 11 dogs 3 to
7 days after transient coronary occlusion. Analysis of data recorded
simultaneously from 232 bipolar sites at 4 intramural levels showed that VT
in each dog was due to intramural reentry comprising endocardial bi
directional conduction block, a fast alternate limb of endocardial
conduction (1.1 ±0.1 M/sec during sustained VT), slow intra-myocardial
conduction (0.4 ±0.1 M/sec), with return to the endocardium initiating the
next beat. The slow limb of the reentry was subepicardial in each dog with
sustained VT (n = 5), and greater epicardial delay was evident in this
group compared to dogs with nonsustained VT both in sinus rhythm
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(epicardial activation time = 46 ±5 versus 24 ±1 ms; p < .01) and with
pacing (68 ±3 versus 54 ±3 ms; p < .02). Animals with only nonsustained
ventricular tachycardia exhibited reentry confined to subendocardial
zones. These findings demonstrate, for the first time, intramural reentry
in vivo and delineate the critical factors important for development and
assessment of therapeutic interventions.
Invasion of inflammatory cells during evolving myocardial infarction
occurs in association with maximal arrhythmogenesis and we have recently
shown that this is reflected by increased capacity for synthesis of
thromboxane A2 (TXA2), a putative arrhythmogenic metabolite. 4 Using
programmed electrical stimulation in conscious dogs, we demonstrated no
limitation of ventricular tachycardia (VT) by thromboxane synthetase
blockade despite verified inhibition within the infarct. With the three
dimensional cardiac mapping system, we assessed simultaneous regional
activation information at 232 sites from 4 intramural layers in 5
anesthetized dogs 3 to 7 days after transient coronary artery occlusion.
Infusion of OKY-1581 (100 ~g/kg/min) a thromboxane synthetase inhibitor,
did not alter ventricular refractory periods during pacing at 300 ms (ERP =
156 ±12 to 172 ±31 ms, NS) or 250 ms (ERP = 145 ±8 to 146 ±12 ms, NS).
OKY-1581 did not affect epicardial activation time in sinus rhythm (34 ±8
to 33 ±8 ms, NS) or with pacing 60 ±6 to 61 ±5 ms). It also did not alter
transmural activation time in normal or peri-infarct zones with sinus
rhythm (peri-infarct transmural activation time = 11.1 ±1 to 11.1 ±1 ms) or
pacing (9 ±2 to 9 ±1 ms). Thus, inhibition of thromboxane synthesis during
infarction fails to protect against arrhythmogenesis and exerts negligible
electrophysiological effects.
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The research in this project is designed to define the kinetics of
positron-emitting tracers that are potentially useful for the noninvasive
characterization of myocardial perfusion and metabolism and for the
determination of adrenergic-receptor occupancy. Studies are conducted in
isolated rabbit hearts perfused with washed sheep erythrocytes suspended in
a modified Krebs-Henseleit buffer. The methodology permits control of
factors that can modify myocardial perfusion and metabolism. Studies are
also conducted in anesthetized, open-chest dogs prior to the implementation
of approaches of proven value in studies using positron-emission
tomography.
The development of accurate, quantitative, noninvasive measurements
of myocardial metabolism and perfusion is dependent on the thorough
characterization of the factors that can influence tracer kinetics. Since
fatty acid is the major fuel for the myocardium under normal circumstances,
we currently utilize 11C-palmitate to estimate myocardial metabolism. In
addition to the external detection of myocardial time-activity curves via
coincidence detection of emitted gamma photons in isolated hearts and via a
B-probe in open-chest dogs (with data fed to the isolated-probe data
acquisition system) we measure a number of myocardial and metabolic
functions such as left-ventricular pressure and arteriovenous differences
of substrate simultaneously. Washout curves of 11C-palmitate are analyzed
and correlated with myocardial work and substrate utilization. Assessments
of myocardial metabolism based on external detection of accumulation of
radiolabeled substrates may be influenced as a result of alterations in
flow, by altered substrate delivery as well as altered work (with
concomitant changes in metabolic requirements).
To determine whether reduced delivery limits substrate utilization
under defined conditions of reduced perfusion, an isolated rabbit heart
preparation was employed in which flow was reduced but myocardial oxygen
consumption (MV02) and work were kept constant by adjustment of left
ventricular end-diastolic pressure and heart rate. During the past year we
completed a study in 27 isolated perfused rabbit hearts to determine
whether substrate extractions (palmitate, glucose, oxygen) were limited
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under conditions of low flow. 1 Myocardial work was kept constant by
adjustment of left ventricular end-diastolic pressure and heart rate while
flow was reduced from 1.S to O.S mg/min. Consumption of 11C-palmitate
remained constant (48.8 ±11.6 in low work hearts and 68.8 ±23.3 nmols/g/min
in high work hearts) because the proportion of palmitate extracted
increased (8.8 ±4 to 29.1 ±7.2% and 10.3 ±3.4 to 21 ±6.1% in high work
hearts). The results of the study indicate that despite reduction of flow,
hearts at constant work loads can extract increasing proportions of
delivered substrates such that net utilization remains constant until flow
is reduced below the level required to maintain cellular function. They
suggest that under conditions of low flow, impaired extraction of
substrates reflects either primarily or secondarily depressed myocardial
metabolism rather than simply decreased delivery of substrate. The study
has implications on the interpretation of remote detection of radiolabeled
fatty acid clearance from hearts either with isolated-probe data
acquisition systems or with positron-emission tomography. The question
addressed is whether altered extraction of substrate reflects reduced
metabolic demand or decreased substrate availability per see The results
suggest that decreased net extraction of radiolabeled palmitate in zones of
transient ischemia in vivo (detectable by positron-emission tomography) is
not attributable simply to decreased substrate delivery. They suggest that
impaired net extraction of substrates reflects either transiently or
persistently depressed regional metabolism. 1
In the past year we have extended and completed a series of studies
for the measurement of myocardial blood flow with H21S0.2,3 Noninvasive
quantification of regional myocardial blood flow is necessary for the
assessment of dynamic and fixed coronary vascular obstruction and for
objective assessment of therapy designed to augment nutritional perfusion.
The current approach for the measurement of blood flow with diffusible
tracers derives from the work of Kety and Schmidt.
Using H21S0 (t1/2 = 2.1 min), we demonstrated that a modification of
the tissue autoradiographic approach permitted quantification of myocardial
blood flow (MBF) in open-chest dogs with direct myocardial tissue assay and
that noninvasive estimation with positron-emission tomography (PET)
delineated relative MBF in intact dogs. In open-chest anesthetized dogs,
the single-pass extraction fraction of H21S0 averaged 96 ±S% at flows of 80
to 100 ml/100 g/min. This high extraction fraction did not differ
significantly over the range of 12 to 238 ml/100 g/min. MBF calculated
after a 60 sec i.v. infusion with H21S0 and direct tissue analysis
correlated well with results obtained with results obtained with
microspheres (r ~ .94, n = 9 dogs). Subsequently the approach was adapted
for preliminarr use with PET. Estimation of myocardial content of
radiolabeled H2 So after i.v. infusion of 20 to 30 mCi of H21S0 was
corrected for vascular-pool radioactivity with the use of tomographic data
obtained after separate administration of C1S 0 (to label red blood cells).
Tomograms obtained in vivo in six dogs with either normal or reduced
regional blood flow correlated closely with the tomographically detectable
distribution of 68Ga-labeled microspheres (r = .93) and with microsphere
distribution determined post-mortem (r = .9S). The technique accurately
reflects myocardial blood flow. Using PET, rapid sequential noninvasive
estimation of relative regional MBF has been demonstrated and should
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ultimately permit improved objective assessment of nutritional blood flow
in patients in res~onse to medical and surgical interventions designed to
augment perfusion. ,3
We have previously shown that myocardial washout of extracted
llC-palmitate is quantitatively diminished with ischemia or hypoxia. To
define the quantitative influence of back diffusion of non-metabolized
tracer, llC-palmitate was injected intracoronarily in 15 open-chest dogs
with the LAD perfused extra-corporeallY.~ Myocardial blood flow (MBF) was
measured with H2150. Arterial and coronary-venous total fatty acids, 11C02
, llC-palmitate, lactate, and 02 were measured directly. Under baseline
conditions or under conditions with no intervention (control), 60.0 ±13%
(mean ±SD) of initially extracted l1 C- pal mitate was oxidized to 11C02' and
10.1 ±6.2% was liberated unaltered as from 1 to 20 min after injection of
tracer. With ischemia (arterial flow (20% of control, n=6), or hypoxia
(perfusion of venous blood at normal flow, n=6), (25% of initially
extracted llC-palmitate was oxidized to 11C02 but >17% appeared as
unchanged llC-palmitate. Quantitative analysis of efflux from 1-20 min
revealed that with ischemia and hypoxia llC-palmitate back-diffusion
comprised ~O.3 ±11 .2% and ~8.9 ±17.3% of total efflux compared with 10.5
±3.6% in controls. The fraction of extracted llC-palmitate liberated as
11C02 (in 1-10 min) correlated closely with MV02 (r=.82, n=27). Thus, with
hypoxia or ischemia, assessment of oxidation of fatty acid based on
analysis of residue time-activity curves must be corrected for back
diffusion of initially extracted but non-metabolized fatty acid.~
To evaluate the extent of early recovery of l1C-palmitate (11Cp)
metabolism after 20 minutes of myocardial ischemia followed by reperfusion,
16 open-chested anesthetized dogs were perfused extracorporeally through
the LAD or LCX. 5 Arterial and local coronary venous fatty acids, 11C02,
llCp, lactate, glucose, and oxygen were measured directly and regional
residue time-activity curves assessed with a B-probe after intracoronary
injection of llCp.
Under baseline conditions or those with no
intervention, 66.1 ±11.5% of initially extracted llCp was oxidized to 11C02
and 10.5 ±5.9% liberated from myocardium as unaltered l1Cp from 1 to 20 min
after injection of tracer. With ischemia (flow ( 30% of baseline, n=6),
25.5 ±13.8% of initially extracted llCp was oxidized to 11C02 and 17.2
±9.3% released as llCp. After 30 min of reperfusion (n=7), ~2 ±19% of l1Cp
was oxidized to ll C02 and 8.6 ±3.9% released as llCp while the
monoexponential clearance of residual llCp (t1/2) increased from 5.3 ±0.9
min to 9.5 ±3.2 min. MV02decreased from 16.9 ±5.0 (baseline) to 9.8 ±~.~
(reperfusion) ml/l00 g/min. Thus, despite brief (20 min) myocardial
ischemia, myocardial metabolism of fatty acid remains depressed when
accessed early after reperfusion. 5
It has been established that adrenoreceptor number and binding
affinities may change in a number of cardiac disease states such as
ischemia and congestive heart failure. To assess the feasibility of
characterizing cardiac B-receptors noninvasively, a study was completed in
the past year in isolated, isovolumically beating rabbit hearts to extend
our earlier observations. 125I-hydroxybenzylpindolol was added to the
recirculating perfusate for ~O minutes. Uptake and release were monitored
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externally with a single gamma probe and the isolated-probe data
acquisition system. Specificity of binding was assessed by measuring the
clearance of the ligand from the heart during perfusion with D- or
L-isomers of adrenoreceptor agonists and antagonists. The L-isomers of
epinephrine, norepinephrine and isoproterenol cause significant
dissociation of the ligand from its binding sites, while no effect was seen
with D-isomers or perfusate.
Thus specific binding of 125 1
hydroxybenzylpindolol to cardiac B-receptors can be detected externally.6
These earlier studies demonstrated that hearts from animals treated with
thyroid hormone eXhibited increased uptake of the ligand
(125I-hydroxybenzylpindolol) which was detectable externally and was
confirmed by an increase in receptor number by means of Scatchard analysis
of ventricular membrane preparations. In the past year these studies were
extended to determine the feasibility of distinguishing specific and non
specific binding. We conducted studies in vitro and in vivo with
13 1 I-labeled d- and l-pindolol (13 1 I-d-P, 13 1 I-l-P). Each isomer was
iodinated with chloramine T and purified by high-pressure liquid
chromatography. In rabbit left-ventricular-membrane preparations, binding
of 13 1I-l-P (Kd=0.37 ±0.18 (SD) nM) was saturable and stereospecific. In
contrast 131I-d-P did not exhibit specific binding over the concentration
range of 0.05 - 10 nM. To determine whether specific binding could be
assessed in vivo, we injected New Zealand white rabbits with 500 ~Ci (0.3
nmols) 13 1 I-l-P (n=4) or 131I-d-P (n=4) and sequential one-minute
scintigrams were obtained for eight minutes. 13 1 I-l-P exhibited marked
uptake in the lung and heart, which was blocked by pretreatment with 0.2
mg/kg propranolol. Binding of 13 1 I-d-P was diffuse and not affected by
propranolol. Thus, with the use of labeled isomers and ligands, the 1
isomer for detection of specific and non-specific sites, and the d-isomer
for detection of non-specific sites, noninvasive visualization and
quantification of specific receptor binding is possible in vivo under
conditions devoid of disruption of the normal receptor environment. 7
Cardiac dysfunction seen in hearts from diabetic animals has been
attributed to vascular atherosclerotic lesions even though specific
cellular metabolic defects have been observed as well. To characterize the
relationship between MV02, substrate utilization, and myocardial work we
evaluated hearts isolated from normal (n=13) and alloxan-induced diabetic
rabbits (n a 8). The paced, isovolumically beating hearts were retrogradely
perfused with RBC-enriched buffer. Hearts from diabetic rabbits exhibited
diminished peak LV systolic pressure (55 ±8 (SE) versus 88 ±5 mm Hg in
hearts from normal rabbits). Similarly dP/dt was reduced (670 ±122 versus
1091 ±88 mm Hg/sec) and LV pressure-time index was also reduced in diabetic
hearts (LVPTI, 2024 ±298 versus 3198 ±210 mm Hg.sec/min) (p < .01 for
each). Levels of LVEDP and coronary flow were equivalent.
Despite
diminution of levels of work of >35% compared to hearts from normals, MV02
in hearts from diabetic rabbits diminished only 16%. MV02/LVPTI, an index
of 02 utilization/unit work, was higher in hearts from diabetics (1.88
±0.17 versus 1.41 ±0.12, p < .05). Exogenous palmitate utilization was not
different between the two groups, but hearts from diabetics produced
lactate (613 ±337 nmols/g/min) compared with net extraction of lactate in
normals (-253 ±114, P < .01). The results are consistent with a partial
uncoupling of MV02 from myocardial work and suggest that a metabolic defect
independent from vascular damage may contribute to the dysfunction of
hearts from diabetic animals. 8
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The studies performed in the past year with 11C-palmitate have
permitted a better understanding of factors that influence the uptake and
efflux of this tracer in intact animals and specifically have looked at the
influence of back diffusion of nonmetabolized 11C-palmitate. Studies
planned for the next year include further characterization of the kinetics
of 11C-palmitate handling in association with direct kinetics of
11C-palmitate handling in association with direct determinations of efflux.
In addition, preliminary investigations will be undertaken to evaluate the
handling of fatty-acid analogs, including beta-methyl-heptadecanoic acid,
under conditions of normoxia and ischemia. The studies performed in the
past year have confirmed and validated the H2150 diffusible tracer
technique for the measurement of myocardial perfusion. The studies of
H2150 have been extended to intact animals and patients and tissue
perfusion has been characterized based upon the clearance of H2150 with the
use of positron-emission tomography. The results of studies with beta
adrenoreceptor ligands have been encouraging and raise the possibility that
receptor occupancy may be detectable by positron-emission tomography in
vivo. Finally, the studies in diabetic hearts have suggested partial
uncoupling of myocardial oxygen consumption from myocardial work in this
model, and will lead to further investigation of mitochondrial function in
diabetic hearts in the next year.
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Subforms of individual CK isoenzymes were delineated with a non
denaturing procedure developed to permit quantification. Analysis of 2-ml
plasma samples precipitated with ETOH to remove globulins was accomplished
with 2- to 10-~1 aliquots subjected first to agarose electrophoresis. Each
aliquot contained between 1 and 10 mIU of MM CK activity. Separated
subforms of the MM isoenzyme (isoforms) were transferred to nitrocellulose,
treated with anti-MM CK and 125I-anti-IgG. The resulting native blot was
exposed to film, isoforms localized autoradiographically, and isoforms
quantified by well counting. Reproducibility was consistently within 11%.
Intrapreparative conversion of one isoform to another did not occur.
Values were linear from 1 to 10 mIU for each isoform (MMA' MMB, and MMC)
with correlation coefficients of .93 to .96 (n = 225 determinations).
Results correlated closely with those obtained by chromatofocusing, a more
laborious procedure developed and validated previously (average difference
= 0.3 ±1.4 (SE) %, n = 74). The blot procedure was 100-fold more
sensitive, permitted assay of as many as 40 samples simultaneously, and
provided quantitative assessment of isoform profiles in 2-ml plasma samples
under conditions preclUding intrapreparative conversion.
With the use of the isoform analysis procedures developed in this
project, studies were performed to evaluate the potential of isoform assays
for early detection of myocardial infarction. Eight conscious dogs were
subjected to coronary occlusion. Plasma samples were obtained before
occlusion and serially thereafter for analysis of MMA' MMB' and MMC. In
control samples values averaged 12 ±5 (SO), 22 ±6, and 66 ±10% of total MM
CK respectively. The fraction of MMC, the isoform formed slowly in plasma
from MMA via MMB, decreased within 1 hr (p < .01), reached a minimum of 14
±4% of MM in 5 ±1 hr, and returned to baseline in 13 ±3 hr. Thus, even
though total CK activity did not become significantly elevated for 4 hr
after coronary occlusion, early significant changes in plasma isoform
proportions permitted detection of infarction within 1 hr after coronary
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occlusion. Changes in isoform proportions were consistent, independent of
peak total CK activity or cumulative CK release over a 10-fold range, and
antecedent to elevated total CK regardless of infarct size.
Ongoing activities in this project include mathematical modeling of
processes involved in isoform release, clearance, and interconversion with
correlative experiments designed to assess the applicability of assumptions
in models undergoing development and the utility of models in delineating
precisely the time of occurrence of initial myocardial irreversible injury
on the one hand and reperfusion with accelerated washout of the tissue
isoform on the other. Appropriate application of validated models should
permit differentiation between reperfusion with accelerated washout of
already liberated tissue enzyme from liberation of enzyme associated with
reperfusion injury.

A-8.

Multicenter Investigation of Limitation of Infarct Size (MILlS)

Personnel:

A. S. Jaffe, M.D., Medicine
G. G. Ahumada, M.D., Medicine
H~ D. Ambos, BCL
D. R. Biello, M.D., Radiology
T. L. Buettner, Medicine
K. W. Clark, BCL
E. D. Galie, R.N., Medicine
E. M. Geltman, M.D., Medicine
F. Lifshits, Medicine
J. M. McAninch, Medicine
J. P. Miller, BCL
S. R. Mumm, Medicine
D. S. Payne, Medicine
J. E. Perez, M.D., Medicine
C. S. Ritter, Medicine
B. A. Siegel, M.D., Radiology
B. E. Sobel, M.D., Medicine
L. J. Thomas, Jr., BCL
A. J. Tiefenbrunn, M.D., Medicine
R. A. Wettach, Medicine
A. L. Ysaguirre, Medicine

Support:

RR 01380
HV 72941
Washington University

The MILlS protocol was initiated on August 1, 1978. The goals of
the study were to evaluate the efficacy of the administration of
hyaluronidase and of propranolol in limiting the extent of myocardial
infarction. The primary end-point selected for analysis was MB-CK infarct
size corrected for body surface area.
Other end-points included
ventricular function as assessed by radionuclide ventriculograms, the
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incidence of positive pyrophosphate images, determinations of infarct size
from the pyrophosphate imaging, total creatine-kinase infarct size,
mortality and dysrhythmias at 10 days. Data were collected from five
clinical centers including Washington University, the Massachusetts General
Hospital, the Medical Center of Vermont, Parkland Hospital in Dallas, and
the Peter Bent Brigham Hospital. All data were analyzed in core laboratory
facilities in a blinded fashion. The Creatine Kinase Reference Laboratory
and Holter Analysis Reference Laboratory were at Washington University.
The Electrocardiographic Reference Laboratory was at the Peter Bent Brigham
Hospital. The Infarct Scintigraphy Laboratory was at Parkland Memorial
Hospital. The Radionuclide Ventricular Function Laboratory was at Duke
University. Data from the clinical centers and core laboratories were
centrally analyzed at the Data Coordinating Center at the Research Triangle
Institute.
The Washington University components of this project included the
Clinical Unit, directed by the Clinical Unit Director, Dr. Allan S. Jaffe,
the Creatine Kinase (CK) Core Laboratory, directed by Dr. Burton E. Sobel,
and the Holter Core Reference Laboratory, directed by Dr. Lewis Thomas, Jr.
The Principal Investigator for this study at Washington University was Dr.
Jaffe.
In February of 1983, the Policy Board mandated that propranolol
administration be discontinued. All investigators were notified, reviewed
the data and supported the recommendation of the Policy Board.
Subsequently, an abstract of the propranolol data was presented at a
session of the American Heart Association meeting in November of 1983. The
data from that abstract are summarized in Table I. Two hundred sixty-nine
patients were randomized to receive propranolol or beta blockers on the
basis of at least 30 minutes of chest discomfort and ST-segment change,
either elevation or depression of 1 mm or greater. Only patients who could
receive therapy < 18 hours from the onset of their chest-pain syndrome were
included. One hundred thirty-four patients were randomized to receive
propranolol and 135 served as controls. Propranolol was given in a dose of
.1 mg/kg intravenously over an initial three minute period, followed three
hours thereafter by a second dose of half the initial dosage, and then oral
therapy for the next nine days. In 18 patients who received propranolol
and 14 patients in the control group, infarct size could not be calculated.
Infarct size was not different between treated and control groups for the
total group or for subsets stratified by time from the onset of symptoms to
therapy into subsets treated 0 to 8 or 8 to 18 hours after onset. In
addition, there were no significant differences between propranolol and
control groups in the incidence of infarction, the amount or percentage of
R-wave loss on the electrocardiogram, the change in left ventricular
ejection fraction between 0 and 10 days, the incidence of positive
pyrophosphate images, or mortality. The mean time to therapy was 8.9 ±0.2
hours. It is conceivable that the overall negative results were due to
late administration of drug since other studies utilizing beta blockers
have suggested salutary effects on infarct size when earlier administration
of therapy is initiated. 1 ,2
1983.

The hyaluronidase arm of the study was terminated on December 31,
By that time 9,444 patients had been screened for eligibility and a
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total of 985 had been randomized. Washington University contributed 244
patients (25%) of the overall recruitment. Analysis of the hyaluronidase
data is ongoing and presently principal investigators who have been
unblinded to the data are restricted from discussing the information until
such time as the true nature of the data can be more completely defined.
During the last several years, several data bank studies from the
MILlS investigation have reached fruition. Such investigations had
involved a variety of different components of the MILlS effort at
Washington University. Data from MILlS compared the clinical and
electrocardiographic criteria for acute myocardial infarction. Diagnosis
by MB creatine kinase was utilized as the reference standard. The presence
of 30 minutes of chest discomfort and either new Q waves, 1 mm of ST
elevation or depression in two of the three inferior leads, two of the six
precordial leads, or in 1 or L, or left-bundle-branch block had an overall
sensitivity of 81% for infarction. The overall infarct rate in this
population, however, was 49%. The diagnostic specificity of these criteria
was 69% and the predictive value 72%.3 In addition, a computer algorithm
was devised to estimate infarct size when the initial portions of the MB
creatine kinase time-activity curves were missing. This investigation
allowed for calculation of infarct size in an additional 20% of patients.
The basis of the computer algorithm were complete time-activity curves from
120 patients.
Estimates of CK infarct size based on data-inclusion
intervals beginning at 24, 12, 8 and 4 hours before peak were 11, 14, 23,
and 47% smaller than values based on complete curves but the correlations
were good between complete and incomplete estimates with r values ranging
from .91 to .98. When the correction factors which were derived from these
relations were tested on a new population, the corrected estimates were
Within 7% of those based on the total curves. This correction was not
different in relation to locus (transmural or nontransmural) or the
location (anterior or inferior) of infarction. 4 The pathological
correlates and significance of persistently positive pyrophosphate images
were also described. The data suggested that MB-CK-determined infarct size
was similar between patients with and without persistently positive images,
17.4 ±10.6 MB CK-gm-eq/m 2 for patients with persistently positive
pyrophosphate scintigrams compared to 16.0 ±14.6 MB CK-gm-eq/m 2 .
Similarly, myocardial infarct areas by pyrophosphate images in patients who
had well localized and intense uptake of tracer anteriorly were also not
significantly different, 33.7 ±13.4 for patients with persistently positive
images compared to 34.4 ±13.1 cm 2 for patients without persistently
positive images. Nonetheless, patients with persistently positive images
had lower ejection fractions (0.42 ±0.14 ejection fraction units compared
to .49 ±0.14, p < .01) early after the onset of infarction as well as
subsequently. Therefore as expected, there was a greater incidence of
congestive heart failure in these patients (41 compared to 24%, p < .01).
It was speculated that the presence of a persistently positive
pyrophosphate image in patients with similar infarct size but greater
impairment in left ventricular function might reflect ongoing intermittent
necrosis or even perhaps "chronic ischemia,"S A large number of MILlS data
bank studies are near completion at the present time and should be
published in the near future. These include studies comparing the
sensitivity of a variety of diagnostic measures for acute infarction, data
evaluating the effects of infarction in patients with hypertension, an
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analysis of the predictive value of ventricular ectopic depolarization and
left ventricular function on the incidence of sudden death, data on the
effects of abrupt beta blocker withdrawal and a manuscript defining the
relationship between morphometric measures of infarct size obtained at
pathology and creatine-kinase determined infarct size determined at the
central laboratory.
The latter manuscript confirms the excellent
relationship between morphology and creatine kinase determined infarct size
in 49 patients. The overall correlation coefficient (Spearman) was .87 for
the 25 hearts where enzymatic estimates of infarct size were available. 6
The MILlS study was a very successful endeavor, both overall and for
Washington University.
In addition to continued analysis of the
hyaluronidase data, more than 40 ongoing data bank studies are now
proceeding in an attempt to define a variety of important clinical
relationships in patients with acute infarction. Continued involvement of
the investigators has been assured and analysis of the data will extend for
at least one and perhaps two more years.
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Table 1
Infarct-Size Index and Peak Plasma MB Creatine Kinase
Propranolol

Placebo

P Value

Infarct-size index (gram-equivalents of MB creatine kinase/m 2 )
Total population
No. of patients
Mean ±S.E.
Range

116
13. 3±1 .2
0.0-58.1

121
13. 6±1• 1
0.0-58.7

0.87

Early-randomization subgroup (0-8 hr)
No. of patients
Mean ±S.E.
Range

67
13. 8±1 .4
0.0-50.0

57
15.2±1.8
0.0-58.7

0.53

Late-randomization subgroup (8-18 hr)
No. of patients
Mean ±S.E.
Range

49
12.7±2.0
0.0-58.1

64
12. 2±1• 4
0.0-51 .2

0.83

Peak plasma MB creatine kinase (IU/liter)
Total population
No. of patients
Mean ±S.E.
Range

133
121.3±9.5
0-540

134
118.8±8.1
0-507

0.84

Early-randomization subgroup (0-8 hr)
No. of patients
Mean ±S.E.
Range

75
121 • 4± 11 .2
6-486

59
140.4±13.9
5-507

0.29

Late-randomization subgroup (8-18 hr)
No. of patients
Mean ±S.E.
Range

58
121.3±16.4
0-540

75
101.8±9.1
0-336

0.31
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A-9.

Model Development for Cardiac Diastolic Mechanics

Personnel:

P.
M.
P.
J.

B. Kurnik. M.D •• Medicine
R. Courtois. M.A •• Medicine
A. LUdbrook. M.D •• Medicine
Markham. BCL

Support:

RR 01380
HL 17646
HL 25430
Barnes Hospital
Washington University

During the past year. our studies of cardiac diastolic mechanics (PR 19.
A-15). i.e •• the passive mechanical properties of the left ventricular (LV)
muscle and chamber. have continued with emphasis on (1) refining our
theoretical models of the stress-strain and pressure-volume relations and
(2) evaluating these models in a number of physiologic and pathophysiologic
situations in the animal and in the human catheterization laboratories.
Values for stress are computed from several variables including
intra- and extra-cavitary pressures. measured in the cardiac
catheterization lab using catheter-tip micromanometers. and the cavity
radii calculated from the area and the longest chord of the ventricle as
measured from single-plane angiographic silhouettes. To reduce the errors
associated with the angiographic measurements. the area and the major chord
were smoothed by fitting to a fourth-order polynomial. Stress can be
derived as a function of strain. and strain as a function of radius to
yield a stress-radius relationship for estimating elastic stiffness of the
LV muscle. Our technique has a number of unique advantages over previous
models. including (1) lack of explicit assumptions about the stress-radius
relation. (2) avoidance of need for direct measurement of strain. and (3)
performance of stress-strain analysis independently of pressure-volume
calculation.
A dedicated Hewlett-Packard 5600 M computer system is used for all
phases of this diastolic modeling. As described in PR 19. the angiographic
data are digitized by sonic tablet and the raw areas. largest chords. and
wall thicknesses are smoothed and utilized to derive volume and wall
masses.
In the last year. the system has been programmed to read
hemodynamic information off-line from F-M magnetic tape and to detect and
calculate a variety of pressure and dP/dt functions. The hemodynamic and
dimensional data are now integrated automatically for calculation of a
variety of stress-strain and pressure-volume curves and indexes. Improved
access to and utilization of the SAS statistical system has also been
implemented.
The analysis of early diastole. particularly as regards pressure and
stress decay. is of fundamental importance and complements our previous
investigation of filling-phase characterization. Our computer system has
been programmed to digitize the pressure decay at 5 msec intervals and
models of time-constant derivation are being tested.
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Applications of our model to two important physiologic systems in
man have been tested. Previous work by our group had demonstrated a
reduction of LV end-diastolic pressure and volume by nifedipine, as well as
a downward shift of the pressure-volume curve, without alteration of
chamber stiffness. With our new model we have demonstrated that myocardial
stiffness is also unchanged by nifedipine, indicating that constraints
external to the LV mediate these effects of nifedipine. Additionally, this
model was used to determine whether or not global myocardial stiffness
differed between patients with normal LV function and those with LV
function impaired by CAD. Despite differences in ejection fraction and
end-diastolic pressure and volume, global myocardial stiffness was similar
in the two groups.
Since May, 1984, research has been extended into a dog model,
utilizing full-scale high-fidelity angiographic and hemodynamic monitoring.
This will allow more extensive instrumentation and intervention than is
available in the clinical setting, Which will greatly add to refinement and
expansion of our diastolic modeling. In particular, the effects of
thrombolysis on diastolic mechanics is being investigated.
During the next year, efforts will be directed at developing models
of regional stiffness which would greatly assist in characterization of
segmental diseases such as CAD. We plan to expand our hemodynamic
monitoring to allow assessment of transmural rather than just intracavitary
pressure.

~f

~

f··.·.··"·'·l··

!.~rl
r·

o ,;"

tl~

A-10.

SCOR Patient Information Database
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B. Schechtman, BCL
D. Ambos, BCL
D. Galie, R.N., Medicine
M. Geltman, M.D., Medicine
S. Jaffe, M.D., Medicine
Markham, BCL
E. Sobel, M.D., Medicine
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The Specialized Center for Research (SCOR) database currently
contains information pertinent to more than 1700 patients who suffered
acute myocardial infarction. The variables contained in this database
describe the patient's cardiovascular history, in-hospital course, and long
term progress via follow-up examination. Until this year, the data have
been entered into the Interdata 7/16 computer system in the coronary care
unit and then transferred via magnetic tape to the IBM System/370 at the
University's Computing Facilities. There, a permanent SAS database has
been maintained in order to address a variety of clinical questions.
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Currently, the data entry and storage system is being redesigned. When
this process is completed, data will be entered through the use of
interactive SAS under the Conversational Monitoring System (CMS) operating
system. This will permit on-line retrieval and editing of all data and
will provide on-line access to all SAS statistical procedures and data
management capabilities. Through the use of CMS, all data will be stored
on disk as SAS datasets. Backups will be maintained on tape.
Studies which have utilized the SCOR database include the use of
positron-emission tomography to determine whether patients with myocardial
infarction (MI) and apparent reciprocal ST-segment depression exhibit
abnormal metabolism in zones distant from the primary zone of infarction; a
consideration of the etiology of elevations in plasma MB creatine kinase in
patients after cardiac catheterization; a study of the effect of clot lysis
induced by intracoronary streptokinase on myocardial metabolic integrity
and viability; a controlled trial employing prophylactic antivasospastic
therapy to assess the contribution of coronary vasospasm to chest pain in
patients with non-transmural MI; and a study utilizing positron emission
tomography to assess the effects on the heart itself of coronary
thrombolysis induced with either tissue-type plasminogen activator or
streptokinase.

A-11.

Lipoprotein Kinetics in Familial Hyperlipidemia

Personnel:

R. E. Ostlund, Jr., M.D., Medicine
R. A. Levy, M.D., Hahnemann Medical College
J. Markham, BCL

Support:

RR 01380
HL 29229

The objective of this project has been to determine parameters of
apolipoprotein-B metabolism in subjects with familial hypercholesterolemia.
Two unrelated patients with familial hypercholesterolemia but with
divergent clinical features were chosen. One had classic disease with half
of the expected cell-surface low-density lipoprotein apoB receptors and the
other had only a mild deficiency of low-density lipoprotein receptors but
overproduction of cholesterol was present. ApoB in low density lipoprotein
was labeled with 125-iodine and apoB in very-Iow-density lipoprotein was
labeled with 131-iodine.
The data were analyzed using various multicompartment models. Low
density lipoprotein apoB turnover was found to fit a two-pool model
consisting of a vascular space and a small extravascular space with
irreversible removal of lipoprotein from the blood. The fractional rate of
the exit of low-density lipoprotein apoB from the vascular compartment was

-51

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I

O.09/hr. in the classic patient and O.15/hr. in the patient with atypically
high skin-fibroblast apoB receptor activity. These results support the
physiologic relevance of the in vitro skin-fibroblast assay.
Over the next year we expect to start studies of cholesterol
turnover and high-density apolipoprotein turnover in humans. Data from the
studies will be analyzed by multicompartment models.
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B.

Quantitative Imaging:

Ultrasonic Tissue Characterization

Although ultrasound has proven to be a useful source of diagnostic
information, results of examinations based on current ultrasonic methods
are primarily qualitative and pictorial. In a collaborative effort with
Cardiology and the Department of Physics work has continued on methods of
tissue characterization via ultrasound. Our overall goal is to use
ultrasound for the noninvasive identification of tissue pathologies within
two-dimensional images of tissue properties. Specific objectives of this
effort are: 1) to investigate the. magnitude and character of anisotropy in
tissue, 2) to systematize the representation of the ultrasonic field and to
reduce the data needed to describe that field by determining the moments of
the spatial distribution of energy over the receiver aperture, 3) to seek
improvement in measurement capability of imaging systems via interactive,
adaptive beamforming for both linear and variable-aperture transducer
arrays, 4) to test the hypothesis that quantitative images based on
intrinsic tissue properties can be produced with reflected ultrasound, and
5) to construct a digital mUltiprocessor system to perform post-echo
ultrasonic estimation of attenuation, phase velocity and backscatter in two
dimensions.
Quantitative images based on ultrasonic tissue properties have been
made at the BCL for several years using transmitted ultrasound with a
multiple-frequency tomographic reconstruction system. In the past year we
have extended that processing environment (B-7), so that it now supports
acquisition, storage, and processing of reflected ultrasound from arrays,
as well as transmitted ultrasound using single-element transducers.
The cyclic variation in backscatter from canine myocardium that we
reported previously was found to diminish during ischemia, but returned
following reperfusion (B-2). This study required development of extensive
software to analyze time-varying ultrasonic parameters (B-1). In order to
elucidate causes for the variation of attenuation and backscatter with
state of contraction in cardiac muscle, these parameters were measured in
skeletal muscle as the state of contraction was changed (B-3).
The other three studies we performed showed some of the limitations
of the transducer on quantitative imaging. A two-dimensional receiving
array was simulated by scanning a small-aperture, broadband piezoelectric
transducer (B-4). The first three spatial moments of the acoustic field at
this simulated receiver gave a good description of the ultrasonic field
after transmission through a polyethylene slab. We measured the pressure
patterns generated by single-elements of linear-array transducers and the
signal scattered from a slotted tube to develop a phenomenological model
for the acousto-electric transfer function of transducer elements (B-5).
The diffraction-limited performance of linear phased arrays in pUlse-echo
mode was simulated to provide estimates of the size of tissue regions which
could be characterized at locations throughout the field of view of the
array (B-6).
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B-1.

Software Development for Analysis of Time-Varying Ultrasonic
Parameters

Personnel:

J. G. Mottley, BCL
J. G. Miller, BCL

Support:

RR 01362
HL 17646
HL 28998

Analysis of the data reported in Section B-2 required the
development of an extensive system of computer programs.
The data
consisted of simultaneously digitized recordings of the outputs of a
spectrum analyzer and the time derivative of the left ventricular pressure.
Backscatter data were recorded from separate sites in the apical region of
the left ventricle under several conditions, i.e., normal (before arterial
occlusion), during ischemia, and at several intervals after reperfusion.
In order to properly synchronize the values of the ultrasonic
parameters to the left ventricular pressure, the following processes were
carried out. Data from the spectrum analyzer at each frequency were
referenced to measurements from a planar reflector and expressed
logarithmically. A typical example of the backscatter recorded at a single
frequency (in this case 4 MHz) and from a single site in the apex is
presented in Figure 1 along with the simultaneous recording of the time
derivative of left ventricular pressure.

..

In order to permit averaging of the data to enhance components of
the backscattered signal which are synchronous with the heart cycle, and to
deal with the variation in heart rate among animals and the changing
fraction of the heart cycle occupied by systole as the heart rate changed,
the data acquired during each cardiac cycle were time-renormalized by
dividing systole into one set of 16 uniform time windows and diastole into
another set of 16 uniform time windows.
Renormalization was accomplished by first finding the onset of
systole, defined as the start of the upstroke of the derivative of left
ventricular pressure, and the onset of diastole, defined as the nadir of
the pressure derivative. The data recorded during each phase of the heart
cycle were then distributed among 16 uniform time windows assigned to that
phase. Data assigned to each window were then averaged. The measurements
of the derivative of left ventricular pressure were time-renormalized in an
analogous fashion.
After time-renormalization had been accomplished, the frequency
averaged (integrated) backscatter was calculated at each site. Within each
time window, the integrated backscatter values from similarly defined
regions of all animals were averaged. The average integrated backscatter
value was thus available as a function of occurrence throughout the cardiac
cycle.
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Figure 1. An example of the backscatter at 4 MHz from a single site in the
apical region of a dog heart, recorded as a function of time. The back
scatter is shown in units of decibels down from a planar, nearly-perfect
reflector. The lower panel depicts the time derivative of the left
ventricular pressure.
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In order to more clearly identify changes in the integrated
backscatter throughout the cardiac cycle, the relative integrated
backscatter was calculated by offsetting the integrated backscatter from
each region of the heart by the time-average of the backscatter from the
same region. The relative integrated backscatter is therefore centered
around zero dB and has equal positive and negative excursions.
For quantification of differences in amplitude of the cyclic
variation of relative integrated backscatter for each condition of the
heart, the relative integrated backscatter was Fourier transformed over the
cardiac cycle, and the real and imaginary parts of the fundamental
frequency (i.e., the frequency which would have one complete cycle over the
cardiac period) were used to calculate the amplitude and phase of the
cosine which would best fit the data. The cosine curve is mathematically
identical to the curve which would be obtained by fitting the data with
least-squared-error technique to a functional form Acos(wt+~) where A is
the amplitude, w is the frequency of the fundamental, given by w = 2~/T, if
T is the duration of the normalized cycle, and ~ is the phase offset. The
amplitude of the fundamental was used as an index of the magnitude of the
cyclic variation during each treatment.

B-2.

.

Time Variation of Ultrasonic Backscatter from Canine Cardiac Muscle:
Modification by Ischemia and Reperfusion

Personnel:

J.
R.
J.
J.
B.
L.

G.
M.
G.
E.
E.
J.

Mottley, BCL
Glueck, M.D., Medicine
Miller, BCL
Perez, M.D., Medicine
Sobel, M.D., Medicine
Thomas, Jr., BCL

Support:

RR 01362
HL 17646
HL 28998

The variation of the ultrasonic backscatter with contraction of
canine myocardium (PR 19, B-1) was studied by dividing the cardiac cycle
into 32 time windows and comparing the backscatter measured during each
window (B-1). Backscatter of the muscle was measured over a range of
frequencies (3-7 MHz in 1-MHz steps). Simultaneous measurements of the
time derivative of the left ventricular pressure were recorded.
The apparent backscatter of the muscle increased significantly
during diastole, relative to levels measured during systole (see Figure 1).
Using the peak-to-peak amplitude of the time variation as an index, we
observed in four canine preparations that transient ischemia of 5-10
minutes duration eliminated the cyclic pattern of variation. Following
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reperfusion, the pattern of variation returned slowly, with the amplitude
of variation returning to approximately 75% of pre-occlusion values in 2
hours (see Figure 2).
The cyclic pattern of variation of the ultrasonic backscatter
appears to correlate with local mechanical performance, which is similarly
attenuated by ischemia and recovers slowly with reperfusion following short
periods of transient ischemia.
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of ischemia. The solid line is a cosine fit to the data, as described
in the text.
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B-3.

Variation of Ultrasonic Attenuation and Backscatter of Amphibian
Skeletal Muscle with State of Contraction

Personnel:

J.
R.
J.
J.
B.
L.

G.
M.
G.
E.
E.
J.

Mottley, BCL
Glueck, M.D., Medicine
Miller, BCL
Perez, M.D., Medicine
Sobel, M.D., Medicine
Thomas, Jr., BCL

Support:

RR 01362
HL 17646
HL 28998

The variation of the ultrasonic attenuation coefficient and the
backscatter with contraction of skeletal muscle was studied in an isolated
frog gastrocnemius muscle preparation, in which electrical stimulation
induced tetany of the muscle. Both backscatter and attenuation of the
muscle were measured over a range of frequencies (2-8 MHz in 1-MHz steps)
prior to and during ten successive stimulations of the muscle, which was
suspended in a bath of amphibian Ringer's solution. Simultaneous
measurements of the displacement of the end of the muscle acting against a
stiff spring were recorded.
Results of the measurements of the slope of the attenuation with
frequency are illustrated in Figure 1, in which the average slope of
attenuation from 12 muscles is plotted for successive stimulations. The
slope of the attenuation increased significantly between rest and
stimulation. The magnitude of the change between relaxation and tetany
decreased with successive stimulations, presumably reflecting effects
arising from fatigue. The apparent backscatter of the muscle (i.e.,
without compensation for the attenuation of intervening tissue and of the
tissue within the electronic gate) did not increase significantly. After
compensation of the backscatter for the attenuation, the intrinsic
backscatter transfer function did increase significantly with contraction.
The magnitude of increase was largest for the earlier stimulations and
declined with successive stimulations, presumably indicating fatigue (see
Figure 1).
Research to elucidate the possible relationships between the force
of the contraction and the magnitude of the change in attenuation or
backscatter is continuing.
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the slope of the attenuation coefficient as a function of frequency for
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the integrated backscatter under the same conditions. Error bars indicate
standard error of the means, obtained from 12 muscles from 7 frogs.
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B-4.

Determination of the Spatial Moments of Acoustic Fields

Personnel:

P. H. Johnston. BCL
J. G. Miller, BCL

Support:

RR 01362
HL 17646
HL 28998

We have proposed that the low-order spatial moments of the power in
an acoustic field represent a limited variable set which contains most of
the information that is meaningful for quantitative imaging in an
inherently inhomogeneous medium such as soft tissue (PR 19. B-3).
Specifically, the first three moments, MO through M2, allow one to
calculate the total incident power 1 0 (for "Intensity"), lateral deviation
~ (for "centroid"), and root-mean-squared beamwidth w (for "width") of the
acoustic field according to
MO,

10 =
+

+

(1)

c = M1/Mo,

w2 = M2/ MO -

I

IM11 2/Mo 2 .

We have previously demonstrated (PR 19, B-3) the use of a two
dimensional array simulated by scanning a small phase-insensitive
acoustoelectric receiver. In this report we show results from measurements
made by scanning a small-aperture (1.4 mm) broadband piezoelectric receiver
fabricated in our laboratory. This approach allowed the measurement of
broadband rf signals using a spectrum analyzer, which facilitated the
measurement of the spatial moments of the received field as a function of
frequency. A block diagram of the experimental arrangement is presented in
Figure 1. The transmitted beam from a fixed transmitting transducer
(Panametrics V309, 0.5" diameter. 4" focal length, 5-MHz center frequency)
was scanned in a plane perpendicular to the transmitter axis using the
small-aperture receiver. The received signal was amplified, filtered, and
gated into a spectrum analyzer (HP8551A). Under control of an LSI 11/23
computer, data from the spectrum analyzer was read via an IEEE-488 bus and
stored on disc for subsequent processing. The computer also controlled the
stepper-motor drives for the raster scanner. For this study, raster scans
were made of either 11 x 11 elements with 1 mm spacing or 21 x 21 elements
with 0.5 mm spacing to simulate a 1 cm by 1 cm sparsely sampled receiving
array.
The spatial distribution of power at 5 MHz in the focal zone of the
transmitting transducer in a homogeneous water-only path is presented in
Figure 2. Each pixel represents the measurement from a single element of a
simulated two-dimensional array of 21 x 21 elements with 0.5 mm spacing.
The 32 gray levels correspond to quantitative relative amplitudes ranging
from the maximum (black) to the minimum value (white) measured by the

-62

T

r-1

\

t~

~I

--.B...

....

~

MATCHING
CIRCUIT
II;

11\

ATIENUATOR
\11

METROTEK
PULSER

LOW NOISE
PREAMP
II;

II\RIG

TIMING
GENERATOR

GATE~
.

X

.,

.....

METROTEK
RECEIVER

\1/

SPECTRUM
ANALYZER
I

11/23

Figure 1.

I

IEEE-488

MOTOR
CONTROLLER

Block diagram of simulated array data-acquisition system.

-63



I
I
I
I
I
I
I
I
I
I
I
I
,J
I

5

y
o
(mm)

. {gill
Jt;~t\I;:.: • •ii.i .~'J,~).;,;.

.....................

:::
.
.....
..... ........, . . . . . . . . . . ...

jj1~ )))~ )j{:):j:t»> )~

-5

-5

x

o

5
(mm)

rl

}~~:'
r"

,

"

,
'bl'
~,

;{'IS.. ..
:;

~-~

~

·~· ·'·.·I

Figure 2. Gray scale representation of the spatial power distribution
at 5 MHz in the focus of the transmitting transducer as measured by
a 21 x 21 element simulated two-dimensional receiver array.

#:

-64

simulated array. One can clearly see the main lobe of the beam, as well as
the first sidelobe and parts of the second sidelobe in the corners. This
figure serves to define our coordinate system, with the center element
defined as the origin, and X and Y directions defined as horizontal and
vertical respectively.
A one-dimensional graph of the power at 5 MHz measured by the
receiver elements lying along Y=O is presented as a solid line in Figure 3.
The line is similar to the [2Jl(X)/x]2 form predicted for the power from a
focused circular transducer as illustrated by the arrows which indicate
predicted locations.
The distribution of power in the focal zone of the transmitting
transducer in a water-only path is presented in Figure 4 for the
frequencies 2, 5, and 8 MHz as measured by an 11 x 11 element simulated
two-dimensional receiving array with 1.0 mm element spacing. These
grayscale images demonstrate the variable width of the spatial distribution
of acoustic power with frequency. The main lobe of power clearly decreases
in spatial extent as the frequency increases. To the right of each
grayscale image is a table of beam parameters based on the first three two
dimensional spatial moments calculated for that image. The quantity I o is
the total relative power received by the array, and is expressed as dB
relative to the power received at 5 MHz. The nominally 5-MHz center
frequency transmitting transducer yields a maximum power which is down by
approximately 10 dB at 2 MHz and at 8 MHz (i.e., by 9.9 dB and 11.6 dB
respectively). The values of the x- and y-components of the measured
centroid vector ~ are approximately zero (i.e., less than one half element
spacing), indicating that the beam is aligned with the center of the
receiving array. The width calculated from the spatial moments decreases
with frequency in agreement with visual inspection of the grayscale images.
The moments calculations tabulated in Figure 4 were performed using
only values obtained from those elements which yielded signals no more than
12 dB below the peak value measured. The significance of this truncation
will be addressed below.
A measurement of the attenuation coefficient of a sample using the
zeroth spatial moment is presented in Figure 5. The top curve in the upper
panel is the zeroth moment MO measurement for the transmitted beam in a
water-only path as a function of frequency over a 21 x 21 element simulated
two-dimensional receiver array with 0.5 mm spacing. The lower curve in the
upper panel corresponds to MO measured after insertion at perpendicular
incidence of a 2 mm thick planar slab of polyethylene into the path of the
beam. The attenuation coefficient is determined by comparing the two MO
curves in the upper panel. The result is plotted in the lower panel as a
solid curve. The dotted curve in the lower panel is a least squares line
fit to the data, yielding a slope of 6.2 dB/em-MHz. For purposes of
comparison, a relatively large aperture (0.64 cm2) acoustoelectric receiver
was also used to measure the attenuation of the polyethylene slab. The
acoustoelectric measurement yielded a slope of 5.7 dB/em-MHz. The
reasonable agreement (-7% difference) between the slope values obtained
suggests the viability of quantitative measurements based on the method of
moments.
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In order to illustrate the use of the first spatial moment to
identify lateral deviations of the transmitted beam. the 2-mm polyethylene
plate was rotated in the path of the beam to an incident angle of
approximately 45 degrees from the normal. The refraction suffered by the
5-MHz beam during passage through the plate is illustrated in grayscale
format in Figure 6. In the upper panel is an image of the beam after
transmission through a water-only path. Below is an image after the
insertion of the polyethylene plate at 45 degree incidence. The
corresponding beam parameters calculated from the two-dimensional spatial
moments are shown to the right of the images. We note a significant shift
of the beam to the left after the polyethylene plate is inserted at 45
degree incidence.
The magnitude of the shift is determined to be
approximately 1 mm on the basis of the change in value of c x • a result in
good agreement with the result noted by visual inspection of the grayscale
images.
In the discussion accompanying Figure 2 we noted that the beam width
decreases with frequency. In order to assure that the width w calculated
from the two-dimensional spatial moments of the beam reliably indicates
beamwidth. a threshold criterion must be applied to the data prior to
calculating the spatial moments. We will now describe the physical basis
of the necessity for this cutoff procedure.
A two-dimensional moments calculation is very sensitive to the value
of power measured by receiver elements far away from the origin (0.0). To
illustrate this. consider a function F(r) defined from 0 to R in one
dimension. The nth one-dimensional moment of F(r) is
R

Mn

r n F(r) dr.

f

(2)

o
Hence the values of moments M1. M2 • ... are increasingly more sensitive to
the value of power measured at greater distances r from the origin. If the
same function is rotated to produce a cylindrically symmetric two
dimensional function. the nth two-dimensional moment is
R

Mn

f r n F(r) 2~r dr.
o

0)

Thus. the value F(r) at any distance r from the origin is weighted by an
additional factor 2~r in the two-dimensional integral [Eq. (3)J as opposed
to the one-dimensional integral [Eq. (2)J.
For the case of a transmitted beam considered here. the weighting
factor in the two-dimensional moments substantially magnifies the relative
importance of the sidelobes and noise level measured at some distance from
the center of the beam.
Practical transducers have bandpass
characteristics. so that at some frequencies there may be two sidelobes
above the noise level. while at other frequencies there is one or none
above the noise. This variable signal-to-noise ratio over frequency may
confuse the interpretation of two-dimensional spatial moments for the
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received beam in broadband transmission measurements. Furthermore, because
the beamwidth varies with frequency, a two-dimensional receiving array of
finite size, say 1 cm, will capture a variable fraction of the total
transmitted power, depending on the ratio of beam width to size of the
aperture. These considerations indicate that it is necessary to truncate
the beam function at some level above the noise level prior to calculating
the spatial moments, and that care must be taken to restrict the range of
frequencies measured in accordance with the size of the aperture.
In order to illustrate the effects described above, we shall plot
the beam width calculated from simulated receiving array data using a set
of threshold-cutoff levels ranging from 3 dB to 21 dB. In Figure 7 we show
a one-dimensional scan line through a 5 MHz beam showing the cutoff points
to be used in two-dimensional moments calculations below.
In Figure 8 we show the 5-MHz beam width calculated from data taken
by a simulated 11 x 11 receiver array with 1.0 mm spacing, plotted as a
function of the cutoff level used. In this and the remaining figures, the
value of width calculated using no threshold is plotted as a 30-dB value.
Also indicated are the levels at which the peaks of the first and second
sidelobes occur, and the noise level eXhibited by the system during this
measurement. The width calculated using a 3-dB cutoff is relatively small,
because only the very top of the power distribution is used. The beam
width increases smoothly as the cutoff level is increased. Between 15 dB
and 18 dB, however, the calculation picks up the effects of the first
sidelobe of the power distribution, and reflects this in an abrupt increase
in the rate of rise of beam width as a function of cutoff level. As the
cutoff level is increased beyond 21 dB, the entire aperture is included, so
the width value becomes constant.
In Figures 9 and 10 we illustrate the effect of signal-to-noise
ratio on the selection of cutoff level. In Figure 9 we show the width
calculated for an 8-MHz beam in a case of very good signal-to-noise ratio.
The measured beam width is represented as the solid line. The noise level
of approximately 29 dB is marked with a dash-dot line. Using the width w5
determined at 5 MHz at each cutoff and an assumed inverse-frequency
dependence for width, a predicted beam width w8 calculated according to
w8 = (8/5)w5 is shown as the dashed curve. The measured beam width follows
the predicted dependence well up to 18 dB.
In Figure 10 we depict a case analogous to that in Figure 9, but
with a relatively poor signal-to-noise ratio. The measured beam width is
again plotted as a solid line, with the noise level indicated as a vertical
dot-dash line and a predicted beamwidth based on the measured 5-MHz width
is shown as a dashed line. In this case the estimated width deviates
dramatically from the predicted width below a cutoff of 12 dB. This effect
arises from the heavy weighting of the noise which is measured by pixels
away from the center and which begin to be included at this cutoff level.
A related effect resulting from the relative
the receiving array aperture is illustrated in Figure
width calculated for 2 MHz is shown versus cutoff
predicted from the measured 5-MHz data as w2 = (2/5)w5
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line for comparison. The measured beam width rises with increasing cutoff
in reasonable agreement with the predicted curve up to about 9 dB, after
which the value remains constant. All the receiver elements received power
within 12 dB of the peak because the main lobe of the beam fills the
aperture. The square shape of the receiver aperture artifactually
truncates the power distribution, and thus distorts the estimated beam
width.
The overall approach to quantitative ultrasonic imaging based on
information derived from the spatial moments of the received ultrasonic
field continues to look very promising. Work is continuing along several
parallel lines, including an investigation of the interdependences among
the size of simulated array aperture, frequency bandwidth, truncation
level, and signal-to-noise ratio.

B-5.

The Electroacoustic Transfer Function of Linear Transducer Arrays

Personnel:

R. M. Arthur, BCL
S. R. Broadstone, BCL
M. L. Seiger, B.S., Electrical Engineering

Support:

RR 01362
Washington University

Transducer behavior must be taken into account in order to make
quantitative ultrasonic measurements (PR 19, B-6). The energy transmitted
or received by a transducer element is dependent on signal frequency and on
the angle of propagation or incidence. It is also affected by cross-talk
from nearby elements. A scanner was added to the processing environment
(B-7) to permit mapping the pressure fields generated by individual
elements of transducer arrays and to capture the signal received by the
element when its transmitted beam is scattered by a reflector moved through
its field of view. Broadband pulses were used to excite transducer
elements in order to calibrate the element for quantitative pulse-echo
imaging.
The excitation pulse, the pressure field recovered by a hydrophone,
and the scattered signal received by the element itself were recorded as a
function of hydrophone or scatterer range and angle. Signals were sampled
at 50 MHz with 8 bits of precision. Spectra were determined by Fourier
transform. By comparing the received signals to the excitation pulse we
calculated the ability of the element to insonify and its sensitiVity to
scatterers in a given region of its field of view. We are now applying
this technique to elements of 3.5 and 5 MHz, 32-element linear arrays,
composed of piezo-electric material. 1
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These studies may also permit development of a phenomenological
model for the transfer function of the transducer element itself, i.e. the
relation between the electrical excitation and the motion of the face of
the transducer. We hope to be able to infer transducer vibration modes by
removing diffraction effects from the calibration studies described above.
To characterize the transfer function of a given transducer we propose to
model each element as a collection of facets or subelements. The
diffraction patterns of these facets will be calculated using the impulse
response method employed in our model for studying phased-array resolution
(8-6). Calculations will be compared to the calibration measurements in
order to fix facet motion on a least-squared-error basis.
1.

8-6.

R. M. Arthur, M. L. Sieger, and D. W. Stein, "Assessing Ultrasonic
Arrays for Imaging Tissue Properties," Ultrasonic Imaging, vol. 6,
p. 209, 1984.

Diffraction-Limited Lateral Resolution of Ultrasonic Phased Arrays

Personnel:

R. M. Arthur, 8CL

Support:

RR 01362
Washington University

The objective of this study was to determine the diffraction-limited
resolution of an ultrasonic linear phased array as a measure of the maximum
number, that is as a limit on the number, of independent scan lines
appropriate for tissue characterization. The approach was to simulate a
linear array, so that its ability to separate two point targets located on
an arc in regions throughout the field of view of the array could be
calculated (PR 19, 8-5).
The simulated transducer was composed of 16 rectangular elements.
Its center frequency was 2.25 MHz. In terms of wavelength in the medium,
each element was 0.9 of a wavelength wide and 12 wavelengths high. The
spacing between element centers was 1.8 lambda. The height and width of
the array were 8 and 19.4 mm, respectively. Each element was driven by a
sinusoid at the center frequency (2.25 MHz) with an exponential envelope.
The excitation was applied to the elements of the array with delays to
produce point focus and beam steering. The receive signal was formed using
the same delays, that is, the focal point of the array was the same on both
transmit and receive.
The impulse response of an element in an infinite baffle which
undergoes uniform logitudinal motion can be readily calculated using the
method of Lockwood and Willette. 1 The impulse response is proportional to
the pressure in the medium. The signal received by the array upon
scattering from two point targets was found, again using the impulse
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response of the array. The impulse response from target to array is the
same as that from array to target. The array output was the sum of the
signals from each of the targets in the medium.
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In this study the focal points on transmit and receive were moved
together along an arc for various separations of two point targets which
were also on the arc. A scan was generated from the peak of the received
signal for a given look direction. In Figure 1 we see two scans. The
dashed lines indicate the position of the point targets. As expected, the
scan at 20 mm (the width of the array) is symmetric about the axis because
the targets are symmetrically placed about the axis. In the scan for
targets in the vicinity of 30 degrees at 100 mm, which is 5 times the width
of the array, the peaks of the received signals are roughly an order of
magnitude smaller than the peaks of vet) at 20 mm. Signal amplitude falls
off both with an increase in radius and with an increase in off-axis angle.
In order to resolve the two targets, the peaks in the scans must be
distinct. In this study the criterion used was that the smaller peak must
be at least 3 dB above the minimum between the two peaks.
For that criterion we find the angular resolution shown in Figure 2.
Angular resolution gets better then converges with an increase in radius.
For radii equal to or greater than 3 times the width of the array, angUlar
resolution as a function of off-axis angle is about the same. It is
roughly linear and undergoes about a 2:1 change from 0 to 45 degrees. The
angular resolution curves were used to find the number of independent scan
lines in the 45-degree field of view of the 16-element array which was
simulated.
Simulations of 32-element arrays with element width the same or half
as wide as that of the 16-element array showed that array width was the
primary determinant of resolution and that the number of independent scan
lines in the field of view of a linear array beyond a range two to three
times the width of the array, the number of independent lines in the field
of view is nearly constant.
1.

J. C. Lockwood and J. G. Willette, "High-Speed Method for Computing
the Exact Solution for the Pressure Variations in the Nearfield of a
Baffled Piston," Journal of the Acoustical Society of America, vol.
53, pp. 735-741, 1973.
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B-7.

The Processing Environment for Ultrasonic Tissue Characterization
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Major modification and upgrading of the processing environment for
the tissue-characterization project (PR 19, B-7) is now complete. The
processing environment is built around a DEC LSI-ll/23 microcomputer, which
is interfaced to: 1) two 50-megabyte disk drives to provide programming
storage; 2) an FPS 100E array processor to significantly improve execution
time for both simulations and data analysis; 3) a 9-track, industry
compatible tape drive for backup storage; 4) an electrostatic
printer/plotter; 5) a digital plotter; 6) a 16-bit parallel input/output
port for connection to a video display; 7) six serial lines; 8) analog-to
digital and digital-to-analog converters; and 9) an IEEE-488 bus for
communication with instrumentation, such as our data-acquisition circuitry.
This year we added a Winchester drive with a total of 111 M bytes of
storage. It houses our operating systems and signal and image processing
libraries, which are too large for the RK05 drives. It also has sufficient
capacity to store a typical tomographic or linear-array scan. In addition
we added a scanner which can rotate and translate a linear array, to
determine the behavior of individual elements throughout its field of view,
as well as to collect signals for two-dimensional imaging with reflected
ultrasound. Driver software for the Biomation recorder, stepper motors,
and other hardware of the scanning systems is now operational. We can
fully support acquisition of both transmitted and reflected ultrasound on
the LSI-ll/23.
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C.

Quantitative Imaging: Radiation Treatment Planning

About half of all cancer patients are treated with ionizing
radiation during the course of their disease. The goal of radiation
therapy is to control the malignant disease by delivering adequate
radiation dose to the tumor volume while minimizing the dose to the
surrounding normal tissues.
Treatment planning in radiation therapy is a procedure for
appropriately selecting and placing sources of ionizing radiation so that
their combined effect yields an optimal spatial distribution of absorbed
dose in a particular region of the body. In the presence of tissues with
inhomogeneous scatter and absorption properties, presently available
methods of absorbed-dose calculation are approximate. Thus, their real
utility in radiation-treatment planning is limited. We and several other
groups have recognized for a number of years that computed tomography (CT)
may provide a remedy for the shortcomings of present methods of absorbed
dose calculatio~. Accordingly, in 1977 we began the development of a new
approach to absorbed-dose prediction that is based on fundamental physical
principles and takes advantage of information provided by CT scanning.
The general objectives of this project are to develop algorithms for
computing three-dimensional dose distributions within inhomogeneous tissue
regions valid for radiation fields of arbitrary shape and size, and to
apply advanced computer technology in the implementation of these
algorithms to render them clinically useful. A specific objective of our
initial work was to investigate the validity of the physical basis of the
mathematical model on which our method depends. Comparison between
measured and calculated dose in complicated geometric phantoms and in the
Rando phantom show excellent agreement (C-1). In addition, a new
investigation into treatment verification using our dose calculation
algorithm has been started (C-1). This may provide an effective way to
verify that the planned treatment is actually delivered to the patient,
which is as important as developing an effective plan in the first place.
An integrated circuit to perform the ray-tracing part of the dose
calculation has been designed (C-2) and is being fabricated, and
preliminary work is in progress for display of information to aid treatment
beam placement and display of calculated dose distributions to aid
treatment plan evaluation (C-3).
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C-1.

Algorithm Development for Radiation Treatment Planning

~
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Imperative in any radiation treatment planning (RTP)system is a
method of accurate dose calculation. As mentioned in our last progress
report, we have implemented on a VAX-11/780, a new delta-volume algorithm
based on the work by Wong and Henkelman. 1 ,2 We have demonstrated that, in
stringent phantoms irradiated by cobalt-60 beams, the calculation of
correction factors agrees with measurements, usually to within one percent.
During the past year we have continued our evaluation of the algorithm for
cobalt-60 irradiations and are close to the completion of the important
"photon-transport phase" of the RTP project where the incorporation of
electron-transport for dose calculations is not necessary (e.g. cobalt-60
or equivalent radiation beams). The work can be described in two parts:
voxel-based dose calculations; and methods for treatment verification.
We have performed verification studies in the more realistic
Alderson Rando anthropomorphic phantom. X-ray CT scans of the Rando
phantom in the upright position were made. In this manner, contiguous
scan data at the desired x-ray beam width could be obtained without data
interpolation and scan artifacts between the transverse sections of the
phantom. The Rando phantom was irradiated anterior-to-posterior in the
thoracic region with a 15 cm x 15 cm cobalt-60 beam. Dose measurements
were made with high precision thermoluminescent dosimeters 3 placed
primarily in the lungs and mediastinum of the Rando phantom. For dose
calculations, the CT numbers were converted to electron densities
determined by narrow-beam cobalt-60 transmission measurements through
sections of the phantom composed of the various materials used in the
phantom construction. Comparison of the calculations and measurements are
shown in Figure 1 as a histogram distribution of percent differences.
Linear interpolation of calculated values was used to account for the
unavoidable positioning mismatch between the dosimeters and the calculation
grid.
The average difference of 60 samples of comparison was
-0.25% ± 2.96%.
The agreement is excellent considering the discrepancies in the
positions of the measurements and calculations, and the errors introduced
due to the finite dimensions of the input voxel data.
This study demonstrates that we are able to perform accurate dose
calculations based on actual CT pixel-based input data and is the first
time that such a truly three-dimensional dose calculation has been
attempted. With our prototype delta-volume implementation, actual clinical
cobalt-60 dose calculations can now be made within the limitations of the
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No. of
samples
Ave. Difference:
12
All samples (n=60)
: -0·25% :t 2·96%
Mediastinal samples (n=19)
10
: -2·67% :t 2·82%
Non-Mediastinal samples (n=41)
: 0·84% :t 2·31%
8

I

I

~ Mediastinal sample

I

All samples:
6SO/0 within :t 3% difference
92% within :t 5% difference

6

Figure 1.

Comparison of TLD tleasurements with ~-Volume Calculations

present algorithmic design such as field dimensions, grid spacing, and
computation time.
Verification that the intended treatment plan is carried out is as
important as development of the plan. While we may be able to arrive at an
optimized treatment plan for the patient based on the delta-volume
calculations, we have been concerned that to date, there is a paucity of
non-invasive techniques to verify the execution of the plan. The customary
practice of exposing port films with the irradiating beam on the exit side
of the patient merely provides a test of the geometric reproducibility
without verification of the dose calculations. Recently, we have begun
investigating a new approach to treatment verification based on the
comparison of the calculated and measured exit-dose distribution. Provided
that the patient set-up remains the same for dose calculations and
treatment, a necessary condition for treatment planning, such comparison
should yield good agreement. A study was conducted using the phantom
geometry shown in Figure 2a. The calculated correction factors for this
phantom (i.e., the ratio of dose in medium to the dose in water) agreed
very well with measurements. The average difference was 1.8% ± 1.4%. In
Figure 2b, only two points of comparison show a difference larger than 3%,
one of which is probably due to positioning error of the dosimeter (see
axis (b» and the other is located in the more rapidly changing penumbral
region (see axis (a».
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Encouraged by these results, we proceeded to apply this verification
approach in the more realistic Rando phantom. Profiles of correction
factors were measured at the exit side of the phantom using an ionization
chamber. Figure 3 shows the results of two profiles 5 em superior and
inferior to the horizontal axis of the beam. The measurements and
calculations are shown as continuous and dashed lines respectively.
Excellent agreement was obtained. Of the 57 points used for direct
comparison, 80% agreed to within ± 3%. Largest errors occurred, once
again, in the mediastinal and penumbral regions. The stUdy suggests that
accurate prediction of the exit dose distribution may be used for non
invasive treatment verification, a level of quality control that has not
been attempted before. We hope that in the future, with a better detection
device, and appropriate methods for data analysis (see Section C-3 for the
gray-scale images of the exit-correction factors distribution), such an
approach will place treatment planning closer to the clinical setting and
help to enhance treatment accuracy.
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Next, we intend to:
(1)

Ini tiate the "photon-electron-transport" phase of the RTP project in
order to extend the algorithm to higher photon energies.

(2)

Increase or modify the resolution of the primary intensities and dose
calculation grids of our prototype algorithm for more appropriate
comparisons with measurements and verification studies in high dose
gradient region, and to accommodate larger field dimensions.

(3)

Perform actual clinical dose calculations, including exit dose
verification studies based on film dosimetry, for patients receiving
cobalt-60 irradiations in the head and neck, and thoracic regions.

(4)

Examine different methods of data (or image) analysis such as image
subtraction so as to quantify our exit-dose treatment verification
technique.

(5)

Investigate the subtraction from the digitized exit dose distribution
obtained from port films of the calculated scattered dose
contributions so as to improve the usually poor contrast of the port
films.

1.

J. W. Wong and R. M. Henkelman, "A New Approach to CT Pixel-Based
Photon Dose Calculations in Heterogeneous Media," Medical Physics,
vol. 10(2), pp. 199-208, March/April 1983.

2.

J. Wong, "A New Approach to Photon Dose Calculations in Radiotherapy
Treatment Planning," Ph.D. Thesis, Department of Medical Biophysics,
University of Toronto, July 1982.

3.

M. K. Keller, E. D. Slessinger, J. W. Wong, J. Van Dyk, and P. M. K.
Leung, "A Practical Method for Precise Thermoluminescent Dosimetry,"
Journal of the American Association of Medical Dosimetrists, vol.
8(3), pp. 22-26, 1983.
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C-2.

Integrated Circuit Implementation for Absorbed-Dose Computation
in Radiation Treatment Planning
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The design of two integrated circuits for ray-tracing and
attenuation calculation for absorbed-dose calculations has been completed
and both circuits have been submitted for fabrication, one to MOSIS1 and
one to VLSI Technology Incorporated (VTI). We expect to receive the
fabricated circuits and to start testing and evaluating them in August or
September. The two circuits implement different versions of the ray
tracing algorithm for dose calculations. The first IC, which is being
fabricated by VTI, uses a fixed voxel size for attenuation calculations,
and as a result, requires a long time for dose computation in large
volumes. After initialization and loading of associated memory by a host,
it calculates the sum of the augmented first-scatter dose at each voxel in
the volume from each voxel. The circuit includes about 12,000 field-effect
transistors, 168 cell definitions, and is about 6.5 mm by 6.1 mm with 5
micron feature sizes. Figure 1 shows a plot of the finished design.
The second IC, which was designed as a class project in EE563,
calculates dose contribution from a volume of 8 by 8 by 10 voxels to a
single voxel upon a command from the host. However, the IC can be used to
calculate the dose with 1 cm voxels, 2 cm voxels, 4 cm voxels, etc. until
the dose contribution from an entire volume has been calculated. This
allows a much smaller number of attenuation calculations than the first
method by using lower resolution for the scattering volume that is further
away from the dose point. The time savings for calculation of first
scatter dose using this technique is about an order of magnitude for
volumes of 32 voxels per side. 2
This circuit includes about 6300 field
effect transistors, 117 cell definitions, and is about 3.6 mm by 6.6 mm
with 4 micron feature sizes. This second circuit requires less area
because of the smaller feature size and because it requires more frequent
attention from its host. However, under typical operating conditions, it
will compute for about 10ms intervals before requiring a few words of data
transfer to and from the host.
The design of these two ICs has been a difficult and time-consuming
experience and although we have learne~ much as a result, it is clear that
a less labor intensive technique is required to provide new designs with
less effort and to allow modifications and corrections to be incorporated
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Figure 1.

Plot of

~-Volume

Ray-Tracing Integrated Circuit

more easily into completed designs. We are obviously not the only
organizatio~encounteringsuch difficulties and significant effort is being
expended by other universities and by industry to reduce the time required
for design
and modification of integrated circuits. We presently have a
preliminary version of the VIVID system being developed by the
Microelectronics Center of North Carolina and expect to get a significantly
improved version within a month or two. VIVID allows design to be
completed without explicit specification of dimensions or absolute
position, only relative position. When the design is complete, a program
adds absolute coordinates and attempts to compact the circuit to remove
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unneeded and wasted space. This makes initial design and subsequent
changes much qUicker and easier than design that uses absolute coordinates.
1.

D. Cohen and G. Lewicki, "MOSIS -- The ARPA Silicon Broker,"
Proceedings of the Second Cal tech Conference on VLSI, pp. 29-44,
January 1981.

2.

F. U. Rosenberger, K. Krippner, D. Stein, Jr., and J. W. Wong,
"Implementation of the Delta-Volume Dose Calculation Algorithm,"
Proceedings of the Eighth International Conference on the Use of
Computers in Radiation Therapy, pp. 78-82, July 9-12, 1984.

C-3.

Displays for Radiation Treatment Planning
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Experimental displays of conventional treatment plans were
demonstrated using the MMS-X system and reported on last year (PR 19, C-2).
These displays were used to demonstrate their usefulness and practicality
for improving the interpretation and development of radiation treatment
plans.
The displays utilized stroke graphics to represent isodose
contours and outlines of anatomical features.
Our Lexidata system has been used to display and photograph
calculated and measured exit dose distributions (C-1) to allow subjective
evaluation of the effectiveness of exit dose calculations. Figures 1a and
lb show measured and calculated exit dose data as displayed for comparison
and evaluation. The qualitative comparison is good, with the major
difference due to the calculation being performed at only half the
resolution of the measurements.
The MASSCOMP MCS-SOO has stimulated work toward implementing raster
displays similar to those achieved on the MMS-X. We are presently
implementing a generalized set of display software for the graphics system
to provide support for a variety of applications including the development
and evaluation of displays for planning beam placement and for evaluating
calculated dose distributions.
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Figure lao A gray-scale image of the digitized measured
correction factor profiles from our Rando study.
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Figure lb. The corresponding calculated correction factor image
of a 25 x 25 matrix, linearly interpolated for comparison to
the 50 x 50 matrix of the measured image.
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Quantitative Imaging:

Positron-Emission Tomography

Stimulated by the clinical impact of the EMI transmission
tomographic scanner in 1973, experimental studies were initiated in
collaboration with the Division of Radiation Sciences to evaluate positron
coincidence-detection as a method for emission reconstruction tomography.
This collaborative activity resulted in a prototype scanner called PETT
(Positron-Emission Transaxial Tomograph). Extensive studies in patients
and animals were conducted with the PETT III scanner in collaboration with
the divisions of Neurology and Cardiology. A subsequent scanner, PETT IV,
utilized concepts developed with its predecessor but incorporated a novel
technique for the simultaneous collection of four tomographic slices from a
single set of detectors. PETT IV is now located in the Cardiac Care Unit
for use in the SCOR project for the quantification of regions of myocardial
ischemia and infarction (0-1, 0-2). Subsequent scanners have been
developed that permit more rapid data collection and improved spatial
resolution. One of these, PETT V, was used in experimental studies in dog
hearts. PETT VI became operational during the summer of 1980 and employs
fast detectors and an entirely circular motion for rapid data acquisition.
Further experimental and clinical studies with this system occurred over
this past year (0-3, 0-4). One of the most exciting recent developments
for emission tomography results because of new developments in crystal
technology and high-speed electronics. These now permit the propagation
time of each of the two photons created in an annihilation to be measured.
Theoretical and experimental studies of tomography systems that utilize
this new information continued, and the software and hardware needed to
realize the predicted benefits were developed (0-5 to 0-11); the new system
is called Super PETT I.
Studies of ways to improve the detector
electronics for the improved measurement of time-of-flight continued during
the year (0-12). Work was initiated on a new approach for estimating
parameters in dynamic studies using list-mode data (0-13) and on using side
information, such as CT and MR data, to improve PET reconstructions (0-14).
A study of finite-register effects in implementing reconstructions from PET
data has been initiated as a necessary step for special processor design
(0-15). A new time-of-flight instrument for neurological studies is under
development (0-16, 0-17). A reconstruction algorithm for single-photon
tomography is being studied for use with data collected with a multiview
gamma camera (0-19).
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The overall goal of this project is to implement and evaluate
procedures required to translate into intact animals the results obtained
with selected positron-emitting tracers used to characterize myocardial
metabolism and perfusion in isolated hearts and anesthetized. closed-chest
dog studies performed with the Isolated Probe Data Acquisition System
(Project A-6). Utilizing positron-emission tomography with PETT VI. the
distribution of tracer and the time course of its uptake and clearance from
the myocardium can be quantified. Such studies are intimately related to
the clinical studies using positron-emission tomography.
During the past year. we have demonstrated that using H2150
(t1/2 - 2.1 min) and a modification of the classical Kety-Schmidt
autoradiographic approach. quantification of myocardial blood flow in
anesthetized dogs was possible. The approach was adapted for use with PET
by estimating the myocardial content of radiolabeled H20 after intravenous
infusion of 20-30 mCi of H2150. corrected for vascular radioactivity with
the use of tomographic data obtained after the administration of C15 0 by
inhalation to label red blood cells. Tomograms obtained in vivo in six
dogs with either normal or reduced regional blood flow correlated closely
with tomographically detectable distribution of 68Ga-Iabeled microspheres
(r = 0.93) and with postmortem microsphere distribution (r = 0.95). The
technique thus accurately reflects regional myocardial blood flow and
should permit improved objective assessment of nutritional blood flow in
patients with medical and surgical interventions designed to augment
perfusion. Absolute measurement of myocardial blood flow will necessitate
correction of motion artifacts with gating, and algorithms for correction
of partial volume and spillover effects. 1
In pilot studies performed within the past year. we extended this
technique to demonstrate that non-invasive determination of regional
myocardial blood flow in response to pharmacologically induced vasodilation
can permit detection of functionally significant coronary stenoses without
coronary angiography. We used PETT VI to characterize myocardial blood
flow before and after dipyridamole (1 mg/kg i.v.) in closed-chest dogs with
50-70% reduction of LAD diameter produced by intraluminal placement of
Teflon cylinders (i.d. 0.6-1.1 mm). Relative flow was determined following
i.v. bolus in~ections of 40-60 mCi H2150 with correction for vascular
tracer with C 50 and compared to the distribution of simultaneously
administered radiolabeled microspheres. Control tomograms were homogeneous
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whereas relative myocardial blood flow was markedly diminished in tomograms
after dipyridimole. Although absolute myocardial flow distal to the
stenoses increased after dipyridamole, relative flow determined with PET
was only 43 ± 10% of normal, and correlated closely with the distribution
of microspheres measured in vitro (r = .85). These studies demonstrated
that the manifestations of coronary stenosis insufficient to cause resting
ischemia can be detected by PET with dipyridamole-induced vasodilation.
The approach developed should be applicable to noninvasive diagnosis and
localization of stenoses in patients.
We previously demonstrated that PET can be used to estimate the
salutary response to coronary thrombolysis. These studies have continued
during the current project year. Even though restoration of vessel patency
after reperfusion is demonstrable angiographically, it has been reported
that myocardial blood flow (MBF) declines below 20% of normal at 24 hours
of reperfusion. To evaluate the extent to which externally measured MBF is
maintained after coronary thrombolysis, occlusive thrombus was induced by
placing a copper colI into the LAD in closed-chest dogs. One and one-half
to two hours after thrombosis, lysis was induced with streptokinase. PET
following i.v. administration of H2150 and inhalation of e 15 0 was performed
during ischemia, after streptokinase, and 24 hours after reperfusion.
Radio-labeled microspheres were administered simultaneously at each
interval. Myocardial blood flow was 11% of normal during ischemia,
increased to 80% of normal immediately after reperfusion, and was 49 ± 17%
of normal at 24 hours despite continued anglographic patency. From these
studies, we concluded that MBF is reduced 24 hours after reperfusion and
that sequential evaluation of MBF can be achieved conveniently with PET.2
In the last year, we also studied the beneficial effects of coronary
thrombolysis on myocardial metabolism as well as perfusion. In eight
closed-chest dogs subjected to LAD coronary thrombus, perfusion was
evaluated with the H2150 technique, and metabolism was assessed after i.v.
injection of 11e-palmitate one to two hours after induction of thrombus.
Tomographic data were acquired in the dynamic acquisition mode
(2-minute scans). In normal regions, 11e-palmitate accumulated within two
to four minutes, and the turnover of 1 e-activity from five to fifteen
minutes was exponential with a t1/2 of 13 ± 5 minutes. In the regions
supplied by the LAD, perfusion was diminished to 22% of normal and
clearance of 11e-palmitate increased (tl/2 = 26 ± 4 minutes) indicating
substantial recovery of metabolism. These results indicated that
sequential PET permits prompt assessment of the responses of metabolism and
perfusion to coronary thrombolysis. 3
In addition, we have continued our studies of the salutary effects
of coronary thrombolysis induced with tissue-type plasminogen activator.
PET documented the recovery of metabolism and perfusion after thrombolysis
induced with t-PA, suggesting that this promising agent which does not
induce a systemic thrombolytic state, has salutary effects on perfusion and
metabolism. 4 ,5
The studies completed during the past year have demonstrated the
utility of PET for the evaluation of myocardial metabolism and perfusion
and are currently being implemented in patient studies being designed to
evaluate the efficacy of coronary thrombolysis utilizing Super PETT I.
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During the coming year, we plan to continue our evaluation of the effects
of coronary thrombolysis on the restoration of myocardial perfusion and
metabolism with PET to better characterize the response to this promising
intervention.
Furthermore, we plan to evaluate algorithms, after
institution of cardiac and respiratory gating, to correct for the effects
of partial volume effects and count-spillover. This will enable
measurements of perfusion in absolute terms.
1.

S. R. Bergmann, K. A. A. Fox, A. L. Rand, K. D. McElvany, M. J. Welch,
J. Markham, and B. E. Sobel, "Quantification of Regional Myocardial
Blood Flow in Vivo with H2150 and Positron Emission Tomography,"
Circulation, in press.

2.

R. M. Knabb, M. A. Burnes, B. E. Sobel, K. A. A. Fox, and S. R.
Bergmann, "Myocardial Perfusion Following Coronary Thrombolysis
Assessed with Positron Emission Tomography (PET) with H2150,"
Federation Proceedings, vol. 43, p. 709, 1984 (abstract).

3.

S. R. Bergmann, K. A. A. Fox, R. M. Knabb, M. A. Burnes, and B. E.
SObel, "Effects of Coronary Thrombolysis on Regional Myocardial
Perfusion and Metabolism Assessed with Positron Emission Tomography,"
Journal of the American College of Cardiology, vol. 3, p. 527, 1984.

4.

S. R. Bergmann, K. A. A. Fox, A. L. Rand, D. Collen, and B. E. Sobel,
"Recovery of Metabolism and Perfusion Assessed with PET after Coronary
Thrombolysis with Plasminogen Activator," Circulation, vol. 68,
pp. 111-38, 1983 (abstract) •

.

5.

F. Van de Werf, S. R. Bergmann, K. A. A. Fox, H. DeGeest, C. F. Hoyng,
B. E. Sobel, and D. Collen, "Coronary Thrombolysis with Intravenously
Administ~red Human Tissue-Type Plasminogen Activator Produced by
Recombinant DNA Technology," Circulation, vol. 69, pp. 605-610, 1984.
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PETT IV Cardiac Studies

Personnel:
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A.
J.
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M.
M.

M. Geltman, M.D., Medicine
D. Ambos, BCL
R. Baird, Medicine
E. Beecher, BCL
S. Jaffee, M.D., Medicine
Markham, BCL
E. Sobel, M.D., Medicine
M. Ter-Pogossian, Ph.D., Radiology
J. Welch, Ph.D., Radiology

Support:

RR 01380
HL 13851
HL 17646

This project was designed to determine the utility of positron
emission tomography (PET) for the assessment of myocardial metabolism after
the intravenous injection of 11C-palmitate in patients with a variety of
cardiac diseases. During the current grant-interval, patients were studied
with ischemic heart disease and congestive cardiomyopathy of various
etiologies to determine the extent of metabolic derangements and their
response to therapeutic interventions.
To determine whether coronary thrombolysis benefits the heart
directly, we utilized positron-emission tomography with 11c-palmitate to
characterize regional myocardial metabolism in 17 patients with initial
infarction. That was performed immediately after admission, again after
intracoronary streptokinase given within 18 hours, and 7 to 10 days later.
Clots were persistent in 9 patients, despite a mean dose of 336,000 units
and marked fibrinogen depletion. Only 2 of these patients exhibited
improved regional metabolism (a decrease in defect size greater than 20%)
in late, compared with early, tomograms. Without lysis, mean metabolic
impairment increased by 4 ± 18% (SO). In contrast, all of the 8 patients
who manifested lysis (mean time to lysis = 5.75 hrs after the onset of
pain) exhibited improved metabolism with 75% eXhibiting more than 20%
reduction in defect size in late compared with early studies, and a mean
improvement of 28 ± 2% (p < 0.01) in the group as a whole. Results were
comparable in patients with anterior and inferior infarction. Thus, clot
lysis induced by intracoronary streptokinase exerts salutary effects on
myocardial metabolic integrity and viability assessed with positron
emission tomography.
Work initiated previously to study the differentiation of ischemic
from nonischemic cardiomyopathy by positron-emission tomography has been
continued during the current grant-interval. We have now analyzed data
from 12 patients with ischemic cardiomyopathy for comparison with 10
patients with nonischemic cardiomyopathy. All patients were studied with
positron-emission tomography after the intravenous injection of 15-20 mCi
of 11C-palmitate intravenously. The spatial characteristics of the
distribution of 11C-palmitate within myocardium of the 10 new patients with
nonischemic congestive cardiomyopathy were virtually identical to the
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spatial charact~ristics of our 17 patients with nonischemic congestive
cardiomyopathy previously studied. In contrast, the distribution of
11C-palmitate in the myocardium of the 12 patients with ischemic
cardiomyopathy were distinct from patients with nonischemic
congestive-cardiomyopathy. Large defects encompassing more than 15% of the
area of a transverse tomographic reconstruction, representing depressed
accumulation of 11C-palmitate, were seen frequently in patients with
ischemic cardiomyopathy.
Ten of the 12 patients with ischemic
cardiomyopathy demonstrated such a defect. None of the patients with
nonischemic cardiomyopathy demonstrated these defects. When analyzed
employing statistical methods previously described, the number of
noncontiguous regions summed for 7 isocount thresholds was 12.1 ± 0.6 for
patients with ischemic cardiomyopathy compared to 17 ± 0.6 among patients
with nonischemic congestive cardiomfopathY. The frequency distribution of
the relative myocardial content of 1 C-palmitate was shifted towards lower
values in patients with nonischemic congestive cardiomyopathy compared to
the non-infarcted zones of patients with ischemic cardiomyopathy or to
normal subjects. Thus, positron-emission tomography, after the intravenous
administration of 11C-palmitate, permits the objective identification of
patients with ischemic from patients with nonischemic congestive
cardiomyopathy, a finding which may have significant therapeutic
implications.
Positron-emission tomography is also being employed in the analysis
of other interventions designed to salvage ischemic myocardium. It is
being used as an endpoint for studies of the efficacy of nifedipine, a
calcium channel blocker, for the salvage of ischemic myocardium in the
setting of acute myocardial infarction. To date, over 40 patients have
been studied in this randomlzed, double-blind trial. However, data have
not been analyzed, since 5 additional patients are required before the
stUdy is terminated and the code can be broken. These data should be
available for the next progress report.
Positron-emission tomography is also being employed as the primary
endpoint for studies of tissue plasminogen activator (tPA) as a new
thrombolytic agent for use in the setting of acute myocardial infarction.
To date. a total of 7 patients have been studied with tPA derived from a
melanoma cell line and. subsequently, 7 patients have been studied with tPA
derived from recombinant DNA technology and studied under an IND provided
by Genentec, Inc. Tomographic data indicate that the reduction in the size
of the defect in accumulation of 11C-palmitate observed with positron
emission tomography when lysis is achieved with tPA is at least comparable
to that observed when lysis is achieved with streptokinase. Since lysis
appears to be achieved more quickly with tPA, ultimately salvage may be
greater. but definitive analysis will require the acquisition of more
patient data.
Studies in progress should complete the analysis of the effects of
nifedipine on myocardial infarct size and the effects of tPA on the
ultimate extent of infarction with positron-emission tomography as the
primary endpoint. Additional studies are in progress which are designed to
study the relationship between defects and cardiac metabolism detected by
positron-emission tomography and abnormalities in proton spin resonance
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detected by magnetic-resonance imaging. These data will help clarify the
impact of partial volume effects and wall-motion abnormalities in the
fenesis of regions of decreased apparent myocardial content of
1C-palmitate in patients with ischemic heart disease and congestive
cardiomyopathy.
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In-Vivo Measurements of Regional Blood Flow and Metabolism in Brain
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E. Raichle, M.D., Neurology and Radiology
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L. Grubb, Jr., M.D., Neurological Surgery
Herscovitch, M.D., Neurology and Radiology
B. Larson, BCL
L. Lauter, Ph.D., Central Institute for the Deaf
Markham, BCL
A. Mintun, M.D., Neurology
J. Powers, M.D., Neurology and Radiology
L. Snyder, BCL
G. SWift, B. A., Radiology
M. Ter-Pogossian, Ph.D., Radiology
J. Welch, Ph.D., Radiology

Support:

RR 01380
HL 13851
HL 25944
NS 06833
ECS 8215181
Washington University

Because of the previously noted CPR 19, 0-3) deficiencies of
compartmental models for estimating cerebral blood flow with PET using
radioactive water as a tracer, we have been led to the formulation and
testing of distributed models for this purpose. The distributed models we
have investigated take into account longitudinal gradients of tracer
concentration along the capillaries but assume that transverse gradients
are zero. The resulting conservative conditions take the form of sets of
partial differential equations in the concentrations, with axial distance
and time as independent variables and with capillary and cellular
permeabilities, surface areas, volumes, and thermodynamic activity
coefficients as parameters. On the basis of solutions of these equations,
we have constructed simulated residue curves and have compared these with
high-temporal-resolution experimental radiowater residue histories obtained
following intracarotid injections of tracer in rhesus monkeys. A two
barrier distributed model was found to provide a realistic simulation of
the experimental curves using plausible assignments of parameter values.
With the same assignments, all other models tested failed to perform as
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satisfactorily. We are therefore encouraged to believe that our two
barrier distributed model can provide insight into the nature of in-vivo
water transport in brain and will allow us to devise simplified versions
suitable for use in our tomographic clinical applications.
Studies of brain receptors have been performed using PET and labeled
spiperone. A three-compartment model, developed previously to describe the
kinetics of spiperone in brain tissue (PR 19, 0-3), was used to evaluate
the PET-acquired time-activity curves of various regions of the brain after
injection of 18F-sPiperone in twelve baboons. These studies demonstrated
the repeatability of the method and the sensitivity of the procedure to a
decrease in the number of receptors available for binding due to previous
injections of unlabeled spiperone. Parameter values estimated from these
data agreed with published values of blood-brain-barrier spiperone
permeability and brain-receptor density. Specialized techniques are under
development for estimation of the parameters for temporal data in each
pixel of the PET reconstruction images. These techniques are based on
sensitivity analysis relating variations in the tissue-activity curves
calculated from the spiperone model to variations in the values of the
parameters. Utilization of the relationships between the tissue-activity
curves and the parameters should permit rapid and accurate estimation of
the parameters and, consequently, generation of an image of receptor
distribution in the brain for each study.
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Maximum-Likelihood Image Reconstruction for-PETT VI

Personnel:

J. O. Gorman, BCL
M. A. Mintun, M.D., Neurology
O. L. Snyder, BCL

Support:

RR 01380
RR 01379
HL 13851
ECS 8215181

The maximum-likelihood image reconstruction algorithm for non-time
of-flight PETT VI data was implemented on two general purpose computers
(DEC POP-11, Perkin-Elmer 3240), and found to produce better images than
those obtained from the filtered back-projection algorithm. Increases were
observed in the signal-to-noise ratio and resolution, and background
artifacts were decreased in the maximum-likelihood images as compared to
images obtained with the linear-filtering algorithm. This is consistent
with earlier studies done for Super PETT I data using a maximum-likelihood
reconstruction algorithm that incorporates time-of-flight (TOF)
information. 1
The maximum-likelihood algorithm has also been applied to Super
PETT I data where the TOF information has been suppressed. Images obtained
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by using the non-TOF maximum-likelihood algorithm with Super PETT I data
appear to be better in preliminary studies than those obtained with the
confidence-weighting algorithm which does use TOF information. This
indicates that the non-TOF maximum-likelihood algorithm may have
applications in TOF PET studies where the TOF information would be used to
improve the quality of the measured data by randoms rejection, and then
suppressed for reconstruction. Processing times per seven-slice study on a
VAX-class machine are on the order of seven hours for the non-TOF algorithm
(which operates on two-dimensional data) and 630 hours for the TOF
algorithm (which operates on three-dimensional data).
1.

D-5.

D. G. Politte and D. L. Snyder, "Results of a Comparative Study of a
Reconstruction Procedure for Producing Improved Estimates of
Radioactivity Distributions in Time-of-Flight Emission Tomography,"
IEEE Transactions on Nuclear Science, vol. NS-31, no. 1, pp. 614-619,
February 1984.

Data-Acquisition for Super PETT I

Personnel:

D. E. Beecher, BCL
D. C. Ficke, B.S., Radiology
T. J. Holmes, BCL

Support:
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HL
HL
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01380
13851
17646
25944

The software development for Super PETT I as described in PR 19, D-5
has continued to be useful in prototype studies of the instrument. The
list-mode, projection-array, and hybrid list-mode data collection protocols
have remained unchanged over the past year and are in routine use.
Auxiliary software to utilize the slice processors as offline array
processors is still under consideration; however, this is not considered
essential to the successful use of Super PETT I in the clinical research
environment.
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Time-or-Flight Data Acquisition System Development for Super PETT I
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Ficke, B.S., Radiology
Phillips, BCL
Schwab, BCL
Ter-Pogossian, Ph.D., Radiology

Support:

RR 01380
HL 13851
HL 17646

The data acquisition system 1 of Super PETT I consists of high-speed
digital electronics for processing positron-annihilation positional
measurements as they occur. When operating in the "list mode," the
digitally encoded measurements are routed as they occur, at a maximum rate
of 200,000 per second, to disk storage and are retrospectively retrieved
for imaging. When operating in the "pre-processing mode," the measurements
are processed as they occur at a maximum rate of 380,000 per second to
construct conventional projection arrays while using the time-of-flight
measurements to rej ect most of the random-coincidences (0-10). In the
"hybrid list-mode" the raw digital code of each measurement is transformed
into fields representing angle, distance, and time-of-flight while
correcting for calibration of the time-of-flight measurement and a physical
translation of the photon-detector array. These corrected measurements are
then transferred to disk storage as in the list-mode while they occur at a
maximum rate of 200,000 per second. The pre-processing and hybrid
list-mode are made possible by seven microcoded "slice-processors".2
The Super PETT I instrument became operational in the list mod~
during May of 1982 and has since been used for medical research studies.
At the present time, the seven slice-processors have been installed, and
microcode for both the pre-processing and hybrid list modes has been
written and tested. Preliminary tests with phantom radioactivity sources
have shown occasional artifacts in the pre-processing mode. We have
determined these artifacts to be due to capacitive signal coupling and
transmission-line reflections on the busses which transfer the measurements
between various data-acquisition devices. Our current efforts are in
addressing these bus anomalies while continuing to test the reliability of
the instrument.
Current plans for the utilization of the system are as follows. The
pre-processing mode is to be used for obtaining calibration data mentioned
in PR 19, 0-13 and for obtaining conventional emission-images within a few
minutes following data collection.
Images reconstructed by the
time-of-flight method 1 will be obtained from list-mode data. The hybrid
list-mode may be used in the future if it becomes necessary to enhance the
data-processing efficiency of the instrument.
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1.

G. J. Blaine, D. C. Ficke, R. E. Hitchens, and T. J. Holmes, "Data
Acquisition Aspects of Super-PETT," IEEE Transactions on Nuclear
Science, vol. NS-29, no. 1, pp. 544-547, February 1982.

2.

T. J. Holmes, R. E. Hitchens, G. J. Blaine, D. C. Ficke, and D. L.
Snyder, "A Dedicated Hardware Architecture for Data Acquisition and
Processing in a Time-of-Flight Emission Tomography System
(Super-PETT)," IEEE Transactions on Nuclear Science, vol. NS-30,
no. 1, pp. 170-174, February 1983.

t~

,I
;';;..0;

i_

i.

"~

1"·.I··
1 ..

I

:i;~



;'
,···.···1
..
~

'~

D-7.

A Reduced Angle Reconstruction Algorithm for Super PETT I

11
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A new sof tware reconstruction system which uses the "reduced-angle"
technique has been designed, implemented, and tested during the past year.
This technique is due to Tomitani,1 who showed by simulation that the
angular sampling requirements of time-of-flight tomography are less than
those of conventional tomography.
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The angle reduction occurs because of the way the data are organized
into a three-dimensional array of measurement points. Previously, the data
had been organized into an array with three indices representing 96
distinct angles, 128 distances from the center of the scanner, and 40
differential time-of-flight values. In the new reduced angle scheme, data
from 16 groups of 6 adjacent angles are coalesced so that the angle index
of the measurement array now takes on 16 values. When the data are parsed
into the 16 group angles, the distance and time-of-flight values are
adjusted so that the location in space of the measurement point is
unaffected, to within the quantization error. This reduced-angle
measurement array is then reconstructed as before.

i:~.~'I

lto:

t·1t'·1
~

:~'.·I
z;;

.t'~~

~~"
'~f

'1
~'

,

.

rt,:,'I',.··,
~ ...

,""

ff'
~,

;.

:'·1
,.

'~'
~f .

*'
\>

The memory requirements of the new 16-angle measurement array are
only one-sixth as great as that of the 96-angle array. Therefore, data
from several image slices can be accommodated in memory simultaneously .
With the current memory of the Perkin-Elmer 3230 host computer, only two
passes through the list-mode data file are required. (The first pass
processes image slices 1 through 4; the second pass finishes with slices 5
through 7). In addition, some of the subsequent processing steps, such as
confidence-weighting and the coordinate transformation and superposition
which form the preimage, are angle dependent and the time needed for their
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computation scales linearly with
7 slices of emission data with
has been reduced from two and
assuming that the processing of
calibration and data correction)

the number of angles. The time to process
approximately one million counts per slice
one half hours to forty-five minutes,
the blank and transmission scans (used for
has already been done.

Images reconstructed from data organized into measurement arrays
with 96 and 16 angles have been shown by Ficke to be of comparable
quality.2
1.

T. Tomitani, "Simulation Study of Reconstruction with Practical
Writing Functions and Noise Evaluation in Time-of-Flight Assisted
Positron Computed Tomography," Proceedings of the Workshop on
Time-of-Flight Tomography, IEEE Catalog No. 82CH1791-3, Washington
University, St. Louis, Missouri, pp. 117-124, May 1982.

2.

D. C. Ficke, D. E. Beecher, G. R. Hoffman, T. J. Holmes, and M. M.
Ter-Pogossian, "Recent Developments in Image Reconstruction Using a
Time-of-Fl1ght Assisted Posi tron Emission Tomograph: Super PETT I,"
IEEE Transactions on Nuclear Science, vol. NS-31 , no. 1, pp. 605-608,
February 1984.

D-8.

A Comparative Study of Image-Reconstruction Approaches for Super

PETT I
Personnel:

D. G. Politte, M.S., Radiology
D. L. Snyder, BCL

Support:

RR 01380
RR 01379
HL 25944
ECS 8215181

We have compared the performance of two image-reconstruction
algorithms for time-of-flight tomography, the confidence-weighting (CW)1
algorithm and the estimated posterior-density weighting (EPDW) algorithm. 2
The EPDW algorithm is a non-linear iterative approach, and predicting its
performance analytically has proven intractable. Therefore, our approach
for comparison has been to implement both algorithms on real and simulated
data in order to compare specific performance-metrics. The results have
been reported;3,4 we briefly summarize them below.
Resolution. The CW algorithm uses an adjustable filter which
controls the resolution of the images. The resolution is a measure of the
smallest features which are distinct. The best resolution obtainable by
the CW algorithm is limited by the geometric resolution, which is a
function of the detector size and placement. However, we have found that
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features as small as half of the geometric resolution can be made distinct
with the EPDWalgorithm.
Signal-to-noise ratio. We find that the EPDW algorithm improves the
signal-to-noise ratio in the myocardium of a simulated left ventricle by at
least 2.1 db over the CW reconstruction. The amount of gain is dependent
on the resolution of the image and is greatest when the resolution is best.
Contrast. The EPDW algorithm provides superior contrast between the
simulated left ventricle and its blood pool.
Background artifact. Registration of activity in regions where
there is none is lessened with the EPDWalgorithm.
Reconstruction time. Computation of images with the EPDW algorithm
is approximately 100 times slower than the computation of images with the
CWalgorithm.
The current implementations of the EPDW algorithm are too slow for
routine clinical use. Further research is needed to explore methods for
speeding its computation.
1.

D. L. Snyder, L. J. Thomas, Jr., and M. M. Ter-Pogossian, "A
Mathematical Model for Positron-Emission Tomography Systems Having
Time-of-Flight Measurements," IEEE Transactions on Nuclear Science,
vol. NS-28, no. 3, pp. 3575-3583, June 1981.

2.

D. L. Snyder and D. G. Politte, "Image Reconstruction from List-Mode
Data in an Emission Tomography System Having Time-of-Flight
Measurements," IEEE Transactions on Nuclear Science, vol. NS-30, no.
3, pp. 1843-1849, June 1983.

3.

D. G. Politte and D. L. Snyder, "Results of a Comparative Study of a
Reconstruction Procedure for Producing Improved Estimates of
Radioactivity Distributions in Time-of-Flight Emission Tomography,"
IEEE Transactions on Nuclear Science, vol. NS-31, no. 1, pp. 614-619,
February 1984.

4.

D. G. Politte, "Reconstruction Algori thIns for Time-of-Flight Assisted
Pos i tron-Emi ss ion Tomographs," Department of Electrical Engineering,
Washington University, St. Louis, Missouri, December 1983 (M.S.
Thesis) .
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Count Normalization for Conventional and Time-of-Flight Tomography

Personnel:

T. J. Holmes, BCL
D. C. Ficke, B.S., Radiology
D. L. Snyder, BCL

Support:

RR 01380
HL 13851
HL 17646
ECS 8215181

Two of the fundamental operations of a positron-emission tomograph
are the sorting and counting of discrete recordings of positron
annihilation events according to measurement vectors which they carry.
Part of the reconstruction process includes the normalization of these
counts with respect to scintillation-detector efficiency, spatial-sampling
density, and photon absorption. There are several ways to combine and
normalize these counts during the image-reconstruction process. We have
performed a statistical analysis on these methods to determine their
relative performance. The combined, normalized counts are treated as
parameter estimators, and the metrics of their performances are their
biases and variances. These results have been published,1 and have
implications on the complexity of the reconstruction process.
1.

D-10.

T. J. Holmes, D. L. Snyder, and D. C. Ficke, "A Statistical Analysis
of Count Normalization Methods Used in Positron-Emission Tomography,"
IEEE Transactions on Nuclear Science, vol. NS-31, no. 1, pp. 521-526,
February 1984.

Modeling of Random-Coincidence Detections in Time-of-Flight
Tomography

Personnel:

T. J. Holmes, BCL
D. C. Ficke, B.S., Radiology
D. L. Snyder, BCL

Support:

RR 01380
HL 13851
HL 17646
ECS 8215181

A random coincidence is defined as the erroneous registration of two
photons, originating from separate positron annihilations, as having
originated from the same positron annihilation. Previous analyses which
did not consider random coincidences indicated that for a certain
radioactivity distribution a gain in image signal-to-noise ratio of about
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5 dB is achieved by the time-of-flight method over the conventional method.
Subsequent experiments 1 have validated this prediction in low counting rate
situations. For higher, typical counting rates these experiments showed a
significantly larger gain of about 9 dB, which was attributed to the way in
which the time-of-flight method suppresses the degrading effects of random
coincidences.
We have developed and published an analytical model 2 which extends a
previous model 3 to consider random coincidences. Calculations of signal
to-noise ratio, using this model, compare well wi th the experiments and
show that the additional gain is indeed due to the treatment of random
coincidences. An understanding of the model leads to an intuitive
explanation of the gain mechanism and a determination of an effective
coincidence-timing window that is achieved by the time-of-flight method.
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M. Yamamoto, D. C. Ficke, and M. M. Ter-Pogossian, "Experimental
Assessment of the Gain Achieved by the Utilization of Time-of-Flight
Information in a Posi tron Emission Tomograph (Super PETT I)," IEEE
Transactions in Medical Imaging, vol. MI-1, pp. 187-192, November
1982.

2.

T. J. Holmes, D. L. Snyder, and D. C. Ficke, "The Effect of Accidental
Coincidences in Time-of-Flight Positron Emission Tomography," IEEE
Transactions in Medical Imaging, to appear.

3.

D. L. Snyder, L. J. Thomas, Jr., and M. M. Ter-Pogossian, "A
Mathematical Model for Positron-Emission Tomography Systems Having
Time-of-Flight Measurements," IEEE Transactions on Nuclear Science,
vol. NS-28, pp. 3575-3583, June 1981.
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0-11.

Effects of Positron-Emission Tomography Scintillation Detectors on
Resolution and Sensitivity

Personnel:

T. J. Holmes, BCL
D. C. Ficke, B.S., Radiology
M. M. Ter-Pogossian, Ph.D., Radiology

Support:

RR 01380
HL 13851
HL 17646

In addition to improvements in signal-to-noise ratio, the trends in
positron-emission tomography have been toward images of higher resolution.
The fundamental parameter that determines this metric is the width of the
scintillation-detector crystal. With linear-filtering reconstruction
methods, a resolution of approximately 0.6 of the detector width is
typically achievable at the center of the image.
This value is
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approximately equal to the full-width at half-maximum (FWHM) of the line
spread function seen in the center of a conventional projection array.
This FWHM is not constant throughout the profile.
It is
significantly greater at the edges of the profile, manifesting a
degradation in image resolution, because the geometry of the scintillation
detectors is such that the gamma-photons penetrate a crystal and are
erroneously absorbed by adjacent crystals. The chosen crystal-geometry and
inter-crystal septa have an impact on this phenomenon and on the detector
sensitivity, which depends upon the radiation's angle of incidence.
Exploiting the methods of Lecomte et al,1 we have analyzed various
high-resolution scintillation detectors for resolution and sensitivity. In
particular, the effects of using a triangle-shaped face and inter-crystal
septa are studied for both BaF2 and BGO crystals. The results indicate
that usage of the tungsten septa alone causes an improvement in resolution
in areas away from the center of the image but also causes a degradation in
sensitivity in those areas, and that usage of a triangle face alone causes
no improvement in resolution, while usage of septa and a triangle face in
combination causes a similar resolution improvement with a lesser
degradation in sensitivity. Current plans are to analyze a wider range of
detector geometries at various angles of incidence.
1•

0-12.

R. Lecomte, D. Schmitt, and G. Lamoureux, "Geometry Study of a High
Resolution PET Detection System Using Small Detectors," IEEE
Transactions on Nuclear Science, vol. NS-31, no. 1, pp. 556-561,
February 1984.

Studies of Detector Electronics for Time-of-Flight Tomography
Systems

Personnel:

R. O. Gregory, BCL
G. L. Engel, BCL

Support:

RR 01380
RR 01828
Washington University

During this time period, work was initiated on a novel gamma ray
detector. In time-of-flight positron-emission tomography machines, such as
Super PETT I and II, gamma photons are detected via their interaction with
a scintillator crystal and a photomultiplier tUbe. The intent of the novel
detector is to combine the scintillator and photomultiplier tUbe in one
structure, with a view towards an improvement in time and space resolution
of the time-of-flight measurement. A proposal to the Department of Health
and Human Services in Spring 1983 describes the proposed structure in
detail. 1
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Work carried out subsequent to July 1, 1983 has been mainly in the
area of photocathode deposition. We have been depositing thin films of
antimony and alkali metals, including cesium, sodium, and rubidium, on
glass substrates and measuring their photoemissive characteristics. These
materials, deposited in the proper proportions, constitute the bulk of
commercial photocathodes described in the literature. Development of this
technique was felt to be necessary because photocathodes, once deposited,
are extremely sensitive to trace amounts of oxygen or water vapor and so
are not transportable outside of an ultra high vacuum environment. We have
deposited photocathodes with what appears to be adequate quantum
efficiency; however, we have not been able to obtain photocathodes whose
photo-emission does not deteriorate with time. We have concluded that the
reason for this is because we have been depositing the photocathodes in a
large demountable vacuum system with attainable vacuums in the 5x10- 7 to
5x10- 6 range. Although these vacuum values are within the range considered
appropriate for this work,2 in large systems the attainable vacuum is
strongly dependent on the pumping rate and a high capacity pump may mask
leaks that would be apparent in a smaller or non-pumped enclosure. The
solution is to move to a small, bakeable envelope, which is in fact the
technique used in ordinary photomultiplier construction where evaporation
takes place from sources placed within the tube itself. Although we are
reluctant to do so because our available volume is small, it appears that
we will have to move to this technique also; and so we are in the process
of assembling suitably small emission sources and arranging with a glass
blower for the necessary envelope.
1.

"A New Approach to Fast Gamma-Radiation Detection," Grant Application
to DHHS under the BRP Small Grants Program for Pilot Projects, January
27, 1983.

2.

A. H. Sommer, Photoemissive Materials: Preparation, Properties, and
Uses, John Wiley, New York, 1968.

D-13.

Maximum-Likelihood Estimation of Parameters in Dynamic Tracer
Studies

Personnel:

J. M. Ollinger, BCL
D. L. Snyder, BCL

Support:

RR 01380
RR 01379
ECS 8215181

~:':

The primary advantage of positron emission tomography over other
imaging modalities is its ability to provide information on physiological
and biochemical processes. Although this information is both temporally
and spatially dependent, conventional reconstruction-algorithms suppress
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The temporal aspects and display only the spatial variations of the data.
The goal of this research is to utilize the time-dependency of the data to
estimate physiological parameters of interest.
Analyses of biological processes using compartmental models
represent the tracer activity distribution (intensity) as a linear
combination of the solutions to a set of linear differential equations.
Physiological parameters of interest, e.g. blood flow or blood volume,
appear as coefficients in these equations. The intensity can therefore be
represented as a sum of decaying exponentials convolved with an input
function:

A(t)

a

i(t)

M

*ma1
L

A
Tm

~

exp(-t/Tm),

where the input function, i(t), is proportional to the tracer concentration
within the blood, and is assumed to be known. Snyder 1 proposed a method
which estimates the Am and Tm of this equation. The analytical solution of
the differential equation can then be used to solve for the physiological
parameters of interest.
The method can be summarized as follows. After a number of images
have been reconstructed, regions of interest are specified in each. Data
from the images are then used to weight each event in the list-mode data
with the probability that it occurred in the region of interest •. The EM
algorithm of statistics, as discussed by Dempster, Laird, and Rubin,2 is
then used to find the maximum-likelihood estimates of the parameters from
histograms formed from the weighted list-mode data.
The number of
reconstructed images is small, perhaps only one in some clinical studies.
The principal advantage of the EM algorithm over other maximum-likelihood
techniques is that it decouples the set of equations which must be solved.
Evaluation of the method to date has concentrated on the estimation
step. Testing of the histogram-generation step will be done in the near
future.
The algorithm was evaluated for a bolus input-function by comparing
it to a gradient method of maximum-likelihood estimation proposed by
Markham,3 which in turn was compared favorably to several other methods. 3
The EM algorithm always converged to a unique solution, even for very poor
initial estimates. The variance of the estimation error and the bias were
consistently lower than that of the gradient method, and were considerably
better for small numbers of bins. This algorithm is, therefore, an
attractive approach for an impulsive input-function.
The extended algorithm for arbitrary input functions is of greater
practical interest, since non-bolus input functions are frequently
encountered in practice. This algorithm is currently being evaluated.
Issues to be addressed include the uniqueness of the solution, sensitivity
to poor starting values, and the incorporation of side information in the
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form of physiological parameters measured in other tests. This version of
the algorithm could be applied to several experiments currently being
performed at the Mallinckrodt Institute of Radiology if these issues are
satisfactorily resolved.
1.

D. L. Snyder, "Parameter Estimation for Dynamic Studies in Emission
Tomography Systems Having List-Mode Data," IEEE Transactions on
Nuclear Science, no. 2, pp. 925-932, April 1984.

2.

A. P. Dempster, N. M. Laird, and D. B. Rubin, "Maximum Likelihood
from Incomplete Data via the EM Algorithm," J. R. Statistical
Society, vol. 39, pp. 1-38, 1977.

3.

J. Markham, D. L. Snyder, and J. R. Cox, Jr., "A Numerical
Implementation of the Maximum-Likelihood Method of Parameter
Estimation for Tracer-Kinetic Data," Mathematical Biosciences,
no. 28, pp. 275-300, 1976.

0-14.

Utilization of Side Information in Image Reconstruction

Personnel:

D. L. Snyder, BCL

Support:

RR 01380
RR 01379
ECS 8215181

Anatomical information derived from x-ray and magnetic-resonance
tomographic sections is useful for producing mare accurate reconstructions
of radioactivity distributions in the same section from emission-tomography
data. Additionally, attenuation information acquired for calibration in
emission tomography is necessary for producing accurate reconstructions of
activity. An algorithm based on the maximum-likelihood method of
statistics has been identified for utilizing both of these forms of side
information. 1
1.

D. L. Snyder, "Utilizing Side Information in Emission Tomography,"
IEEE Transactions on Nuclear Science, vol. NS-31, no. 1, pp. 533-537,
February 1984.
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0-15.

Effects of Finite-Precision Arithmetic on the Maximum-Likelihood
Algorithm for PETT Image Reconstruction

Personnel:

J. O. Gorman, BCL
O. L. Snyder, BCL

Support:

RR 01380
RR 01379
ECS 8215181

Since the introduction of the maximum-likelihood algorithm for PET
image reconstruction,1,2 there has been increasing interest among
researchers to use this algorithm for reconstruction in clinical studies.
Although the algorithm has produced better images than other available PET
reconstruction techniques,3 it is also more computationally burdensome.
Reconstruction times for the maximum-likelihood algorithm implemented on a
VAX-class machine are too long for the algorithm to be of practical use
clinically. A specialized hardware processor, perhaps implemented using
VLSI,4 could supply the additional computational speed needed to make the
algorithm useful in the clinical environment.
A study has been initiated to investigate the effects of finite
length registers and finite-precision arithmetic on the algorithm.
Knowledge of the effects of fixed-point arithmetic and tradeoffs in image
quality as a function of register sizes are the first steps toward an
efficient hardware implementation of the algorithm.
1.

L. A. Shepp and Y. Vardi, "Maximum-Likelihood Reconstruction for
Emission Tomography," IEEE Transactions in Medical Imaging, vol. MI-1,
no. 2, pp. 113-121, October 1982.

2.

O. L. Snyder and O. G. Politte, "Image Reconstruction from List-Mode
Data in an Emission Tomography System Having Time-of-Flight
Measurements," IEEE Transactions on Nuclear Science, vol. NS-30,
no. 3, pp. 1843-1849, June 1983.

3.

o.

4.

C. E. Molnar, "VLSI Systems for Time-of Flight PET," Proceedings of
Workshop on Time-of-Flight Tomography, IEEE Catalog No. 82CH1791-3,
Washington University, St. Louis, Missouri, pp. 167-170, May 1982.

G. Politte and O. L. Snyder, "Results of a Comparative Study of a
Reconstruction Procedure for Producing Improved Estimates of
Radioacti vi ty 0 istri but ions in Time-of-Flight Emission Tomography,"
IEEE Transactions on Nuclear Science, vol. NS-31, no. 1, pp. 614-619,
February 1984.
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D-16.

Slice Processor Selection for Super PETT II

Personnel:

D. E. Beecher, BCL
D. C. Ficke, B.S., Radiology

Support:

RR 01380
HL 13851

The motivation for the utilization of seven slice-processors is a
result of considerable experience gained in the design, fabrication, and
use of Super PETT I, which uses the list-mode data collection and time-of
flight information in the image-reconstruction process. While these two
concepts have proven to be useful and desirable, they both place high
demands on the supporting computer system.
The incorporation of list-mode data-collection requires list-mode
events first to be buffered in computer memory and then transferred to disk
as they occur. If lOOK events/second is used as a target goal for the
count rate in each slice, the computer system's I/O throughput capacity
must be able to sustain 1.4M bytes/second, and the disk subsystem must be
able to sustain a 700K event/second rate.
In addition, the proper incorporation of the time-of-flight
information and its associated correction factors for the "confidence
weighted" pre-image and the subsequent two-dimensional f 11 ter ing to form
final images are formidable CPU intensive tasks. This problem is
compounded by processing seven simultaneously collected slices from the
event list.
In the development of Super PETT I, it was recognized that auxiliary
processing power was necessary to use the time-of-flight information
effectively. For this reason, seven specialized slice-processors were
designed and built to form attenuation arrays and aid in on-the-fly data
corrections before recording the data in the event list.
From this
experience it was apparent that the design, fabrication, debugging and
software development involved in such specialized hardware components was a
formidable task and has yielded results which are less than desirable,
although at that time this approach was perhaps the only available. In
Super PETT I, the event rate is limited to about 400K events/second in the
list-mode, and post processing requires about 35 minutes for a set of seven
slices, each containing about 1 million events.
Recently however, several commercially available 32-bit processors
were introduced which we felt could be used successfully in this
environment, and we began to explore these possibilities for Super PETT II.
There are several reasons why this particular approach is very attractive.
The general scheme consisting of individual low-cost processors and disks
for each slice very much improves total system event-rates since each slice
is serviced by a single processor and disk. This implies no contention
between slices for DMA input and storage. The reconstruction process is
also enhanced by allowing each slice processor to reconstruct one slice in
parallel with the other six. Another very important point lies in the fact
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that these systems are equipped with the total complement of support
software found on larger machines which greatly reduces the software
development time associated with the slice processors. Vendor supplied
systems can also be placed under maintenance contracts to avoid excessive
down time due to hardware and software related problems.
Several systems were examined and tested to determine their
potential usefulness. They were: Perkin-Elmer 3205, Digital Equipment
Corporation (DEC) Micro-VAX, and Hewlett-Packard (H-P) 9000. Due to our
existing in-hoUse expertise with Perkin-Elmer, we were somewhat predisposed
to a Perkin-Elmer solution if indeed it proved to be competitively cost
effective. However, we realized that it could be advantageous to switch to
DEC or H-P if conditions dictated. In an evaluation effort, we designed a
specialized interface to simulate event generation from Super PETT II and
ran a series of tests involving the list-mode data transfer and the ability
to do on-the-fly processing. We ran these tests initially on the Perkin
Elmer 3205 and obtained good results with the ability to collect
approximately 200K bytes/second of event data per slice. With proper
hardware preprocessing each event may be reduced to 2 bytes yielding 700K
events/second for the entire system. For instance, one preprocessing
strategy reduces each event to 5 bits of angle information, 4 bits of time
of-flight information, and 7 bits of displacement information.
Similar tests on a Micro-VAX system yielded only 120K bytes/second
from a single slice which translates into 420K events/second for the total
system. This drop in effective throughput was deemed unacceptable given
that the Micro-VAX and 3205 are comparably priced. The H-P 9000 was not
directly tested. However, we did speak at length with H-P technical
personnel and discovered that the 9000 did not readily allow the
incorporation of custom-designed interfaces; and the machines cost was
substantially higher than that of the Micro-VAX or the 3205.
The combination of price, performance, and compatibility indicated
that the 3205 was the best choice for this application. The Perkin-Elmer
3205 processor is implemented as a single-board CPU with built-in hardware
floating point, a high-speed DMA port, and memory which can be expanded on
the single board to 1 megabyte. An additional memory board can be added to
expand the total memory to 4 megabytes. A second board contains the
medium-speed multiplexor bus, a multiple peripheral controller, universal
clock, watchdog timer, loader storage unit, 8-line communications
mUltiplexor, line printer interface, and high-speed data handling
capabilities. Figure 1 shows the internal configuration of a single slice
processor. Each 3205 is also configured with an 80 megabyte fixed disk
drive fo~ data storage and a dual-port option for intersystem
communication. Figure 2 illustrates the entire proposed configuration to
support Super PETT II for neurological studies.
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Slice Processor Configuration
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D-17.

Super PETT II Detector Design
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Ficke, B.S., Radiology
Holmes, BCL
Hood, B.S., Radiology
Ter-Pogossian, Ph.D., Radiology

A new detector module has been designed, fabricated, and tested for
use in Super PETT II, a time-of-flight assisted positron-emission tomograph
which is currently being developed.
The detector module as shown in Figure 1 consists of eight barium
fluoride scintillation-detectors coupled to five high speed photomultiplier
tubes. In this arrangement, four tubes are each coupled to two detectors
for the purpose of photon timing and energy information, while the central
tube is coupled to four detectors for resolving the photon positional
information by an electronic coincidence detection scheme with the timing
tubes.
When this module is tested by scanning a line source, the response
as shown in Figure 1 is obtained which indicates a spatial resolution of
4 mm FWHM.
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Figure 1. The Super PETT II petector module is shown with its
measured spatial resolution.
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0-18.

Three-Dimensional Image Construction and Display

Personnel:

D. E. Beecher, BCL
J. R. Cox, Jr., BCL
L. J. Thomas, Jr., BCL

Support:

RR 01380
HL 13851

Work has continued on the research as described in (PR 19, 0-6) and
the results of this research have been published. 1 Further research is
planned in the following areas:
1.

Three-Dimensional Object Definition

Current techniques employ a simple thresholding algorithm to define
the object(s) of interest in a scene. Although this technique has proven
to be useful in pilot studies, new techniques are being explored in order
to define three-dimensional objects more effectively. Gradient techniques
which define object boundaries based on changes in a local neighborhood may
yield superior results. Also transparency techniques may prove to be quite
effective in alleviating the need to do any object definition.
2.

Parallelism

The algorithm as described in (1) has a very high degree of
parallelism which may be exploited via a custom-designed VLSI
implementation. This may make real-time shaded-surface display possible.

3.

Shading Algorithms

Initial efforts in this area were very simplistic in that only a
depth cue was utilized to produce the three-dimensional effect. Much work
is planned in this area to improve the visualization by enhancing the
shading algorithm used in view generation.
The concept of local
neighborhoods will be studied to determine the orientation of planes which
may exist within the object. This information when combined with angle
information, should substantially improve the views generated.
4.

Generation of Non-Orthogonal Views

The system as originally implemented generates only orthogonal views
of the voxel volume. Generation of non-orthogonal views will require
slight modifications of the original algorithm but should not substantially
increase view generation time.
5.

Multiple-Intensity Level Displays

The current scheme thresholds at a single intensity level to
determine an object space. However if color is used as a secondary cue,
multiple intensity levels can be displayed simultaneously which should
improve the contextual information contained in the visualization.
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1.

D-19.

D. E. Beecher, J. R. Cox, Jr., and L. J. ThOlllas, Jr., "A New Voxel
Model Approach for Three-Dimensional View Generation," Proceedings of
the Eighth Conference on Computers in Radiology, St. Louis, Missouri,
May 23-25, 1984, in press.

Maximum-Likelihood Estimation for Single-Photon Emission Computed
Tomography

Personnel:

D. L. Snyder, BCL
M. I. Miller, BCL
T. R. Miller, Radiology

Support:

RR 01380
HL 17646
RR 01379
ECS 8215181

An algorithm is being developed for producing maximum-likelihood
estimates of activity distributions for emission-tomography systems which
employ tracers that emit single photons. This algorithm takes into account
both the depth-dependent point spread function of single-photon detectors
and the non-uniform attenuation of photons from the emission point to the
detector. More accurate quantitative reconstructions of activity
distributions should result compared to al~orithms in present use.

-120

E.

Systems for Specialized Biomedical Studies

This section reports on a variety of instruments, systems, and
methods which are not easily grouped under the major report headings.
There is one common thread; much of the work relates directly to the
nervous system. For example, the data recording system described in PR-19
(E-3) is being combined with a versatile and remotely controllable signal
amplifier and conditioner. This should find general application in future
projects. In a related study large-scale electrode arrays receive signals
from the brain which are then analyzed by computers.
Electrical concomitants of nervous system actiVity are no longer the
only minimally invasive method of studying the functional anatomy of the
brain. The PETT system shows promise of displaying a variety of responses
to sensory stimulation and software for this purpose is under development.
Studies of the auditory nervous system are helped by the application
of statistical methods originally designed for use in nuclear medicine,
whilst a computer is providing information on the responses of the eye to
colored stimuli. This is finding clinical use in cases with retinal or
optic nerve diseases. The remaining neurological project has been the
introduction of the autoradiographic analysis method, using computer
imaging of silver grains, to the Laboratory for Neuro Imaging (LONI) where
it is co-located with larger computer systems.
There are a number of projects which involve the development of
specialized mathematical algorithms especially related to biomedical
imaging and work continues on the application of computer technology to DNA
restriction mapping.
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E-1.

An Automated Autoradiographic Analysis System for Neuroanatomical
Studies

Personnel:

R.
E.
S.
J.
A.

E.
G.
R.
L.
W.

Hermes, BCL
Jones, M.D., Ph.D., Anatomy
Phillips, BCL
Price, Ph.D., Anatomy
Toga, Ph.D., Neurology

Support:

RR 01380
NS 15070

The silver grain counting system developed several years ago for
automated analysis of neuroanatomical autoradiographs (PR 18, C-1; PR 19,
E-1) was moved to the Laboratory for Neuro Imaging (LONI). The LONI
laboratory consists of a VAX 11/750 with an image display system. An
Eikonix flat bed scanner for digitizing images of interest is interfaced to
the VAX. The LONI system serves as a general resource for neuroanatomist
and other researchers. Placement of the silver grain counting system in
close proximity to the LONI system has made use of the system more
convenient for users of both systems.
The silver grain counting system has a well designed data
acquisition and image display system. Data analysis software on the system
is very specialized for the task of counting silver grains.
The
specialized nature of the analysis software has prohibited use of the
system for other data ~nalysis problems which could take advantage of the
data acquisition system. The current proximity of the LONI system makes
possible the connection of the two systems where data may be acquired on
the specialized syste~, and subsequent data analysis, display, and
archiving may be conducted on the larger system.
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E-2.

DNA Restriction-Mapping

Personnel':

J.
M.
M.
M.

Support:

RR 01380
GM 27889
GM 28232
Washington University

G.
S.
V.
R.

Dunham, BCL and Electrical Engineering
Frank, M.D., Genetics
Olson, Ph.D., Genetics
Weber, Electrical Engineering

The DNA mapping project, under the direction of M. V. Olson of the
Department of Genetics, will generate approximately 5000 fragments of DNA
randomly sampled from a particular yeast. These fragments will be cloned
using recombinant DNA techniques, completely digested with a restriction
enzyme run on an agarose gel using electrophoretic techniques and
photographed. An automated gel reading system was developed by BCL to
determine the location of bands on the gel and has been reported. 1
One effort has been to characterize the noise introduced by
digitizing the gel photographs for further analysis. M. Weber has obtained
a characterization of the system. 2 To summarize, an analysis of the
various noise sources within the CCD camera of the digitizer suggests that
the overall noise is a combination of Poisson and Gaussian components.
Since these noises are quantized, the overall noise should appear as a
quantized Gaussian whose variance is a linear function of the input light
intensity. A histogram at 12 bits showed that the output was roughly a
quantized Gaussian. In time, they were found to be uncorrelated, and hence
independent. When Viewing a single sample, one gets approximately 6 bits
of useful information while temporal averaging of 32 samples yields 8 bits
of useful information, useful in the sense that the true value is obtained
with probability 0.95 or higher. After proper normalization, all the
pixels seemed to consistently reflect the input intensity level on the
average. However, a few pixels had a large variance, tending to fluctuate
widely about the mean value. These wide fluctuations suggests that such
pixels are unreliable and perhaps should be noted in later stages of
processing the digitized gel photographs.
Accurate band detection and estimation of location is critical to
the success of the overall reconstruction of the yeast genome from the
clones. A review early in the progress report period found that the
original band detection algorithm was unsatisfactory for several reasons.
Two approaches were undertaken to improve the band detection algorithms, an
ad hoc approach by M. Frank and an analytic method based upon a statistical
model of the overall gel photography by M. Weber.
The ad hoc approach by M. Frank reads the gel at two light intensity
levels and attempts to compensate for nonuniform light intensities across
the gel. First, peaks are detected which potentially correspond to bands.
Next, several properties of the band shape are used to determine if a band
is an isolated band or a cluster of bands. If an isolated band is found,
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then it is determined whether it is a singlet, doublet or triplet.
cluster of bands is found, then further work is performed to determine
many bands are in the cluster and then their locations are estimated.
algorithm was implemented and found to yield improved performance over
original algorithm.

If a
how
The
the

Another approach was undertaken by M. Weber based upon a model
described in Reference 2. Briefly, the model shows that the concentration
of DNA from a band is approximately:
C(x) • Co e

-aX

e

(x-J,J)2/202

where x is the distance down the gel lance, Co is the actual DNA
concentration, 2 is a factor related to gel mobility and the amount of time
a gel is run, J,J is the true location of the band and 02 is the variance of
the band shape. Since a negative is taken, the transmittance of the film
is roughly proportional to 1/C(x) and implies that large concentrations
appear as small transmittances. Some experimental work described in
Reference 2 provides a partial verification of the model.
Based upon the model for the digitizer noise process and the model
for the band DNA concentration, a detector was developed using ideas from
statistical detection and estimation theory. Two filters were developed,
one to locate the center of bands and the other to estimate the
concentration of DNA. Applying the filter to real data indicated that the
approach has potential for estimating band location and concentration.
Several potential problems were also observed. First, since a negative was
taken, the digitized image must be numerically inverted and accuracy
becomes a problem when using a linear analog/digital converter. Second,
the large dynamic range of the light on the gel suggests that the gel needs
to be" scanned at a multiple number of intensities, a conclusion
independently reached by M. Frank. Third, not all gels give consistent
results, for equimolar DNA samples. The cause of this problem has not been
identified at the present time. Possible explanations include reciprocity
failure of the film, incorrect film exposure and light-source problems.

1.

A. J. Gray, D. E. Beecher, and M. V. Olson, "Computer-Based Image
Analysis of One-Dimensional Electrophoretic Gels Used for the
Separation of DNA Restriction Fragments," Nucleic Acids Research,
vol. 12, pp. 473-491, 1984.

2.

M. R. Weber, "Band Detection for DNA Electrophoretic Gels," Master of
Science thesis, Department of Electrical Engineering, Washington
University, St. Louis, Missouri, 1984.

E-3.

Development of Multi-Channel Analog Data Recorder

Personnel:

H. W. Shipton, BCL
S. R. Broadstone, B.A., B.S., Electrical Engineering

Support:

RR 07054
Washington University

The prototype model described in PR-19 has been re-engineered and an
improved filter system incorporated. The system has been tested in this
new form but extensive trials in a realistic environment await the
completion of the data acquisition system (E-4) with which the system will
be packaged.

E-4.

Development of a Data Acquisition System

Personnel:

H. W. Shipton, BCL
S. R. Broads tone , B.A., B.S., Electrical Engineering

Support:

Washington University

Most biological amplifiers are direct descendants of the
differential amplifiers developed early in the vacuum tube era and few
systems exist which take advantage of the stability and reliability of
solid state amplifiers. An investigation has been carried out into the
desirable features of a "universal" biophysical amplifier than can be
produced simply and incorporated into many different devices.
The
desirable features include low input-stage noise and the ability to accept
high-impedance electrodes. They must also be capable of operating with
considerable offset potentials since in clinical practice these often
approach 200 millivolts.
It is desirable that gain and filter settings be capable of control
from devices (e.g. computers) which are located away from the biological
preparation.
The problem of common mode rejection ratio is frequently misstated.
Obtaining ratios of the order of 130 db is trivial in a laboratory but
neither necessary nor practicable under operational conditions. It is of
considerable importance that CMRR should be preserved with 10-15% electrode
impedance imbalances and also that it should not vary over the frequency
range of the amplifier.
Consideration of these factors led to the design of a system in
which the input stage is a low gain JFET differential amplifier with a
constant current injected into the source so as to stabilize the working
point. It was found difficult to obtain a repeatable design owing to wide
tolerances of obtainable commercial components. This stage is followed by
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an instrumentation amplifier which has switch controllable gains in the
sequence 1, 2, 5. Unfortunately, no available silicon switches have
sufficiently low "on" resistances to permit them to be used to set the
instrumentation amplifier. The necessity of using reed relays or DIP
switches complicates gain control. It is understood that early next year
at least one manufacturer will produce an instrumentation whose gain can be
controlled by a typical computer bus. Samples of this are not yet
available.
A major advantage of the present system is that up to the output of
the instrumentation amplifier, the system is directly coupled so that only
one high pass filter occurs in the system. This has great advantages in
minimizing blocking time, undesirable phase shifts and frequency dependent
CMRR.
The system can be adjusted over the entire range of commonly
measured biophysical measurements by the adjustment of no more than one
resistor and two capacitors.
A multi-channel version of the system is currently undergoing tests
and will form part of the analog tape system described in E-3.

E-5.
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Color Perimetry Studies

Personnel:

W. M. Hart, Jr., M.D., Ph.D., Ophthalmology
K. W. Clark, BCL

Support:

RR 01380
EY 03703

During the past year the color perimetry video system has been in
clinical use at the Department of Ophthalmology. The system has been used
for visual field evaluation of patients with known or suspected optic nerve
and retinal diseases. The perimetry device consists of a color video
tangent screen with a diagonal size of 19 inches which is placed at a
distance of 10 inches from the patient's eye. Colored test objects which
are square in shape and variable in size are presented on the tangent
screen under real-time control by a graphics tablet. The test objects are
of various colors and are presented in a background of a neutral gray
color. Luminance values for the gray background and for the colored test
objects are calibrated by means of a digital video photometer which is used
to generate a lookup table in the memory of a microcomputer (Motorola
Exorset). Colored test objects are matched to a constant-luminance white
surround through the use of heterochromatic flicker photometry. Test
objects are then varied only in their size and degree of color saturation.
Clinical studies 1 ,2 over the past year have revealed that visual
field defects resulting from retinal and optic nerve diseases, when plotted
by color contrast perimetry, are identical in shape and size to those
plotted by conventional luminance increment perimetry. No significant
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difference was found either between the use of red or green vs blue test
objects. Studies during the subsequent project year will involve the use
of a yellow color for the adapting surround with test objects that are
modulated in the blue direction from yellow passing through white into
fully saturated blue.
This strategy has been chosen because
neurophysiologic studies of the primate visual system have revealed that
the blue-yellow color-opponent channel is the only one that can be expected
to be completely isolated from luminance difference detection mechanisms.

1.

W. M. Hart, Jr., R. K. Hagen, and K. W. Clark, "Color-Contrast
Perimetry,"
Investigative Ophthalmology and Visual Science,
vol. 25, pp. 400-413, 1984.

2.

W. M. Hart, Jr., and M. O. Gordon, "Color Perimetry of Glaucomatous
Visual Field Defects," Ophthalmology, vol. 91,
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pp. 338-346, 1984.

Isolated-Scintillation-Probe Data Acquisition System

Personnel:

D. E. Beecher, BCL
H. D. Ambos, Medicine
R. E. Hermes, BCL

Support:

RR 01380
HL 13851
HL 17646

Hardware and software development has been initiated and continued
over the past year using the newly acquired LSI 11/23 system configuration
as described in PR-19, E-8.
Software system development is now close to completion and will
allow protocols not possible with the current configuration. The software
system is highly modular which will allow the completed system to be easily
maintained and modified in the future. Specifications are not yet complete
for the analysis portion of the system, but will be developed shortly after
the prototype has been finished.
A new hardware probe interface has recently been developed and is
now being tested on the new system. It utilizes a DMA interface to the
LSI 11/23 and will enable real-time acquisition and display of the probe
data. This will enable experiments to be aborted quickly if initial probe
data curves are not promising.
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E-7.

Software Development for Neurological Sciences

Personnel:

D. E. Beecher, BCL
P. T. Fox, M.D., Neurology and Radiology
M. A. Mintun, M.D., Neurology

Support:

RR 01380
NS 06833
McDonnell Center for Studies of Higher Brain Function

Work is currently underway on two separate neurology projects
involving visual evoked response as measured by PET and redesign of a pre
existing software system to analyze PET images.
The software for visual evoked response is separated into three
distinct subsystems. The first is a variable sized checkerboard pattern
which has a user-selectable background and foreground colors.
The
remaining subsystems involve the generation of moving targets. The first
generates a box of a specified size which can be moved at a user-selected
rate. The moving target subsystems also have user-selectable background
and foreground colors.
The software system redesign involves a software analysis system
which has been in place for several months. Although modifications are
needed, the system is very large and the design is such that modifications
to the existing code are very difficult. For this reason it was decided to
redesign the system using structured desigrt techniques in order to make
modifications and maintenance much more manageable than they are at
present. Current efforts are concentrated on the development of libraries
of low-level routines to handle the bulk of the device-dependent I/O
functions necessary in a system of this size. Final system development
should proceed rather qUickly after completion of the library primitives.

E-8.

Maximum-Likelihood Estimation Applied to Electron-Microscopic
Autoradiography

Personnel:

M.
K.
J.
D.
L.

I.
B.
E.
L.
J.

Miller, BCL
Larson, BCL
Saffitz, M.D., Pathology
Snyder, BCL
Thomas, Jr., BCL

Support:

RR 01380
Washington University

For electron-microscopic (EM) autoradiography thin tissue sections
containing beta-emitting radioactive material are overlayed by a
crystalline layer of emulsion. Beta particles leave the tissue sections
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and pass through the emulsion layers where they give rise to latent images
which are subsequently developed into silver grains. The unused emulsion
is dissolved. leaving final specimens consisting of thin sections
containing silver grains. the positions of which are a function of the
distribution of radioactive tracer in the underlying tissue sections. The
production of these autoradiographs at the electron microscopic level is a
technique of growing importance as the tracer distributions offer a wealth
of information about the sites and activity levels of metabolic and
pharmacologic processes of the subcellular organelles. We have developed
new algorithms for localizing and quantifying. within ultrastructural
features. the radioisotope source distributions which are reflected in the
observed silvep grain measurements.
The quantitative analysis of EM autoradiographs used for identifying
the distribution of radioactive sources must be a statistical one because
of the nature of radioactive processes and the low number of radioactive
events involved. Due to the nature of the radioactive emission spread. it
is not possible to assume a priori that a particular silver grain
originated from radioactivity in the particular organelle over which it
lies. Analytical methods taking both emission spread and cellular anatomy
into account are essential for estimating the relative concentrations of
tracers in various cell compartments. One such analysis is the mask
analysis technique of Salpeter and Bachmann' which may be used with the
computer algorithm of Land and Salpeter. 2 The mask-analysis algorithm
utilizes a set of transparent plastic overlays (masks) containing 288
equally probable source-grain pairs. each denoting the relative
hypothetical positions of a point source of radiation and a silver grain
resulting from that point source. The hypothetical source-grain pairs are
generated from a grain-distribution point-spread function that is
characteristic of a given autoradiographic system and depends upon
variables including isotope type. section thickness. emulsion type and
thickness. and photographic parameters.,.3 The masks are manually placed
over individual photographs and the tissue structures over which
hypothetical source-grain pairs occur are recorded. The information
derived from the mask technique defines the relative sizes and
juxtapositions of the tissue structures and is utilized to generate a table
of transition probabilities which we call P(mli). All the algorithms
proposed to date are similar in that they require this table of transition
probability estimates (Blackett and Parry4 call them cross-scatter
estimates; Williams 5 ca ll s them cross-fire estimates; Salpeter and
coworkers 3 call them source-to-grain probability pairs). The transition
probabilities p(mli) may be viewed as an estimate of the probability that a
given disintegration occurring in one structure i may give rise to a silver
grain measurement within some structure m.
Once the table of transition probability estimates has been
generated. the silver grain measurement statistic N~in each organelle may
be computed using the circle method of Williams.~ The silver grain
statistic Nm is generated by combining across all of the micrograph slices
the number of silver grains located in a particUlar organelle structure m.
So that the Nm statistic becomes approximately Gaussian. there should be at
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least 8-10 silver grains measured in anyone organelle type. The Land and
Salpeter routine minimizes the sum of the squared errors between the actual
silver grain measurement statistics Nm and a linear weighted sum of the
hypothetical estimates of the underlying sources of radioactivity. The
squared-error statistic that is minimized is generally assumed to be
Chi-squared, and it is for this reason that experiments are designed so
that there are a minimum of 8-10 silver grains in anyone organelle. The
distribution of radioactive-source estimates that minimizes the squared
error statistic becomes the best guess of the distribution of the
underlying radioactivity.
One of the important features of the mask-analysis algorithm is that
data derived from anyone micrograph are not preserved and processed
individually for each EM slice. Rather, the silver grain measurement
points are added within anyone organelle structure across all of the
slices to generate the single measurement statistic Nm• Also, the
transition probabilities are generated not for each slice geometry
separately, but rather by applying to all of the different micrographs the
mask method and then averaging these together to get estimates of the
transition probabilities. It occurred to us that since the geometry of
every EM slice is different, algorithms'which use the EM data obtained from
each micrograph separately, may have a higher performance than those
algorithms which average the measurement points together. Also, in using
the mask method there are many overlays which must be applied to the large
number of micrographs in order to obtain estimates of the transition
probabilities. The errors in the radioactive-intensity estimates are due
partly to statistical variations in the table of transition-probability
estimates. These vary due to the random nature of the micrograph
geometries and the limited sampling of the hypothetical source-grain pairs.
Another issue which is of concern to us is that the mask method must be
modified as the geometries of the cellular organelle structures change. 6 ,7
Of particular difficulty are linear source compartments like cell
membranes. Modifications to the point-spread function and mask setup must
be included for proper utilization of the mask-analysis algorithm. 7
From our study we have identified an algorithm using the technique
of maximum-likelihood estimation based on Poisson emission and measurement
statistics. Unlike present algorithms, our's uses knowledge of the number
of measurements as well as the particular source geometry from which these
measurements arose and then processes the data from each micrograph
separately rather than the summed count statistic Nm• It maximizes the
likelihood function of the data based on a recursive algorithm which is a
nonlinear functional of the observed data and requires no minimum data
collection in order for it to provide valid estimates of the radioactive
intensities. Our algorithm does not use the mask analysis, nor does it
generate the table of transition probabilities; what it requires is the
form of the universal point-spread function describing the beta-particle
emission spread. The maximum likelihood estimation scheme does not depend
on the source geometries; particular geometries are included as side
constraints.
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The new maximum-likelihood algorithm which we have developed for
analyzing electron-microscopic autoradiographs is based on maximizing the
likelihood of observing the data by using a recursive procedure first
introduced by Dempster, Laird and Rubin. 8 This approach was then used by
Shepp and Vardi 9 and Snyder and coworkers 10 ,11 for estimating radioactivity
distributions in positron-emission tomography. The method we propose
utilizes information about the detected locations of the silver grain
measurements to which the probability-density function representing the
measurement uncertainty resulting from emission spread is applied. The
algorithm then recursively computes the most probable locations of the
radioactive sources based on the maximum-likelihood method of statistics.
The universal curves worked out empirically by Salpeter and coworkers 1 ,3
and analytically by us for isotopes used in autoradiography are used to
describe the probability density of the measurement uncertainties. It
exploits the a priori knowledge that we obtain from source modeling of the
silver-grain emissions and measurements; i.e., the Poisson statistical
distribution of the emissions and the limit in measurement precision due to
the finite silver-grain size and image spread. The results indicate that
the data-acquisition requirements for the maximum-likelihood algorithm are
more extensive than those necessary for the mask-analysis algorithm,
although our method does lend itself to computer-assisted data acquisition.
The wide variation in geometries in the different micrographs dictates that
the measurements from each micrograph slice must be processed individually
before estimates of the radioactive intensity within particular structures
are derived from the array of micrographs.

1.

M. M. Salpeter, and L. Bachmann, "Autoradiography," in Principles and
Techniques of Electron Microscopy, Biological Applications, M. A.
Hayat, ed., Van Nostrand Reinhold, New York, 1972.
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B. Land, and E. E. Salpeter, "Basis for Computer Program for Mask
Analysis of EM Autoradiographs," Journal of Cell Biology, vol. 76,
p. 142, 1978.
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M. M. Salpeter, F. A. McHenry, and E. E. Salpeter, "Resolution in
Electron Microscopic Autoradiography - IV; Application to Analysis of
Autoradiographs," Journal of Cell Biology, vol. 76, pp. 127-145,
1978.

4.

N. M. Blackett, and D. M. Parry, "A New Method for Analyzing Electron
Microscope Autoradiographs Using Hypothetical Grain Distributions,"
Journal of Cell Biology, vol. 57, p. 9, 1973.

5.

M. A. Williams, "Electron Microscopic Autoradiography:
Its
Applications to Protein Biosynthesis," in Techniques in Protein
Biosynthesis, P. N. Campbell and J. R. Sargent, eds., vol. 3,
Academic Press, London and New York, 1973.
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-131

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I

7.

M. M. Salpeter, C. D. Smith, and J. A. Matthews-Bellinger,
"Acetylcholine Receptor at Neuromuscular Junctions by EM
Autoradi ography Using Mask Analysis and Linear Sources," Journal of
Electron Microscopy Techniques, vol. 1, pp. 63-81, 1984.

8.

A. D. Dempster, N. M. Laird, and D. B. Rubin, "Maximum Likelihood
from Incomplete Data Via the EM Algorithm," Journal of the Royal
Statistical Society, vol. B-39, pp. 1-37, 1977.

9.
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Emission Tomography," IEEE Transactions on Medical Imaging, vol.
MI-1, pp. 113-121, 1982.
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D. L. Snyder, and D. G. Politte, "Image Reconstruction from List-Mode
Data in an Emission Tomography System Having Time-of-Flight
Measurements," IEEE Transactions on Nuclear Science, vol. NS-30,
pp. 1843-1849, 1983.
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E-9.

Maximum-Likelihood Estimation of Auditory Nerve Fiber Responses

Personnel:

M. I. Miller, BCL
W. R. Bosch, M.S., Computer Systems Laboratory
C. E. Molnar, SC.D., Computer Systems Laboratory

Support:

RR 01380
GM 07564
RR 01379

Many investigators have inferred details about intra-cochlear
mechanisms by collecting data from the responses of single cochlear nerve
fibers. These histograms are in general distorted by the existence of
neural refractoriness; that is, the occurrence of a spike decreases the
likelihood of a succeeding spike. Gray 1 demonstrated that the relative
frequency of discharge conditioned on the time r since a previous spike
rises monotonically with r and levels off after 20-25 msec. Gray
interpreted this as indicating a gradual recovery of the nerve fiber's
excitability over an approximately 25 msec interval following a spike
discharge. He concluded that the conventional PST histogram reflected the
combination of both the characteristics of the stimulus related function
and the refractory characteristics of the nerve fiber resulting in the
observed recovery effects. More recently, Gaumond and coworkers 2 have
demonstrated significant differences between post-stimulus-time (PST)
histogram estimates and estimates of the stimulus related function which
have compensated for the recovery based distortion. Johnson and Swami 3
have shown that for simulated point-process models of neural discharge

-132

which contain recovery functions that are similar in form to those measured
by Gray and Gaumond, distortion is introduced that depends on both the
signal being estimated and the recovery function.
For any studies which formulate mathematical and physical models of
the cochlea based on neural discharges, it would be desirable to have
histograms for which the recovery related distortion has been removed.
Gaumond has developed and applied a method for this compensation by
separating post-spike recovery from the important stimulus related function
that results from intracochlear mechanics. His model for neural discharge
basically contains two components. The first results from the excitation
of the fiber, which is closely related to the mechanical motion of cochlear
structures and the resulting action of the hair cells. The second
component is related to the refractory properties of the nerve fiber and
results in the neurons demonstrating recovery effects; i.e., an increase in
the probability of discharge as the time since the previous spike
increases. He denotes these functions as set) and r(r) respectively and
demonstrates that a reasonable model for the probability of discharge of
the nerve fiber at time t is the product of these two functions. From this
model, estimates can be derived for the set) and r(r) functions separately
by maximizing the joint likelihood equations of having observed the neural
event process. The likelihood equations of Gaumond that arise are based on
a Markov-chain model of neural discharge in which the probability of
transition from a state in the Markov-chain is dependent on both the
acoustic stimulus during that time (s(t» and on the time since the
previous discharge of the nerve fiber (r(r». The equations that must be
maximized are quite complex and to date a closed form solution for both
set) and r(r) has not been identified. In order to get explicit estimates
of the stimulus related function set) from the likelihood equations,
Gaumond first obtains separately derived estimates of the recovery function
r(r), and than maximizes the equation with respect to set) based on the
previous estimate of r(r).
Under the assumptions of the Gaumond model for separating the
refractory related aspects of neural discharge from their time-varying rate
of discharge due to the applied stimulus, Johnson and Swami 3 have taken an
alternative approach to solving for the maximum-likelihood estimate (MLE)
of set). Assuming an a priori knowledge of the recovery function r(r) they
have derived the likelihood equation of the observed histogram based on an
intensity description of the point process. The key concept for this
alternative approach is that the Markov-chain can be considered as a
self-exciting point-process in which the intensity depends on response of
the nerve fiber. Following Johnson's previous work,4 Johnson and Swami
compute what they call the "maximum-likelihood PST histogram" of the
responses of a model neuron to a periodic stimulus which compensates for
the distortion introduced by the relative refractoriness of neural
discharge. They define relative refractoriness to occur when the recovery
function is known and is non-zero for all r, they show their histogram
estimate to be an unbiased estimate of set); Johnson and Swami conclude
that the distortions introduced by relative refractory effects are removed.
They note, however, that this technique can not remove the effects of
absolute refractoriness (i.e., the distortion introduced when the recovery
function r(r) is zero).
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The new approach which we have established has been motivated by the
joint estimation equations of Gaumond under the condition that there is not
a separate a priori knowledge of the recovery function r(r). If in
different nerve fibers and under varying stimulus conditions the recovery
function changes ,then an algorithm based on an a priori knowledge of r(r)
derived from a previous estimation procedure is unacceptable. A scheme
which from a single data set collected under a single stimulus condition
provides estimates for the recovery function r(r) and the stimulus
dependent function s(t) jointly is therefore invaluable. In order to solve
the likelihood equations for s(t) and r(r) simultaneously when the recovery
function is not known, we have formulated the estimation problem using an
intensity description. This approach has allowed us to independently
verify the MLEs derived by Gaumond and coworkers 2 under conditions when the
recovery function is known. By maximizing the likelihood-function with
respect to s(t) under the constraint that the stimulus-related function
s(t) is periodic we have also been able to derive estimates of the
stimulus-dependent cochlear output function which does not suffer from
absolute recovery related distortion in the same way as Johnson and Swami's
recovery corrected PST histogram does. The technique of deriving MLEs
subject to constraints, has been recently used and elaborated by Snyder. 5
Finally, by adopting an intensity description of the process we have been
able to adopt a recursive algorithm, introduced in the statistics
1 i terature as the "EM" algorithm, 6 for der i ving the maximum-likel ihood
estimates of both the stimulus related function s(t) and the recovery
related components in the response histograms.
We are excited about the suitability of the recursive algorithm for
the removal of the distortion in cochlear histograms under conditions when
the recovery function is unknown. This algorithm has been studied
extensively for maximum-likelihood estimation in positron-emission
tomography and has desirable global convergence properties. For maximizing
the exponential family (Poisson as an example) of likelihood equations the
recursive algorithm will in general converge. We show that under very mild
conditions a unique maximizer of the likelihood equations arising from
neural refractoriness exists and starting from any initial estimate the
recursive algorithm will converge to that maximizer.
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An Automated System for the Monitoring of Patients with Epidural
Electrode Arrays
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M. Gregorie, M.D., Neurological Surgery
Lombardo, B.A., Neurological Surgery
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The purpo~e of this project as detailed in PR 18, E-14 and PR 19,
E-9 is to develop a system which will permit simultaneous recording of the
EEG and somatosensory evoked response (SER) from patients in whom epidural
electrode arrays have been implanted for the purpose of localizing an
epileptogenic focus.
The CAESER system (computer-aided extraction of somatosensory
evoked responses) consists of a sixteen-channel EEG amplifier, a
sixteen-channel analog-to-digital converter, a Digital Equipment
Corporation (DEC) MINC microcomputer, and a video module which displays the
evoked responses on standard television monitors.
Initially, the CAESER system used the sixteen Grass Instrument Company 8A5
EEG amplifiers in our EEG machine. This meant that the EEG machine could
not be used to monitor the patient for seizures while SERfs were being
acquired. In August 1983, sixteen Grass Model 12 Computer Interface
Amplifiers were installed in the CAESER system, making it possible to
obtain patient SERs while simultaneously monitoring the patient for
seizures.
During the past year, a number of improvements were made to the
original version of the software. The user is now able to view the signals
coming from the EEG amplifiers on the CAESER displays, so that adjustments
can be made to the amplifier settings before the acquisition of SERs
begins. The software variables which the user sets for each run are now
reported in a clearer fashion, new informational messages have been added
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at several points, and error messages have been expanded and clarified. In
addition, the MINC's original LSI-11/02 processor was replaced with a
DEC LSI-11/23, resulting in a noticeable improvement in system performance.
The system has been used to gather SER data from ten patients since
December 1982. In four of these cases, SERs were obtained simultaneously
with seizure monitoring.
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F.

Resource Development Activities

Resource development activities are those which contribute to the
goals of more than one major program of the laboratory, address the needs
of individual users who can benefit from the expertise of the BCL staff and
the inventory of computing and specialized test equipment, or identify new
technologies which may become appropriate foundations for new experimental
tools. Service to users does not follow the usual computation-center
pattern with an established fee schedule and a highly centralized facility.
Rather, senior laboratory staff members consider requests for assistance
from investigators who must address a particular biomedical computing
problem. If an appropriate technology eXists, investigators may be
referred to commercial vendors or fee-for-service organizations when these
are available. In other cases, problems may be approached by the
laboratory provided that the effort complements other activities of the
laboratory. Many times the project can be assigned to a staff member with
appropriate experience and completed in a short time. The investigator
then has his or her results, and a short note describing the work will
appear in the annual report and perhaps the open literature. A few
projects, however, may develop into major initiatives within the
laboratory. Most of the major projects began in this fashion and the
opportunities that supporting activities provide are valued.
The broad spectrum of projects reported on in this section may be
categorized as biomedical applications, system development aids, digital
hardware designs, and ad hoc studies. The biomedical applications
represent new initiatives in which basic explorations are being conducted,
some having potential for becoming major, long term programs.
System development aids primarily benefit BCL staff, but may also be
used by others. Examples include microprocessor development support,
RSX-11 system enhancements and extensions to the MASSCOMP raster graphics
workstation. System software developments reported here also are widely
utilized in a variety of projects.
Many digital hardware designs are one-time, special purpose
projects. Others may have wide appeal and construction of multiple copies
is envisioned, examples being the TERRANET local network and the image
buffer.
The topics of the studies reported in this section are quite varied.
Some are theoretical and address a highly specific problem; others are more
properly thought of as feasibility studies.
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F-1.

Microprocessor Development Support

Personnel:

S. M. Moore, BCL
R. E. Hermes, BCL
S. R. Phillips, BCL

Support:

RR 01380
HS 03792

Locally developed FORTRAN-based cross-assemblers (FOCRAS) and
intelligent consoles continue to play important roles in hardware and
software development activities for 8-bit microprocessor-based systems.
Porting of FOCRAS to a PDP-11/RSX system was completed and verified by
transferring TERRANET software from a TI-980 to the RSX system. Future
software will be done under RSX, FOCRAS support on the TI-980 system will
be discontinued.
Program development support for 16-bit Motorola M68000 (M68K) exists
in many forms. The UNIX V7 operating system has been ported to the M68K
based VERSAmodule system (F-8) which supports program development.
C language programs can be entered, compiled and run directly on the
system. C language compilers and cross-assemblers also exist on both PDP
11/34 and VAX-750 systems for developing stand-alone software for the M68K.
Computer controlled PROM programming capabilities are currently
limited to 2 Kbyte EPROMs using the Intelligent Console and current FOCRAS
software. Larger EPROMs ·can be programmed by reading and concatenating
data from several smaller PROMs and then transferring to larger PROMS using
the DATA I/O universal PROM/PLA programmer. The Data I/O programmer will
be integrated into the FOCRAS system under RSX to allow larger PROMS to be
programmed automatically.
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F-2.

Information Systems Group

Personnel:

J.
G.
S.
S.
L.

R.
J.
M.
R.
J.

Cox, Jr., BCL and Computer Science
Blaine, BCL
Moore, BCL
Phillips, BCL
Thomas, Jr., BCL

Support:

HS 03792
Washington University

The Information Systems Group provided the collaborative structure
within which participants from the Department of Computer Science, the
Computer Systems Laboratory, the School of Medicine, and the Biomedical
Computer Laboratory addressed the development of a methodology for the
design of composite medical-information systems.
The development
activities were divided into four major categories: model, design studies,
implementation and Neonatology Database. The more theoretical portions of
the work on a design methodology fall in the first category and the more
applied tasks in the second. The Neonatology Database provided a relevant
context for testing concepts, models and implementations.
The primary goals of the group, supported by the NCHSR research
grant HS 03792, are now complete. The accomplishments are summarized here
for reference:
1)

a powerful data model, ADS;

2)

implementation of a data language consistent with the ADS
model;

3)

experiments with special hardware implementations for ADS
memory;

4)

testing in a clinical database application;

5)

performance studies of three software implementations of ADS;

6)

demonstration of ADS as an intermediate language for database
translation.

A final report contains specific details of these accomplishments
and future plans. 1

1.

J. R. Cox, Jr., and K. F. Wong, "A Medical Information Systems Design
Methodology," HS 03792 Final Report, July 1984.

-139

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I

I

'I

~

F-3.

Studies in the Design of a Coprocessor for Pattern Matching

~'I

Personnel:

S. M. Moore, BCL
G. J. Blaine, BCL
J. R. Cox, Jr., BCL and Computer Science

t.·····;I·

Support:

RR 01380
HS 03792
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A version of ADS was implemented in C under UNIX to provide
experimental tools for:
1)

studying the feasibility of implementing a truly usable version of
the ADS data model,

~L -

l

2)

gathering initial workload and performance data to use as a guide
for the design of a production version and customized hardware,

r'~;;'1
l!:~:

3)

trying different algorithms, and

.'(I

4)

studying software portability issues.
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Examination of the performance of the ADS system suggested that a hardware
pattern matcher might be necessary to speed operation in a production
version of ADS. An algorithm was found which allows the data to be
searched in time that is linear with the size of the data, and several
archi~ectures for implementing this algorithm were studied.
One
architecture·was used as the basis for a processor which was designed and
built using commercially available integrated circuits and wire-wrap
technology.
•

~·.I•
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The search processor serves as a coprocessor in the Motorola M68000
(M68K) VERSAbus system (F-8). In addition to the search processor, a dual
ported memory was built to provide I/O for the processor. One port can be
accessed by the M68K system through the VERSAbus and the other by the
search processor.
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A simple data retrieval system was designed on the M68K system using
the pattern matcher as the search mechanism. A similar system was built
which implemented the search algorithm in software. Comparisons between
the two systems showed that the hardware search was 500 to 1200 times
faster than the software search on the M68K. The pattern matcher searched
memory 85 to 180 times faster than the ADS implementation on a VAX-750 on a
per node basis. Other comparisons showed the speed of the pattern matcher
to be nearly eqUivalent to the speed of other hardware-based searchers. 1

>t~":

,'r··1

f{

1.

S. M. Moore, "A Pattern Matcher for Searching Binary Trees," Master
of Science thesis, Department of Electrical Engineering, Washington
University, St. Louis, Missouri, May 1984.
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F-4.

An Experimental Local-Area Network:

Personnel:

S.
G.
J.
R.
S.
D.
D.

M.
J.
R.
E.
R.
F.
A.

Support:

RR 01380
Computer Services Corporation
Washington University

TERRANET

Moore, BCL
Blaine, BCL
Cox, Jr., BCL and Computer Science
Hermes, BCL
Phillips, BCL
Sandel, BCL
Schwab, BCL

In the past year, TERRANET has gone from a successful experiment in
local-area networking to an important part in the day-to-day operations of
BCL. TERRANET provides terminal-to-computer and computer-to-computer
communications for most of the time-sharing computer systems in the
laboratory. The current network configuration utilizes each of the
possible 30 stations. These stations include 15 terminals, 11 computer
connections to 7 different machines, and 4 modem or other network gateway
connections. Usage of the network is quite heavy and has indicated that
the overall number of stations in the system should be increased. Design
studies are now in progress to determine how best to realize this increase.
Possibilities include a second TERRANET network or increasing the number of
stations on the current network by increasing the capacity of the network
or by decreasing the data rate per channel.
No major revisions have been made in the hardware configuration of
tap units or insert units. Minor changes were made to one tap unit with
appropriate changes in software to facilitate modem control. Several more
general software changes were made to improve flow control in tap units
connected to modems, terminals, and serial printers. Other software
modifications were done for an experiment which demonstrated that TERRANET
could be connected to and implement the protocol of the GANDALF switch at
the main computing facilities on the Hilltop Campus. All TERRANET software
was moved from the TI-980 system to the PDP-11/RSX system to take advantage
of better software development and backup utilities available under RSX.
Experiments for integrating voice with data communication on the
network were conducted using the test bus (PR 19, F-6). Three tap units
were modified to accommodate the voice transmission. Two units were used
for communication while the third unit was used to monitor the network and
to evaluate the stability of the system. Initial results show that voice
communication is possible with the current design, but more revisions may
be necessary to decrease noise and the cost of the tap units.
Higher level software to provide network services is currently being
developed. A PDP-11/UNIX system will be used to monitor network activity.
Station-to-station connect time will be measured and used to determine
future tap unit allocation as the TERRANET system expands. 'UNIX file
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transfer utilities were modified at the Hilltop Campus to recognize
TERRANET and will be used at BCL. Software is currently being developed to
allow file transfer between RSX- and UNIX-based systems over TERRANET
channels.

F-5.

Inter-System Communication for Data Transfer

Personnel:

G.
J.
K.
R.
E.
M.
D.

J.
D.
H.
E.
W.
I.
W.

Blaine, BCL
Gorman, BCL
Haserodt, M.S., Computer Science
Hermes, BCL
Kiebler, M.S., Computer Systems Laboratory
Miller, BCL
Stein, Jr., BCL

Support:

RR 01380
Washington University

A working group was formed to discuss mechanics for data transport
between various host computing systems, within our local Resource. Media
transfers (9-track magnetic tape, floppy disk, and hard disk) have been
primarily used for this purpose.
The following types

of information exchanges were identified:

1)

binary d;ta files to support acquisition analysis and display of
medical images;

2)

electronic mail for both campus and national collaborators;

3)

remote program execution to allow data submission, application,
execution and remote harvesting of results.

The most immediate needs are based on system resources which include,
VAX-11/750, 4.2BSD UNIX; VAX-11/750, VMS; PDP 11/34, 4.2BSD UNIX;
PDP-11/34, RSX-11; LSI-11/23, RT-11; and MASSCOMP 500, UNIX-masscomp. A
concensus suggested a first level solution to be based on the following
design:
Physical Layer

serial, 9600 bps, asynchronous, RS-232, full
duplex;

Data Link Layer = small packets, error detection and retransmission.
UNIX uucp services provide sufficient flexibility for data transfers
between UNIX systems, likewise, DECNET is a proven means for communication
between DEC operating systems. However, the local predominance of both
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UNIX and RSX-11M necessitates a data transmission link between these
systems as welL
The RSX-11M terminal driver was studied to determine the feasibility
of implementing data transfers via serial communication lines on a
PDP 11/34. The driver was found to have limitations including input
character buffers of limited size (36 characters), and the need for system
interrupts on a character by character basis. Significant modification of
the terminal driver could circumvent these limitations so that efficient
block transfers of data could be accomplished. Alternatively, data
transfers of small data packets (less than 20 characters) seems practical
with no driver changes provided sufficient protocols are provided for data
transmission, verification and correction.
Recent acquisition of an inter-system communication software package
called KERMIT may also prove helpful. KERMIT has been used elsewhere for
communication between dislike systems, including RSX-11M, VMS, and UNIX.
This software is known to work for transmission of ASCII character data,
but tests are still to be conducted to determine its sUitability for binary
data transmission.

F-6.

A Picture Communication System for Radiology

Personnel:

G,
J.
J.
R.
R.
A.
S.
A.
C.

J. Blaine, BCL
C. Chabut, BCL
R. Cox, Jr., BCL and Computer Science
L. Hill, BCL and Radiology
G. "Jost, M.D., Radiology
Kumar, B.Tech., Radiology
R. Phillips, BCL
P. Rueter, B.S., Radiology
D. Shum, BCL

Support:

RR 01380
RR 01379
Mallinckrodt Institute of Radiology
Washington University

A pilot cable system to transport analog and digital radiology
pictures and support terminal-to-computer digital data transmission has
been designed and installed (PR 19, F-7, F-8). A dual-cable 400 MHz system
utilizes "off-the-shelf" cable television components to provide
approximately 50 channels, achieved by frequency multiplexing channels of
6 MHz each. The system provides a workbench environment for the evaluation
of commercial digital transmission equipment in addition to supporting
experiments related to digital picture networking and archiving studies.
The topology is illustrated in Figure 1.
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Figure 1. PACS workbench picture network block diagram illustrating topology
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-144

Over the past year, studies and subsequent designs have been
directed at communicating radiological images using channels based on
frequency division of the 400 MHz channel. Multiple shared
transmit/receive channels were shown to have favorable cost-delay
characteristics. 1 Most of the MIR efforts (F-11) have been directed at
accessing and displaying images which are stored in a database, whereas the
focus of our activities has been upon the digital and analog transmission
and reception of images.
A variety of analog modulators and demodulators for both video
transmission and reception were obtained and have been tested to determine
their bandwidth limitations. 2 Such bandwidth limitations were demonstrated
to have a direct effect upon the transmission and reception of picture
detail.
The lack of readily available high-speed modems, at reasonable cost,
has fostered exploration of novel approaches to the problem. Two
approaches to greater than 1 Mbps rates are currently being explored. The
first utilizes commercial TV modulators and demodulators with a specialized
integrated circuit chip set developed for baseband digital communication
applications. The second is based on the extension of a product by a
recently formed data communications company. A pair of the proprietary
modems have been provided for one evaluation. In order to test these
digi tal communications schemes, a "bit error tester" has been des igned and
fabricated and is now under evaluation. Future digital tests will involve
consideration of bandwidth, phase, and multiple device effects.

1.

C. D. Shum, "Design Analysis of a Wideband Picture Communication
System," Master of Science thesis, Department of Computer Science,
Washington University, St. Loui&, Missouri, December 1983.

2.

J. C. Chabut, "Testing Modulator/Demodulator Frequency Response," BCL
Working Note No. 57, April 1984.

3.

J. R. Cox, G. J. Blaine, R. L. Hill, R. G. Jost, and C. D. Shum,
"Some Design Considerations for Picture Archiving and Communication
Systems," IEEE Computer, vol. 16, no. 9, p. 41, August 1983.
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F-7.

Data Compression Studies

Personnel:

J. G. Dunham, BCL and Electrical Engineering
S. E. Elnahas, M.S., Electrical Engineering
R. G. Jost, M.D., Radiology

Support:

RR 01380
RR 07054
Mallinckrodt Institute of Radiology
Washington University

In radiology, the introduction of new technology has increased the
number of images stored in digital form. Most studies are still recorded
on film, but digitally generated examinations are becoming more common.
Typically, digital exams have a greater number of images per study, so that
half the images produced in some departments today are already generated in
digital form. This trend toward digital imaging in radiology will continue
and should accelerate as conventional examinations find their way into
digital form. As radiologists turn their attention to problems associated
with storing and transmitting these digitally generated images, the need
for data compression will become increasingly important.
A wide spectrum of images is found in a radiology department. The
differences among modalities are significant enough to suggest that
different data compression techniques may be appropriate for different
image classes. In order to study the differences among and within various
image modalities, we have developed 1 an extensive database of digital
diagnostic images for general compression studies. Thirteen different
classes of images are included in the database to represent several imaging
modalities including CT, nuclear medicine, ultrasound, and MRI.
In a preliminary investigation (PR-19), the major classes of data
compression were reviewed with respect to their suitability for picture
archiving and communication systems (PACS) in radiology.
In
PACS
environment, noisy compression provides high compression ratios (20:1,
30:1). The distortion introduced by noisy compression techniques has yet
to be evaluated clinically for different classes of radiological images and
diagnostic modalities. On the other hand, noiseless compression provides
perfect image reproductions with low compression ratios (2:1, 3:1). We
have investigated 1 the possibility of reducing the gap of compression
ratios between noisy and noiseless systems. The compression limits of
linear predictive coding, when followed by entropy coding, are determined
by estimating the noiseless compressibility of the input images.
Arithmetic coding as well as Huffman coding are considered for the entropy
coding part. Formulation of the problem of designing optimal linear
predictors has been studied and solutions discussed. In general, linear
least squared-error (LLSE) predictors do not necessarily minimize the
entropY-of the predictive coder output. However, the performance of most
fourth-order predictors is very close to that of optimal predictors. For
LLSE prediction. there is no need to consider predictors of order higher
than four for all of the image classes in the database. This is an
important result when considering the practical implementation of LLSE

a
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predictors. The use of image training sequences for the design of LLSE
predictors has been proven experimentally to be successful and the results
obtained when predictors are used outside the training sequences are
promising. On the average, one can expect compression ratios between 2.0:1
and 6.3:1 from systems employing arithmetic cOding while one can expect
ratios between 11.7:1 and 3.8:1 from systems employing Huffman coding.
With nonlinear block predictive coding, we have combined 2 noisy and
noiseless compression systems in a novel way that may have a potential
impact on the PACS environment.
The approach does not ignore the
investment in noisy compression systems that can provide attractive high
compression ratios. It may also provide a technical solution to the
sUitability issue, from a clinical standpoint, of noisy compression systems
by allowing a means for perfect reproduction of the input images. We have
investigated the application of adaptive fast discrete cosine transform
CAFDCT) coding to compression of-MRI and CT images. The subjective quality
of image imperfect reproductions from the AFDCT system, at a code rate of
one bit/pixel, is very promising and prompts future research on the
transform coding of diagnostic images and the clinical evaluation of these
systems. The off line storage requirements for archiving MRI and CT images
are reasonably reduced by the noiseless block nonlinear predictive coding
system. The on line performance, however, seems to be bounded by that of
linear predictive coding. We conjecture that, linear systems using
predictive coding techniques, determine the noiseless compressibility of
diagnostic images in radiology.

1.

S. E. Elnahas, R. G. Jost, and J. G. Dunham, "Compression of Digi tal
Diagnostic Images in Radiology," Proceedings of the ACR 8th Conference
on Computer Applications in Radiology 1984, St. Louis, Missouri,
May 23-25, 1984, in press.

2.

S. E. Elnahas, "Data Compression," D.Sc. Dissertation, advisor:
J. G. Dunham, in preparation.

F-8.

M68K/VERSAbus Hardware Support

Personnel:

S. M. Moore, BCL
K. H. Hasero dt, M.S., Computer Science

Support:

RR 01380
HS 03792

The M68000-based VERSAmodule system was used as the host system for
running pattern matcher experiments (F-3). As previously reported CPR 19,
F-10), the system is capable of running the UNIX V7 operating system. User
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access is gained through two serial ports, one connected to a terminal as
the console and the second connected to TERRANET.
Minor modifications were made to the VERSAmodule system to
accomodate the pattern matcher. A dual-ported memory was designed and
interfaced to the system through the VERSAbus.
A PLA on the VERSAmodule
computer board was changed to allow the system to recognize the additional
memory. The pattern matcher interfaces to the M68K system through a
parallel port which already existed on the VERSAmodule computer board. The
parallel interface is used only for control information; all data are
transferred between the VERSAmodule system and pattern matcher through the
dual-ported memory.
When not used for pattern matcher experiments, the dual-ported
memory can be used as data space for user programs. The memory is placed
outside of the normal UNIX address space and can only be addressed when a
user program informs the system of its presence. The memory is not
designed to respond to byte references and so can only be used by programs
which access the memory on a word (16 bit) basis.

F-9.
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Systems Support for Programming and Image Processing

Personnel:

R.
S.
S.
R.
S.
D.

E. Hermes, BCL
Husodo, BCL
M. Moore,BCL
J. Paisley, BCL
R. Phillips, BCL
W. Stein, Jr., BCL

Support:

RR 01380

Hardware and software support of programming and image processing
continues to be an important Resource activity (PR 19, F-11). Most of our
scientific programming is supported by a PDP 11/34 running RSX11M. The
system is configured with disk and tape storage devices which are
predominant in the local computing community. This allows for data
transfers from other research labs to the BCL via a common magnetic storage
media. The system also includes a Lexidata 3400 color display system with
a resolution of 640 by 512 pixels. Recent development of easy to use
display software on this system has simplified the common problem of image
display after the data is processed on the system.
The system, although limited in memory and computational capacity,
supports several simultaneous users doing program entry and debugging.
Programs which require large amounts of system resources are run as
background processes, often overnight. Programs which require extensive
machine time can be run on a second PDP 11/34 running RSX11M. This second
processor is available to run RSX11M or UNIX depending upon user needs.
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Additional computer and display capability is provided by a MASSCOMP
MCS-500 system (F-10). Efforts are underway to provide means for data
transfer between all systems via serial communication (F-5). Display
utilities similar to those used on the Lexidata are being developed so that
a comparable user environment exists on both image display systems.

F-10.

MASSCOMP Workstation System

Personnel:

R.
G.
K.
S.
R.
F.

E. Hermes, BCL
J. Blaine, BCL
H. Haserodt, M.S., Computer Science
Husodo, BCL
J. Paisley, BCL
U. Rosenberger, BCL, and Computer Systems Laboratory

Support:

RR 01380

To further develop image processing support, the laboratory has
acquired a MASSCOMP MCS-500 system. The MASSCOMP system is based upon a
Motorola 68000 processor capable of running UNIX System III. With a
benchmark performance comparable to that of a VAX 11/750, the system can
support a number of simultaneous users as well as support many of the
computational needs of those doing image processing and display.
The system employs two 10 MHz 68000 processors in the CPU and for
IIO control. The CPU resides on a proprietary system bus with one megabyte.
of system memory which may be expanded to six megabytes. The system bus is
extended to a industry standard Multibus which can support many different
peripheral controllers as well as being suitable for interfacing locally
designed subsystems or specialized processors.
The current configuration consists of a chassis housing the system
busses and processor, a 27 megabyte Winchester disk, a 1 megabyte floppy
disk drive, and four serial communication lines. An additional 52 megabyte
Winchester disk will be added soon.,
A vast amount of software is available on the system, including a
large graphics and graphing library, a menu system called Quick Choice, and
all of the software development aids found in most UNIX systems. Efforts
are underway to provide system users with convenient methods for displaying
images and for communicating with other systems.
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F-11.

PACSV:

Personnel:

A.
G.
J.
R.
R.
A.

Support:

RR 01380
RR 01379
Mallinckrodt Institute of Radiology
Washington University

1.

It can store and display a 512 x 512 x 8 image.

2.

The image can be read from an input environment at a maximum
rate of just over 20 x 10 6 bits/sec. Tn other words, an image
can be read in approximately 100 milliseconds.

3.

An image can be transmitted from the PA CSV to an out pu t
environment at the same rate.

4.

Picture display is not interrupted by data reads or writes.

5.

PACSV can be configured to accept any input and output
environment by replacing the input module, the output module,
and a ROM chip. Two input modules have been designed, built,
and tested, with PACSV. One accepts a 9600 baud RS232 signal;
the other obeys a high-speed, 32-bit-parallel, synchronous
transfer protocol over a DR750 bus connected to a VAXll/750.

6.

The composite-video output of PACSV, capable of driving a
standard TV monitor, respects the ETA standard RS330 with only
two minor deviations.
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Kumar, B.Tech., Radiology
J. Blaine, BeL
R. Cox, Jr., BCL and Computer Science
L. Hill, BCL and Radiology
G. Jost, M.D., Radiology
P. Rueter, B.S., Radiology

PACSV (for Picture Archiving and Communication System Viewing
Station) was designed in the first quarter of 1983. During the year
reported here, a prototype was built to prove the design. PACSV addresses
the need for an inexpensive frame-buffer and viewing-station in the PACS
network that is taking shape at the Mallinckrodt Institute of Radiology
(MIR). Its performance specifications are as follows:

,I
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A 512 x 512 x 8 Image Buffer
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The PACSV chip-count is 92 integrated circuits (not including any
input or output modules). Of these, 32 are 64K dynamic RAMS with an access
time of 200 nanoseconds. The memory cost is $210 with the remaining chips
costing another $190 •
At the heart of PACSV lies a ROM-based controller, a very simple
microprogrammed machine that runs at 20 MHz and puts out a sequence of 32
control words every 1.5 ~sec. The following major functions are performed
by this cycle of 32 words:
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1.

Four 32-bit data words are read from the RAM frame-buffer, and
packed into synchronizing-buffer register files. These four
words are destined for display.

2.

Selected registers are opened in the synchronizing-buffer
register files to a digital-to-analog converter in the
video-generation circuit.

3.

A single 32-bit data word may be read from or written into the
RAM frame-buffer, for data I/O.

The ROM-based controller also generates the blanking and sync
signals for the video-generation circuit, and exchanges handshake signals
with the input and output modules. A Motorola MC68000 microprocessor is
used to initialize the system, and to conduct a dialog with the input and
output environments.

F-12.

Word Processing at BCL

Personnel:

Support:

R.
R.
R.
K.
. S.
G.
J.
P.
L.

E.
M.
J.
W.
A.
C.
W.
E.
J.

Hermes, BCL
Arthur, BCL
Bozesky, BCL
Clark, BCL
Gonzalez-Rubio, BCL
Johns, B.S., Computer Systems Laboratory
Matthews, D.Sc., Computer Systems Laboratory
Raith, BCL
Thomas, Jr., BCL

RR 01380

Approximately two years ago, a word processing committee was formed
to determine the word processing needs of the BCL and CSL. The committee
cataloged an extensive list of prerequisites for a word processing system
to support the technical and non-technical writing needs of the
laboratories. The committee reviewed available word processing systems to
determine whether any could meet our demanding and specialized needs.
Unfortunately, none were found suitable.
Within the past year, several circumstances, including the imminent
demise of our current word processing system, caused us to pursue the word
processing issue again. The prevalence of the UNIX operating system
prompted the search for a word processing system supported by UNIX. The
system chosen, called MUSE, has been installed for nearly three months on
the Institute VAX-11/750.
The MUSE system is capable of supporting dozens of different
terminals and printers. MUSE is a menu driven and function key controlled
system which provides what-you-see-is-what-you-get displays on the terminal
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screen. It supports superscripting, subscripting, greek/math symbols, and
underlining without the need for embedded control sequences found in most
other systems. A spelling check system employs the use of a master
dictionary, as well as dictionaries which can be user, site, or subject
specific. Easy to use mechanisms are provided to control text formats and
form generation. File management is part of the MUSE system, meaning that
users do not need to know the UNIX system to manage their file directories.
Output of documents is easily managed by MUSE, allowing the user to vary
fonts, character spacing, and output format at print time.
MUSE is a well documented, easily learned system. MUSE users have
found the system very powerful, yet simple to use. This progress report
was compiled and edited in our first extensive test of MUSE's
capabilities.
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VI.

INDUSTRIAL COLLABORATION

Industrial collaboration provides a mechanism for the deployment of
laboratory developments and benefits the staff by keeping abreast of the
practical considerations of reliability, maintainability, and cost.
The TERRANET system, which provides a simple low-cost interconnect
to support terminal-to-computer and computer-to-computer communications for
modest speeds (up to 9600 bps), is currently being produced and marketed in
Japan under a licensing agreement with Computer Services Corporation (CSK),
a major facilities management consulting firm headquartered in Tokyo. As
part of the initial agreement, CSK supplied two evaluation systems of 10
tap-units each for installation in the Computer Science and Electrical
Engineering Departments at Washington University. A follow-on research
contract with CSK provided partial support of development activities which
integrate voice and data transmission into the TERRANET system.
In conjunction with BCL
communications (F-6), Dr. G. James
for three months as a member of
Hewlett-Packard Laboratories, Palo

activities in picture archiving and
Blaine accepted an opportunity to serve
the Applied Technology Department within
Alto, California.

BCL has analyzed several tens of long-term ECG recordings for a
Mead-Johnson (Evansville, Indiana) sponsored "Multicenter Placebo
Controlled Study of Trazadone's Effects in Depressed Cardiac Patients."
Trazadone, a recently marketed antidepressant drug, is chemically unrelated
to the tricyclic antidepressants. Studies in animals showed few cardiac
effects, and ECG recordings in humans in initial clinical studies showed
few changes. More recent studies in humans examined the cardiac effects of
trazadone in patients with pre-existing cardiovascular disease and
depression. Many of these patients had good responses to depression with
minimal aggravation of their underlying cardiovascular condition, although
a small number of patients developed a change in ventricular ectopic
activity while on trazadone. However, due to the considerable interpatient
and intrapatient daily variability in ventricular ectopic activity and lack
of a placebo control group in these studies, it had previously not been
possible to conclusively attribute changes in ectopic activity to
trazadone. The current study is designed to address the issue of the
cardiac safety of trazadone. The study plans to enroll 160 patients among
8 clinical units. Four long-term ECG recordings per patient (over 2 weeks)
are sent to BCL for analysis. Results are interpreted by the study's
cardiologist, Roger Winkle, M.D., of Stanford University.
BCL personnel have worked closely with Biosensor Corporation
(Brooklyn Center, Minnesota) to implement Argus algorithms (A-1) in a
"real-time analyzer," a device to analyze the ECG rhythm of a patient who
wears the small device and goes about normal activities. The device uses
CMOS microprocessor technology powered with 5-day lithium batteries.
Counts and waveforms of significant events are stored for subsequent
telephone transmission (on demand or at suggested intervals) to a central
station which plots a report for the patient's physician. Biosensor

-153

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I

brought a prototype of their device to BCL a year ago for intensive side
by-side debugging; BCL personnel have visited Biosensor to observe first
hand their development, manufacturing, and marketing procedures.
Throughout the year, BCL has provided Biosensor with a variety of digitized
waveforms; Biosensor runs a digital waveform through their implementation
and returns to BCL beat-by-beat results; BCL then prints a condensed plot
of waveform and labels for proper evaluation.
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VII.

TRAINING ACTIVITIES AND SEMINARS

Training activities of the Biomedical Computer Laboratory are
directed toward the goals of informing the local and national scientific
communities about resource projects and facilities and of instructing a
broad spectrum of people in the application of advanced computer-techniques
to problems in clinical medicine and biological research. Training
activities include the teaching of formal courses at the School of Medicine
and the School of Engineering as well as supervision of graduate students
by Laboratory staff. Both individual and small-group training about
resource facilities are made available to the biomedical scientist.
National workshops and symposia on topics of interest and importance to the
resource and community are supported.
The bringing together of biomedical scientists, engineers, and
computer scientists provides important cross-fertilization between
disciplines. In these settings, students and staff find the need and
opportunity to test the relevance of theory and the usefulness of
technology in applications to real problems. Also, the biomedical
scientists are aided in learning new techniques for acquiring useful
information. To this end, some of the courses offered are addressed to
biologists without strong technical backgrounds who want and need a below
the-surface appreciation of biomedical computing. Laboratory personnel
also participate in regularly scheduled conferences in the clinical
departments where both the biological and technological issues are
examined.
Seminars and presentations relating to resource projects and
applications are conducted by Laboratory staff as well as scientists and
engineers from the national community. During the year the following
activities were supported:
Seminars
"Reconstruction Algorithm for
Time-of-Flight Assisted Positron
Emission Tomographs"
September 19, 1983

"A Description of the
Laboratory of Neuro Imaging"
November 22, 1983

David G. Politte
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri
Cosponsor: Department of Electrical
Engineering
Arthur Toga
Research Assistant and
Professor in Neurology
Washington University
St. Louis, Missouri
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"Coding of Speech in the
Auditory Nerve"
December 12, 1983

Michael I. Miller
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri
Sponsor: Department of Electrical
Engineering

"Toward the Prediction of
Protein Function and Structure:
Applications to Oncogene and
MHC Products"
April 5, 1984

Sponsor:

"The Future of Image Processing
at Lexidata"

Charles DeLisi
Laboratory of Mathematical
Biology
National Cancer Institute
Bethesda, Maryland
Institute for Biomedical
Computing
Dave Ellenberger
Lexidata Corporation
Waltham, Massachusetts

Apr il 19, 1984
"A Pattern Matcher for Searching
Binary Trees"

Steve M. Moore
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri

May 1, 1984

John Gorman
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri

"Experimental Evaluation of the
Maximum-Likelihood Method for
Reconstructing Radiotracer
Distributions in Positron
Emission Tomography"
May 10, 1984

John Ollinger
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri

"A Preliminary Evaluation of the
EM Algorithm for Estimating
Parameters in Dynamic Tracer
Studies"
May 17, 1984

Michael I.
Biomedical
Washington
St. Louis,

"Maximum-Likelihood Recon
struction for Electron
Microscopic Autoradiographs"
June 7, 1984
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Miller
Computer Laboratory
University
Missouri

Donald L. Snyder
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri

"Maximum-Likelihood Recon
struction for Single-Photon
Emission Computed-Tomography"
June 14, 1984

R. M. Arthur
Biomedical Computer Laboratory
Department of Electrical
Engineering
and
J. G. Miller
Biomedical Computer Laboratory
Department of Physics
Washington University
St. Louis, Missouri

"Recent Results in Quantitative
Ultrasonic Imaging"
June 21, 1984

John Chabut
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri

"Picture Transmission"
June 28, 1984

Russell E.
Biomedical
Washington
St. Louis,

"The MASSCOMP Raster Graphics
Workstation"
June 28, 1984

Hermes
Computer Laboratory
University
Missouri

Other Activities
"A Workshop for Cardiologists:
Personal Computers in Office
Practice"
August 8-12, 1983

"Mockingbird:
Amanuensis"

faculty included:
J. R. Cox, Jr.,
L. J. Thomas, Jr., and
K. W. Clark
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri
Sponsor: American College of Cardiology
held at: Bethesda, Maryland
video film presentation by
J. T. Maxwell III and
S. M. Ornstein
Xerox Corporation

A Composer's

November 8, 1983
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A Lecture Series in support of Biomedical Engineering 3/2 Intensive Course
Sponsored by the Program in Biomedical Engineering
Sever Institute of Technology
Washington University
Harold W. Shipton
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri

"Scope of Biomedical Engineering"
January 2, 1984

"Biomedical Instrumentation and
Transducers"

R. Martin Arthur
Department of Electrical
Engineering
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri

January 3, 1984

"Computers:

G. James Blaine
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri

Technology and Scale"

January 4, 1984

Lewis J. Thomas, Jr.
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri

"Computers, Cardiologists and
Cardiograms"
January 5, 1984
"An Engineer Looks at the Brain"
and "New Techniques in EEG""

Harold W. Shipton
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri

January 7, 1984

Kenneth B.
Biomedical
Washington
St. Louis,

"Physical Principles of Tracer
Kinetics in Biological
Applications"

Larson
Computer Laboratory
University
Missouri

January 12, 1984
"Biophysical Measurements"

Harold W. Shipton
Biomedical Computer Laboratory
Washington University
St. Louis, Missouri

January 14, 1984
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